<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Explor Res Clin Soc Pharm</journal-id><journal-id journal-id-type="iso-abbrev">Explor Res Clin Soc Pharm</journal-id><journal-id journal-id-type="pmc-domain-id">4203</journal-id><journal-id journal-id-type="pmc-domain">ercsp</journal-id><journal-title-group><journal-title>Exploratory Research in Clinical and Social Pharmacy</journal-title></journal-title-group><issn pub-type="epub">2667-2766</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11615539</article-id><article-id pub-id-type="pmcid-ver">PMC11615539.1</article-id><article-id pub-id-type="pmcaid">11615539</article-id><article-id pub-id-type="pmcaiid">11615539</article-id><article-id pub-id-type="pmid">39634377</article-id><article-id pub-id-type="doi">10.1016/j.rcsop.2024.100538</article-id><article-id pub-id-type="pii">S2667-2766(24)00135-5</article-id><article-id pub-id-type="publisher-id">100538</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A scoping review of motor vehicle operator performance assessments for benzodiazepine receptor agonists</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0005"><name name-style="western"><surname>Murphy</surname><given-names initials="AL">Andrea L.</given-names></name><email>Andrea.murphy@dal.ca</email><xref rid="af0005" ref-type="aff">a</xref><xref rid="af0010" ref-type="aff">b</xref><xref rid="af0015" ref-type="aff">c</xref><xref rid="cr0005" ref-type="corresp">&#8270;</xref></contrib><contrib contrib-type="author" id="au0010"><name name-style="western"><surname>Sawires</surname><given-names initials="K">Korolos</given-names></name><email>KSawires@dal.ca</email><xref rid="af0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au0015"><name name-style="western"><surname>Peltekian</surname><given-names initials="SM">Sophie M.</given-names></name><email>Sophie.Peltekian@dal.ca</email><xref rid="af0020" ref-type="aff">d</xref></contrib><contrib contrib-type="author" id="au0020"><name name-style="western"><surname>Helwig</surname><given-names initials="M">Melissa</given-names></name><email>Melissa.Helwig@Dal.Ca</email><xref rid="af0025" ref-type="aff">e</xref></contrib><contrib contrib-type="author" id="au0025"><name name-style="western"><surname>Macdonald</surname><given-names initials="M">Marilyn</given-names></name><email>Marilyn.Macdonald@Dal.Ca</email><xref rid="af0015" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au0030"><name name-style="western"><surname>Martin-Misener</surname><given-names initials="R">Ruth</given-names></name><email>Ruth.Martin-Misener@Dal.Ca</email><xref rid="af0015" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au0035"><name name-style="western"><surname>Saini</surname><given-names initials="B">Bandana</given-names></name><email>bandana.saini@sydney.edu.au</email><xref rid="af0030" ref-type="aff">f</xref></contrib><contrib contrib-type="author" id="au0040"><name name-style="western"><surname>Neyedli</surname><given-names initials="H">Heather</given-names></name><email>hneyedli@dal.ca</email><xref rid="af0035" ref-type="aff">g</xref></contrib><contrib contrib-type="author" id="au0045"><name name-style="western"><surname>Giacomantonio</surname><given-names initials="C">Chris</given-names></name><email>chrisgiac@dal.ca</email><xref rid="af0040" ref-type="aff">h</xref></contrib><contrib contrib-type="author" id="au0050"><name name-style="western"><surname>Gardner</surname><given-names initials="DM">David M.</given-names></name><email>David.gardner@dal.ca</email><xref rid="af0005" ref-type="aff">a</xref><xref rid="af0010" ref-type="aff">b</xref></contrib><aff id="af0005"><label>a</label>College of Pharmacy, Dalhousie University, Halifax, NS, Canada</aff><aff id="af0010"><label>b</label>Department of Psychiatry, Dalhousie University, Halifax, NS, Canada</aff><aff id="af0015"><label>c</label>School of Nursing, Dalhousie University, Halifax, NS, Canada</aff><aff id="af0020"><label>d</label>Pharmacy Department, Nova Scotia Health Authority, Halifax, NS, Canada</aff><aff id="af0025"><label>e</label>WK Kellogg Health Sciences Library, Dalhousie University, Halifax, NS, Canada</aff><aff id="af0030"><label>f</label>School of Pharmacy, University of Sydney, Sydney, NSW, Australia</aff><aff id="af0035"><label>g</label>School of Health and Human Performance, Dalhousie University, Halifax, NS, Canada</aff><aff id="af0040"><label>h</label>Sociology and Social Anthropology, Dalhousie University, Halifax, NS, Canada</aff></contrib-group><author-notes><corresp id="cr0005"><label>&#8270;</label>Corresponding author at: College of Pharmacy, Dalhousie University, Halifax, NS, Canada. <email>Andrea.murphy@dal.ca</email></corresp></author-notes><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>09</day><month>11</month><year>2024</year></pub-date><volume>16</volume><issue-id pub-id-type="pmc-issue-id">471191</issue-id><elocation-id>100538</elocation-id><history><date date-type="received"><day>21</day><month>12</month><year>2023</year></date><date date-type="rev-recd"><day>1</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>3</day><month>11</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>09</day><month>11</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>04</day><month>12</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-12-05 16:25:26.633"><day>05</day><month>12</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2024 The Authors</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><abstract id="ab0005"><sec><title>Background</title><p>Benzodiazepines and <italic toggle="yes">Z</italic>-drugs (e.g., zopiclone, zolpidem) (benzodiazepine receptor agonists or BZRAs), are prescribed for anxiety and insomnia disorders. However, they are not indicated as first line therapies for long-term management due to harms and efficacy limitations. BZRAs have also been associated with traffic accident risks. Patients taking BZRAs are told to consult with health care providers regarding motor vehicle operation safety. However, advice on driving is variable. The objective of this scoping review is to identify, map, and characterize the evidence for assessments that measure driving performance in people taking BZRAs.</p></sec><sec><title>Methods</title><p>Embase (Elsevier), MEDLINE (Ovid), and PsycINFO (EBSCO) were searched. Covidence was used for screening. Each stage of screening included two independent reviewers. A REDCap database was used for data extraction by two independent reviewers. Results were tabulated and summarised as a narrative.</p></sec><sec><title>Results</title><p>Driving performance was assessed with 20 unique BZRAs across 183 studies (<italic toggle="yes">n</italic>&#160;=&#160;92 experimental; <italic toggle="yes">n</italic>&#160;=&#160;91 observational) in 178 publications. Zopiclone was the most studied. In experimental studies, the Standard Deviation of Lateral Position (SDLP) was used most often (<italic toggle="yes">n</italic>&#160;=&#160;54, 62&#160;%) and many studies (<italic toggle="yes">n</italic>&#160;=&#160;35, 38&#160;%) were conducted in the Netherlands. For observational studies, biological detection (e.g., urine, blood) (<italic toggle="yes">n</italic>&#160;=&#160;73, 80&#160;%) followed by prescription drug/dispensing records (<italic toggle="yes">n</italic>&#160;=&#160;17, 19&#160;%) were the most common impairment measures and Norway (<italic toggle="yes">n</italic>&#160;=&#160;20) is where most studies took place. In experimental studies, most (<italic toggle="yes">n</italic>&#160;=&#160;89, 97&#160;%) were conducted using only one driving setting. Simulated driving in a car (<italic toggle="yes">n</italic>&#160;=&#160;36) and road driving in traffic (n&#160;=&#160;36) were common as compared to nontraffic driving course (n&#160;=&#160;8) and simulated driving (<italic toggle="yes">n</italic>&#160;=&#160;9). In experimental studies, seventy-eight of the 92 studies (85&#160;%) had at least one measure that identified impairment.</p></sec><sec><title>Conclusions</title><p>BZRA effects on motor vehicle driving performance have been studied using heterogenous protocols with multiple measures and settings, ranging from simulation to authentic traffic situations in experimental studies to biological detection and dispensing records in observational studies. Many BZRAs have been studied but study representation does not match prescribing pattern prevalence. The interpretation and contextualization of results for clinical practice is challenging due to the complexity (i.e., protocols, measures, settings). Future work in this area should work to improve knowledge translation of results so information is more readily accessible and applicable to health care providers and patients.</p></sec></abstract><kwd-group id="ks0005"><title>Keywords</title><kwd>Benzodiazepines</kwd><kwd>Driving performance</kwd><kwd>Sedative-hypnotics</kwd><kwd>Traffic accidents</kwd><kwd><italic toggle="yes">Z</italic>-drugs</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s0005"><label>1</label><title>Introduction</title><p id="p0005">Benzodiazepine receptor agonists (BZRAs) (e.g., diazepam, lorazepam, zopiclone, zolpidem) are sedating medications with prevalent use of 3&#160;% to 5&#160;% in the general population.<xref rid="bb0005" ref-type="bibr">1</xref>, <xref rid="bb0010" ref-type="bibr">2.</xref>, <xref rid="bb0015" ref-type="bibr">3</xref>, <xref rid="bb0020" ref-type="bibr">4</xref>, <xref rid="bb0025" ref-type="bibr">5</xref>, <xref rid="bb0030" ref-type="bibr">6</xref> Use increases with age, with estimates of chronic use ranging between 10&#160;% to 20&#160;%<xref rid="bb0020" ref-type="bibr"><sup>4</sup></xref> in older adults with these individuals more likely to use BZRAs more than prescribed.<xref rid="bb0035" ref-type="bibr"><sup>7</sup></xref><sup>,</sup><xref rid="bb0040" ref-type="bibr"><sup>8</sup></xref> BZRAs have a narrow role in the management of anxiety disorders and are of limited benefit in the treatment of insomnia.<xref rid="bb0045" ref-type="bibr"><sup>9</sup></xref><sup>,</sup><xref rid="bb0050" ref-type="bibr"><sup>10</sup></xref> Their adverse effects (e.g., falls,<xref rid="bb0055" ref-type="bibr"><sup>11</sup></xref> dependence and withdrawal,<xref rid="bb0060" ref-type="bibr"><sup>12</sup></xref> memory problems,<xref rid="bb0065" ref-type="bibr"><sup>13</sup></xref> pneumonia,<xref rid="bb0070" ref-type="bibr"><sup>14</sup></xref> sleepwalking and sleep driving,<xref rid="bb0075" ref-type="bibr"><sup>15</sup></xref> daytime sedation and impairment<xref rid="bb0080" ref-type="bibr"><sup>16</sup></xref>) are well established. Reducing the use of BZRAs for anxiety-related disorders and insomnia across age groups has proven to be challenging despite numerous guidelines, policies, and campaigns to reduce their use, and it continues to be an active area of investigation.<xref rid="bb0045" ref-type="bibr"><sup>9</sup></xref><sup>,</sup><xref rid="bb0050" ref-type="bibr"><sup>10</sup></xref><sup>,</sup><xref rid="bb0085" ref-type="bibr">17.</xref>, <xref rid="bb0090" ref-type="bibr">18</xref>, <xref rid="bb0095" ref-type="bibr">19</xref>, <xref rid="bb0100" ref-type="bibr">20.</xref>, <xref rid="bb0105" ref-type="bibr">21.</xref> BZRA-related impaired cognition and physical functioning is associated with driving impairment.<xref rid="bb0110" ref-type="bibr">22.</xref>, <xref rid="bb0115" ref-type="bibr">23</xref>, <xref rid="bb0120" ref-type="bibr">24</xref>, <xref rid="bb0125" ref-type="bibr">25</xref> These risks can become greater when BZRAs are combined with other sedating medications (e.g., opioids<xref rid="bb0130" ref-type="bibr"><sup>26</sup></xref>) and non-prescription substances (e.g., alcohol).<xref rid="bb0135" ref-type="bibr"><sup>27</sup></xref> Drivers can experience challenges with controlling speed, lane positioning, and interpretation of traffic signage.<xref rid="bb0080" ref-type="bibr"><sup>16</sup></xref> Driver impairment regulations and penalties vary globally<xref rid="bb0140" ref-type="bibr"><sup>28</sup></xref> and in some places, depend on whether medications are prescribed by a physician.<xref rid="bb0145" ref-type="bibr"><sup>29</sup></xref></p><p id="p0010">Patients are encouraged to consult health care providers regarding safe operation of a motor vehicle while consuming BZRAs. However, the information available to health care providers can be vague and lack consensus regarding individual BZRAs and driving safety. Health care providers will seek a variety of sources to inform patient education and advice regarding BZRA adverse effects (e.g., impairment), including product monographs. For example, a zopiclone monograph includes a black box for &#8220;serious warnings and precautions&#8221; that includes, &#8220;Caution patients that impairment when driving or operating machinery can persist for up to 12 hours after an evening dose&#8221; and, &#8220;Risk for road traffic crashes appears to be highest during the first 2 weeks of therapy.&#8221;<xref rid="bb0150" ref-type="bibr"><sup>30</sup></xref> Patient information for a brand product of zopiclone also indicates that people not drive under several conditions including, but not limited to, &#8220;if it has not been 12 hours or more&#8230;&#8221; since taking the medication, if the person is &#8220;elderly&#8221;, or taking, &#8220;the 7.5 mg dose&#8221;.<xref rid="bb0155" ref-type="bibr"><sup>31</sup></xref> The manufacturer warns patients about &#8220;&#8230;. driving a motor vehicle after ingesting the drug&#8221; as part of their section on &#8220;Driving and Operating Machinery&#8221;.<xref rid="bb0160" ref-type="bibr"><sup>32</sup></xref> Other resources make more general statements by telling patients to avoid driving until it is safe to do so<xref rid="bb0165" ref-type="bibr"><sup>33</sup></xref> or indicating that patients should not operate a motor vehicle until they know how a medication affects them, especially with dosage changes and additions of new medications.<xref rid="bb0170" ref-type="bibr"><sup>34</sup></xref> The Driving under the Influence of Drugs, Alcohol and Medicines (DRUID) project in Europe aimed to improve knowledge of medication-related level of impairment, building on their work of categorizing impairment ranging from none to severe.<xref rid="bb0125" ref-type="bibr"><sup>25</sup></xref> Many centrally acting agents were categorized as a moderate or severe influence for impaired driving.<xref rid="bb0125" ref-type="bibr"><sup>25</sup></xref> This would be expected, but how this work and its evidence base are interpreted by health care providers, and translated to explicit information in shared decision making with patients remains largely unknown.</p><p id="p0015">The content and extent of education given to patients in clinical settings is relatively unexplored, and to our knowledge, there is no direct and objective evaluation in the current literature on practice-based assessments of patient education provided regarding BZRAs and the impact on driving performance. For example, studies using secret or mystery shoppers with insomnia have been used to evaluate pharmacists' patient education, but not specifically with BZRAs. Two studies evaluated pharmacists' advice to a mystery shopper regarding insomnia management with non-prescription products (e.g., sedating antihistamines) and identified areas of improvement including around information on medication-related adverse events.<xref rid="bb0175" ref-type="bibr"><sup>35</sup></xref><sup>,</sup><xref rid="bb0180" ref-type="bibr"><sup>36</sup></xref> Another study regarding sedating antihistamines, albeit for allergies, found only one pharmacist from the 88 included pharmacies cautioned about sedation and avoiding driving.<xref rid="bb0185" ref-type="bibr"><sup>37</sup></xref> In general, pharmacists feel less confident about counselling around risks associated with use of alertness impairing medicines.<xref rid="bb0190" ref-type="bibr"><sup>38</sup></xref> Patient understanding and perceptions of alertness impairment risks may also be inaccurate with respect to the timing of these effects (e.g., immediately after dosing versus several hours after dosing).<xref rid="bb0195" ref-type="bibr"><sup>39</sup></xref></p><p id="p0020">Health care providers seeking to critically appraise literature regarding medications impacting driving safety can also face challenges regarding the complexity of driving performance methods of assessment. Driving assessments vary widely from laboratory cognitive tests, driving simulators, to on-the-road driving tests.<xref rid="bb0200" ref-type="bibr"><sup>40</sup></xref><sup>,</sup><xref rid="bb0205" ref-type="bibr"><sup>41</sup></xref> On-the-road tests, viewed as one with highest fidelity, demonstrate dose-dependent impairment for alcohol, illicit drugs, as well as some sedative-hypnotic medications, antidepressants, and antihistamines.<xref rid="bb0210" ref-type="bibr"><sup>42</sup></xref> Driving simulators can assess performance but are criticized for limited realism.<xref rid="bb0200" ref-type="bibr"><sup>40</sup></xref> Lastly, laboratory cognitive tasks are limited in their validity to compare to real-life driving and whether they can be accurately used to predict performance-related risk.<xref rid="bb0200" ref-type="bibr"><sup>40</sup></xref></p><p id="p0025">Given the prevalence of BZRA use, often with chronicity, and variability in assessment methods for impacts on driving, we conducted a scoping review to identify, map, and characterize the methods used to assess the impact of individual BZRAs on driving performance.</p></sec><sec id="s0010"><label>2</label><title>Methods</title><p id="p0030">The scoping review protocol was developed a priori and published<xref rid="bb0215" ref-type="bibr"><sup>43</sup></xref> and was adhered to with minor modifications as outlined. As part of the initial scoping review process, we conducted a preliminary search of PROSPERO, MEDLINE, the Cochrane Database of Systematic Reviews, and the JBI Database of Systematic Reviews and Implementation Reports and no scoping reviews related to the topic were identified. The review was conducted following the JBI guidance for the conduct of scoping reviews<xref rid="bb0220" ref-type="bibr"><sup>44</sup></xref> and reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR).<xref rid="bb0225" ref-type="bibr"><sup>45</sup></xref></p><p id="p0035">We limited the scope of the review to the BZRAs for pragmatic and clinically-focused reasons. The BZRAs have a high rate of use across ages groups and are the most prevalent class of sedative-hypnotics prescribed for prevalent conditions (e.g., insomnia, anxiety). There are also numerous individual medications that fall within the BZRA group that have a range of pharmacodynamic and pharmacokinetic properties that can cause challenges to determine recommendations regarding their use and driving.</p><sec id="s0015"><label>2.1</label><title>Search strategy</title><p id="p0040">The search strategy aimed to locate both published and unpublished studies. An initial limited search of MEDLINE (Ovid) and Embase (Elsevier) was undertaken to identify articles on the topic. To identify benzodiazepine keywords for the search, benzodiazepines listed in various drug monograph databases (e.g., Micromedex, Lexicomp, and Martindale: The Complete Drug Reference) were searched. The text words contained in the titles and abstracts of relevant articles, and the index terms used to describe the articles were used to develop a full search strategy in MEDLINE (Ovid; see Appendix II). The search strategy, including all identified keywords and index terms, was adapted for each included database. The databases searched for published research, with a search dated June 9, 2020, included Embase (Elsevier), MEDLINE (Ovid), and PsycINFO (EBSCO). This search was rerun to update the results on May 3, 2022. Initial keywords used were &#8220;benzodiazepine,&#8221; &#8220;sedative-hypnotic,&#8221; &#8220;<italic toggle="yes">Z</italic>-drug,&#8221; &#8220;driving impairment,&#8221; and &#8220;driving performance.&#8221;</p><p id="p0045">Grey literature (e.g., policy documents and legislation on driving and medication use, vital statistics) were used during the scoping review process to provide background information, contextualize the issues, and identify application of findings for clinical and policy settings. Other grey literature was not searched given the scoping review question focused on the body of evidence evaluating the methods of driving performance and BZRAs.</p></sec><sec id="s0020"><label>2.2</label><title>Participants</title><p id="p0050">This review considered studies of participants who were new, intermittent, or chronic users of BZRAs (Appendix I, Inclusion and Exclusion Criteria). No exclusions were applied regarding the health status of participants or whether their BZRA use was for an approved indication, if known, as indicated by government agencies (e.g., Health Canada) or practice guidelines. Participants were required to be of licensed age to operate a motor vehicle. Fifteen years of age was chosen as the cut-off based on preliminary review of studies from various countries. Those hospitalized for reasons unrelated to driving or residing in long-term care or assisted living facilities were not considered in this review. All BZRAs that participants were consuming were eligible for inclusion provided there was evidence of one BZRA used and not multiple, and that it was not used intravenously or intramuscularly.</p></sec><sec id="s0025"><label>2.3</label><title>Concept</title><p id="p0055">The current scoping review considered studies in which there is a demonstrated or inferred presence of a BZRA in association with the operation of a motor vehicle (e.g., cars, trucks, motorcycles). Operation of a motor vehicle could have been real or simulated. Outcomes could include direct or indirect objectives or standard subjective measures or indicators of impairment while operating a motor vehicle. However, indirect methods such as electroencephalogram and tests of proprioception were excluded. Experimental and observational studies that had links to outcomes, such as traffic accidents, fatalities, and hospital visits related to operation of a motor vehicle to BZRAs were included.</p></sec><sec id="s0030"><label>2.4</label><title>Context</title><p id="p0060">The setting for studies was not limited by geography and included community-based settings; urban, rural, and remote settings; and international settings.</p></sec><sec id="s0035"><label>2.5</label><title>Types of sources</title><p id="p0065">The scoping review considered experimental studies and observational studies. Example of study designs include randomized controlled trials, cohort and case control studies, cross-sectional studies, prevalence studies, and case-crossovers. Systematic reviews were used for citation chasing and examined for studies related to the scoping review objectives. Only studies published in English were included for data extraction as it was the prevalent language spoken and understood by all members of the team. No date limits were applied.</p></sec><sec id="s0040"><label>2.6</label><title>Study selection</title><p id="p0070">Following the searches, all identified citations were collated and uploaded into Covidence 2019 (Veritas Health Innovation, Melbourne, Australia) and duplicates removed. Covidence was used for title and abstract screening conducted by two independent reviewers for assessment against the inclusion and exclusion criteria. The full texts of selected citations were then assessed in detail against the inclusion and exclusion criteria (Appendix I) by two independent reviewers using Covidence. Any disagreements that arose between the reviewers at each stage of the study selection process were resolved through discussion or via a third reviewer from the team. Reasons for exclusion of full text studies that did not meet the inclusion criteria are presented in the PRISMA flow diagram (<xref rid="f0005" ref-type="fig">Fig. 1</xref>).<sup>30</sup> All studies included for full text were managed using REDCap electronic data capture tools hosted at Dalhousie University. REDCap (Research Electronic Data Capture) is a secure, web-based software platform designed to support data capture for research studies, providing: 1) an intuitive interface for validated data capture; 2) audit trails for tracking data manipulation and export procedures; 3) automated export procedures for seamless data downloads to common statistical packages; and 4) procedures for data integration and interoperability with external sources.<xref rid="bb0230" ref-type="bibr"><sup>46</sup></xref><sup>,</sup><xref rid="bb0235" ref-type="bibr"><sup>47</sup></xref> The data extraction in REDCap differed based on the design of the study being extracted (e.g., experimental, observational) (data dictionary code book and fields available above request). Microsoft Excel, available via our Dalhousie University Microsoft&#174; 365 Subscription, was used in addition to REDCap for further analyses.<fig id="f0005" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Search results and study selection and inclusion process.<xref rid="bb0225" ref-type="bibr"><sup>45</sup></xref></p></caption><alt-text id="al0005">Fig. 1</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="lk0005" position="float" orientation="portrait" xlink:href="gr1.jpg"/></fig></p></sec><sec id="s0045"><label>2.7</label><title>Data extraction</title><p id="p0075">Pairs of two independent reviewers (KS, DMG, ALM, SS, TS, IA, SP) completed data extraction of included studies in REDCap (Appendix III) following training and discussion as a team. Any disagreements that arose between the reviewers during data extraction were resolved through discussion or via a third reviewer. At least 10&#160;% of publications were audited for accuracy by two (ALM, DMG) other team members. The data extracted included specific details about the population (e.g., age, sex), study design (experimental vs observational), year of publication, sample size, country of publication, BZRAs studied (inclusive of dosing regimen, calculated diazepam equivalents), driving assessment setting (on-the-road driving vs driving simulation), measures of driving impairment (e.g., standard deviation of lateral position, accident, road-side assessment), and key findings relevant to the review objective.</p></sec><sec id="s0050"><label>2.8</label><title>Modifications from the study protocol</title><p id="p0080">The data extraction was completed in REDCap versus the JBI System for the Unified Management, Assessment and Review of Information (JBI SUMARI; JBI, Adelaide, Australia) as originally outlined in the protocol. REDCap was chosen due to the research team's experience and familiarity with it as a project and data management tool, and the flexibility with data extraction options (e.g., pull-down menus, branching), and other options available. As per the protocol,<xref rid="bb0215" ref-type="bibr"><sup>43</sup></xref> the data extraction template submitted with the protocol was revised extensively.</p><p id="p0085">In the protocol,<xref rid="bb0215" ref-type="bibr"><sup>43</sup></xref> we described including key findings relevant to the review objective. We decided to report impairment findings for both experimental and observational studies as part of these key findings. In the observational studies, the impairment outcomes (e.g., motor vehicle accident, suspected impairment based on driving behaviours) were often used to identify issues with people's motor vehicle driving performance. Essentially, the impairment findings were often used to identify potential cases in case-control studies. For experimental studies, we included the authors' interpretations regarding impairment findings, without critical appraisal of their validity given this was not the purpose of the scoping review.</p></sec><sec id="s0055"><label>2.9</label><title>Data analysis</title><p id="p0090">The data were analysed to determine how BZRA driving impairment has been assessed and are presented visually in figures and in tabular format. The data in text are presented with experimental studies reported first, followed by observational studies. For readability related to lengthy in-text citations, when citations were over 35 in number, readers are referred to specific appendices for specific citations versus listing lengthy citations.</p></sec></sec><sec id="s0060"><label>3</label><title>Results</title><sec id="s0065"><label>3.1</label><title>Study inclusion</title><p id="p0095">We identified a total of 5886 studies through our searches of EMBASE (Elsevier), MEDLINE (Ovid), and PsycINFO (EBSCO) (<xref rid="f0005" ref-type="fig">Fig. 1</xref>), which were imported to Covidence. Duplicates (<italic toggle="yes">n</italic>&#160;=&#160;1430) were removed before starting title/abstract screening, which resulted in 535 studies moving to full text review. Full texts were then screened and a total of 178 publications were included, with data extraction for 183 studies given some individual publications reported more than one distinct study. Eighteen systematic reviews<xref rid="bb0240" ref-type="bibr">48</xref>, <xref rid="bb0245" ref-type="bibr">49</xref>, <xref rid="bb0250" ref-type="bibr">50</xref>, <xref rid="bb0255" ref-type="bibr">51.</xref>, <xref rid="bb0260" ref-type="bibr">52</xref>, <xref rid="bb0265" ref-type="bibr">53</xref>, <xref rid="bb0270" ref-type="bibr">54</xref>, <xref rid="bb0275" ref-type="bibr">55</xref>, <xref rid="bb0280" ref-type="bibr">56</xref>, <xref rid="bb0285" ref-type="bibr">57</xref>, <xref rid="bb0290" ref-type="bibr">58</xref>, <xref rid="bb0295" ref-type="bibr">59</xref>, <xref rid="bb0300" ref-type="bibr">60</xref>, <xref rid="bb0305" ref-type="bibr">61</xref>, <xref rid="bb0310" ref-type="bibr">62.</xref>, <xref rid="bb0315" ref-type="bibr">63.</xref>, <xref rid="bb0320" ref-type="bibr">64</xref>, <xref rid="bb0325" ref-type="bibr">65</xref> were identified, and their citations examined to find other relevant studies. No additional relevant studies were identified in the systematic reviews' citation lists compared to our own searches.</p><p id="p0100">The most common reason for exclusion in 133 studies was a lack of single entity BZRA use. In these studies, participants were taking more than one substance with the potential to impair driving (e.g. alcohol in combination with a BZRA) or it was not evident that participants were taking a single-entity BZRA. As such, driving impairment observed in these studies may not be an accurate representation of the true impairment caused by a BZRA alone. Other notable reasons for exclusion included wrong study design (<italic toggle="yes">n</italic>&#160;=&#160;143). Studies excluded for wrong study design measured skills indirectly related to driving (e.g., electroencephalogram, hand foot proprioception), or investigated objectives where measuring impaired driving was not part of a focus of the study. Studies excluded for wrong publication type were abstracts, conference proceedings, or letters to the editor. A complete list of reasons for exclusion are provided in the PRISMA flow diagram (<xref rid="f0005" ref-type="fig">Fig. 1</xref>).</p></sec><sec id="s0070"><label>3.2</label><title>Characteristics of included studies</title><sec id="s0075"><label>3.2.1</label><title>Experimental</title><p id="p0105">There were 89 publications categorized as experimental studies, and these included 92 experiments in total (Appendix III).<xref rid="bb0330" ref-type="bibr">66</xref>, <xref rid="bb0335" ref-type="bibr">67</xref>, <xref rid="bb0340" ref-type="bibr">68</xref>, <xref rid="bb0345" ref-type="bibr">69.</xref>, <xref rid="bb0350" ref-type="bibr">70</xref>, <xref rid="bb0355" ref-type="bibr">71</xref>, <xref rid="bb0360" ref-type="bibr">72</xref>, <xref rid="bb0365" ref-type="bibr">73</xref>, <xref rid="bb0370" ref-type="bibr">74</xref>, <xref rid="bb0375" ref-type="bibr">75</xref>, <xref rid="bb0380" ref-type="bibr">76.</xref>, <xref rid="bb0385" ref-type="bibr">77</xref>, <xref rid="bb0390" ref-type="bibr">78.</xref>, <xref rid="bb0395" ref-type="bibr">79</xref>, <xref rid="bb0400" ref-type="bibr">80</xref>, <xref rid="bb0405" ref-type="bibr">81</xref>, <xref rid="bb0410" ref-type="bibr">82</xref>, <xref rid="bb0415" ref-type="bibr">83</xref>, <xref rid="bb0420" ref-type="bibr">84</xref>, <xref rid="bb0425" ref-type="bibr">85</xref>, <xref rid="bb0430" ref-type="bibr">86</xref>, <xref rid="bb0435" ref-type="bibr">87</xref>, <xref rid="bb0440" ref-type="bibr">88</xref>, <xref rid="bb0445" ref-type="bibr">89</xref>, <xref rid="bb0450" ref-type="bibr">90</xref>, <xref rid="bb0455" ref-type="bibr">91</xref>, <xref rid="bb0460" ref-type="bibr">92.</xref>, <xref rid="bb0465" ref-type="bibr">93</xref>, <xref rid="bb0470" ref-type="bibr">94</xref>, <xref rid="bb0475" ref-type="bibr">95</xref>, <xref rid="bb0480" ref-type="bibr">96</xref>, <xref rid="bb0485" ref-type="bibr">97</xref>, <xref rid="bb0490" ref-type="bibr">98</xref>, <xref rid="bb0495" ref-type="bibr">99</xref>, <xref rid="bb0500" ref-type="bibr">100</xref>, <xref rid="bb0505" ref-type="bibr">101</xref>, <xref rid="bb0510" ref-type="bibr">102</xref>, <xref rid="bb0515" ref-type="bibr">103</xref>, <xref rid="bb0520" ref-type="bibr">104</xref>, <xref rid="bb0525" ref-type="bibr">105</xref>, <xref rid="bb0530" ref-type="bibr">106</xref>, <xref rid="bb0535" ref-type="bibr">107</xref>, <xref rid="bb0540" ref-type="bibr">108</xref>, <xref rid="bb0545" ref-type="bibr">109</xref>, <xref rid="bb0550" ref-type="bibr">110</xref>, <xref rid="bb0555" ref-type="bibr">111.</xref>, <xref rid="bb0560" ref-type="bibr">112</xref>, <xref rid="bb0565" ref-type="bibr">113</xref>, <xref rid="bb0570" ref-type="bibr">114</xref>, <xref rid="bb0575" ref-type="bibr">115</xref>, <xref rid="bb0580" ref-type="bibr">116</xref>, <xref rid="bb0585" ref-type="bibr">117</xref>, <xref rid="bb0590" ref-type="bibr">118.</xref>, <xref rid="bb0595" ref-type="bibr">119</xref>, <xref rid="bb0600" ref-type="bibr">120</xref>, <xref rid="bb0605" ref-type="bibr">121</xref>, <xref rid="bb0610" ref-type="bibr">122</xref>, <xref rid="bb0615" ref-type="bibr">123</xref>, <xref rid="bb0620" ref-type="bibr">124</xref>, <xref rid="bb0625" ref-type="bibr">125</xref>, <xref rid="bb0630" ref-type="bibr">126</xref>, <xref rid="bb0635" ref-type="bibr">127</xref>, <xref rid="bb0640" ref-type="bibr">128</xref>, <xref rid="bb0645" ref-type="bibr">129</xref>, <xref rid="bb0650" ref-type="bibr">130</xref>, <xref rid="bb0655" ref-type="bibr">131.</xref>, <xref rid="bb0660" ref-type="bibr">132</xref>, <xref rid="bb0665" ref-type="bibr">133</xref>, <xref rid="bb0670" ref-type="bibr">134.</xref>, <xref rid="bb0675" ref-type="bibr">135</xref>, <xref rid="bb0680" ref-type="bibr">136</xref>, <xref rid="bb0685" ref-type="bibr">137</xref>, <xref rid="bb0690" ref-type="bibr">138</xref>, <xref rid="bb0695" ref-type="bibr">139</xref>, <xref rid="bb0700" ref-type="bibr">140</xref>, <xref rid="bb0705" ref-type="bibr">141</xref>, <xref rid="bb0710" ref-type="bibr">142</xref>, <xref rid="bb0715" ref-type="bibr">143</xref>, <xref rid="bb0720" ref-type="bibr">144.</xref>, <xref rid="bb0725" ref-type="bibr">145</xref>, <xref rid="bb0730" ref-type="bibr">146</xref>, <xref rid="bb0735" ref-type="bibr">147</xref>, <xref rid="bb0740" ref-type="bibr">148</xref>, <xref rid="bb0745" ref-type="bibr">149.</xref>, <xref rid="bb0750" ref-type="bibr">150.</xref>, <xref rid="bb0755" ref-type="bibr">151</xref>, <xref rid="bb0760" ref-type="bibr">152</xref>, <xref rid="bb0765" ref-type="bibr">153.</xref>, <xref rid="bb0770" ref-type="bibr">154</xref> O'Hanlon et al.<xref rid="bb0585" ref-type="bibr"><sup>117</sup></xref> published three experiments in one paper and Vanakoski et al.<xref rid="bb0665" ref-type="bibr"><sup>133</sup></xref> reported on two different experiments. We treated the experiments within the O'Hanlon and Vanakoski papers as distinct studies and completed data extraction from the two papers as five extractions. When these are reported in the text, the same citation is repeated. There were also some publications with common investigators that used data from previously published studies and reanalysed these data using a different metric. For example, Verster et al. in their 2014<xref rid="bb0735" ref-type="bibr"><sup>147</sup></xref> publication used data from Verster et al. in 2002<xref rid="bb0725" ref-type="bibr"><sup>145</sup></xref> and Mets et al.<xref rid="bb0540" ref-type="bibr"><sup>108</sup></xref> from 2011. We treated the Verster et al. from 2014<xref rid="bb0735" ref-type="bibr"><sup>147</sup></xref> as one extraction since the authors combined the sample from the original papers published in 2002 and 2011.</p></sec><sec id="s0080"><label>3.2.2</label><title>Observational</title><p id="p0110">There were 89 publications<xref rid="bb0115" ref-type="bibr"><sup>23</sup></xref><sup>,</sup><xref rid="bb0465" ref-type="bibr"><sup>93</sup></xref><sup>,</sup><xref rid="bb0775" ref-type="bibr">155</xref>, <xref rid="bb0780" ref-type="bibr">156</xref>, <xref rid="bb0785" ref-type="bibr">157.</xref>, <xref rid="bb0790" ref-type="bibr">158</xref>, <xref rid="bb0795" ref-type="bibr">159</xref>, <xref rid="bb0800" ref-type="bibr">160.</xref>, <xref rid="bb0805" ref-type="bibr">161</xref>, <xref rid="bb0810" ref-type="bibr">162</xref>, <xref rid="bb0815" ref-type="bibr">163</xref>, <xref rid="bb0820" ref-type="bibr">164</xref>, <xref rid="bb0825" ref-type="bibr">165</xref>, <xref rid="bb0830" ref-type="bibr">166</xref>, <xref rid="bb0835" ref-type="bibr">167</xref>, <xref rid="bb0840" ref-type="bibr">168</xref>, <xref rid="bb0845" ref-type="bibr">169.</xref>, <xref rid="bb0850" ref-type="bibr">170</xref>, <xref rid="bb0855" ref-type="bibr">171</xref>, <xref rid="bb0860" ref-type="bibr">172</xref>, <xref rid="bb0865" ref-type="bibr">173</xref>, <xref rid="bb0870" ref-type="bibr">174</xref>, <xref rid="bb0875" ref-type="bibr">175</xref>, <xref rid="bb0880" ref-type="bibr">176</xref>, <xref rid="bb0885" ref-type="bibr">177.</xref>, <xref rid="bb0890" ref-type="bibr">178.</xref>, <xref rid="bb0895" ref-type="bibr">179</xref>, <xref rid="bb0900" ref-type="bibr">180</xref>, <xref rid="bb0905" ref-type="bibr">181</xref>, <xref rid="bb0910" ref-type="bibr">182.</xref>, <xref rid="bb0915" ref-type="bibr">183</xref>, <xref rid="bb0920" ref-type="bibr">184</xref>, <xref rid="bb0925" ref-type="bibr">185</xref>, <xref rid="bb0930" ref-type="bibr">186</xref>, <xref rid="bb0935" ref-type="bibr">187</xref>, <xref rid="bb0940" ref-type="bibr">188.</xref>, <xref rid="bb0945" ref-type="bibr">189</xref>, <xref rid="bb0950" ref-type="bibr">190</xref>, <xref rid="bb0955" ref-type="bibr">191</xref>, <xref rid="bb0960" ref-type="bibr">192.</xref>, <xref rid="bb0965" ref-type="bibr">193.</xref>, <xref rid="bb0970" ref-type="bibr">194</xref>, <xref rid="bb0975" ref-type="bibr">195</xref>, <xref rid="bb0980" ref-type="bibr">196.</xref>, <xref rid="bb0985" ref-type="bibr">197</xref>, <xref rid="bb0990" ref-type="bibr">198.</xref>, <xref rid="bb0995" ref-type="bibr">199</xref>, <xref rid="bb1000" ref-type="bibr">200</xref>, <xref rid="bb1005" ref-type="bibr">201</xref>, <xref rid="bb1010" ref-type="bibr">202</xref>, <xref rid="bb1015" ref-type="bibr">203</xref>, <xref rid="bb1020" ref-type="bibr">204</xref>, <xref rid="bb1025" ref-type="bibr">205</xref>, <xref rid="bb1030" ref-type="bibr">206</xref>, <xref rid="bb1035" ref-type="bibr">207</xref>, <xref rid="bb1040" ref-type="bibr">208</xref>, <xref rid="bb1045" ref-type="bibr">209</xref>, <xref rid="bb1050" ref-type="bibr">210</xref>, <xref rid="bb1055" ref-type="bibr">211</xref>, <xref rid="bb1060" ref-type="bibr">212</xref>, <xref rid="bb1065" ref-type="bibr">213</xref>, <xref rid="bb1070" ref-type="bibr">214</xref>, <xref rid="bb1075" ref-type="bibr">215</xref>, <xref rid="bb1080" ref-type="bibr">216</xref>, <xref rid="bb1085" ref-type="bibr">217</xref>, <xref rid="bb1090" ref-type="bibr">218</xref>, <xref rid="bb1095" ref-type="bibr">219.</xref>, <xref rid="bb1100" ref-type="bibr">220.</xref>, <xref rid="bb1105" ref-type="bibr">221</xref>, <xref rid="bb1110" ref-type="bibr">222.</xref>, <xref rid="bb1115" ref-type="bibr">223.</xref>, <xref rid="bb1120" ref-type="bibr">224</xref>, <xref rid="bb1125" ref-type="bibr">225</xref>, <xref rid="bb1130" ref-type="bibr">226</xref>, <xref rid="bb1135" ref-type="bibr">227</xref>, <xref rid="bb1140" ref-type="bibr">228.</xref>, <xref rid="bb1145" ref-type="bibr">229</xref>, <xref rid="bb1150" ref-type="bibr">230.</xref>, <xref rid="bb1155" ref-type="bibr">231</xref>, <xref rid="bb1160" ref-type="bibr">232</xref>, <xref rid="bb1165" ref-type="bibr">233</xref>, <xref rid="bb1170" ref-type="bibr">234</xref>, <xref rid="bb1175" ref-type="bibr">235</xref>, <xref rid="bb1180" ref-type="bibr">236</xref>, <xref rid="bb1185" ref-type="bibr">237.</xref>, <xref rid="bb1190" ref-type="bibr">238</xref>, <xref rid="bb1195" ref-type="bibr">239.</xref>, <xref rid="bb1200" ref-type="bibr">240</xref>, <xref rid="bb1205" ref-type="bibr">241</xref> classified as observational and two studies<xref rid="bb1100" ref-type="bibr"><sup>220</sup></xref><sup>,</sup><xref rid="bb1115" ref-type="bibr"><sup>223</sup></xref> within this group that were extracted as four separate studies, leaving 91 studies in total (Appendix IV).For observational studies, we divided them into two major categories: comparative studies, and non-comparative studies. Within comparative studies, we categorized them using the following taxonomy: cohort-study (prospective or retrospective); case-crossover; and case-control. Non-comparative studies were grouped into one of the following: cross-sectional or prevalence.</p></sec></sec></sec><sec id="s0085"><label>4</label><title>Review findings &#8211; Experimental</title><sec id="s0090"><label>4.1</label><title>Country and date of publication</title><p id="p0115">The country of publication varied between experimental and observational study designs (<xref rid="t0005" ref-type="table">Table 1</xref>). Experimental studies were conducted across 12 different countries in North America, Europe, and Asia with the majority being in the Netherlands (Appendix III).<table-wrap position="float" id="t0005" orientation="portrait"><label>Table 1</label><caption><p>Country of publication and number of experimental studies.</p></caption><alt-text id="al0020">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1"><bold>Country</bold></th><th colspan="1" rowspan="1"><bold>Number of Experiments within Experimental Studies</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">35</td></tr><tr><td colspan="1" rowspan="1">Finland</td><td colspan="1" rowspan="1">11</td></tr><tr><td colspan="1" rowspan="1">United Kingdom<xref rid="tf0005" ref-type="table-fn">a</xref></td><td colspan="1" rowspan="1">9</td></tr><tr><td colspan="1" rowspan="1">France</td><td colspan="1" rowspan="1">8</td></tr><tr><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">8</td></tr><tr><td colspan="1" rowspan="1">Germany</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Sweden</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">Australia</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Japan</td><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">Canada</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Belgium</td><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">Italy</td><td colspan="1" rowspan="1">1</td></tr></tbody></table><table-wrap-foot><fn id="tf0005"><label>a</label><p id="np0005">United Kingdom includes studies from Scotland, England, Wales, and/or Northern Ireland.</p></fn></table-wrap-foot></table-wrap></p><p id="p0120">For experimental studies (Appendix III), we found the highest number (26/92, 28&#160;%) published between 2010 and 2019 inclusive, with fewer in the decades before (<italic toggle="yes">n</italic>&#160;=&#160;17, 2000s; <italic toggle="yes">n</italic>&#160;=&#160;18, 1990s; <italic toggle="yes">n</italic>&#160;=&#160;13, 1980s; <italic toggle="yes">n</italic>&#160;=&#160;11, 1970s). Since 2020 to the time of the search, there were 7 experimental studies published.</p></sec><sec id="s0095"><label>4.2</label><title>Population demographics</title><p id="p0125">A total of 2944 participants were included across the experimental studies. Subject ages in the experimental studies ranged from 18 to 77&#160;years old with a mean age of 38.2&#160;years. Females comprised 31&#160;%, 36&#160;% were males, and for the remaining 33&#160;% sex of participants was not provided or unknown.</p></sec><sec id="s0100"><label>4.3</label><title>BZRAs studied</title><p id="p0130">Across the 92 experimental studies within 89 papers, 20 unique BZRAs were studied (Appendix III). Some BZRAs have been studied more frequently than others. For example, within the <italic toggle="yes">Z</italic>-drugs, zopiclone (<italic toggle="yes">n</italic>&#160;=&#160;30)<xref rid="bb0335" ref-type="bibr"><sup>67</sup></xref><sup>,</sup><xref rid="bb0355" ref-type="bibr"><sup>71</sup></xref><sup>,</sup><xref rid="bb0360" ref-type="bibr"><sup>72</sup></xref><sup>,</sup><xref rid="bb0385" ref-type="bibr"><sup>77</sup></xref><sup>,</sup><xref rid="bb0390" ref-type="bibr"><sup>78</sup></xref><sup>,</sup><xref rid="bb0445" ref-type="bibr"><sup>89</sup></xref><sup>,</sup><xref rid="bb0460" ref-type="bibr"><sup>92</sup></xref><sup>,</sup><xref rid="bb0465" ref-type="bibr"><sup>93</sup></xref><sup>,</sup><xref rid="bb0480" ref-type="bibr">96</xref>, <xref rid="bb0485" ref-type="bibr">97</xref>, <xref rid="bb0490" ref-type="bibr">98</xref>, <xref rid="bb0495" ref-type="bibr">99</xref>, <xref rid="bb0500" ref-type="bibr">100</xref><sup>,</sup><xref rid="bb0520" ref-type="bibr"><sup>104</sup></xref><sup>,</sup><xref rid="bb0525" ref-type="bibr"><sup>105</sup></xref><sup>,</sup><xref rid="bb0535" ref-type="bibr"><sup>107</sup></xref><sup>,</sup><xref rid="bb0540" ref-type="bibr"><sup>108</sup></xref><sup>,</sup><xref rid="bb0565" ref-type="bibr"><sup>113</sup></xref><sup>,</sup><xref rid="bb0605" ref-type="bibr"><sup>121</sup></xref><sup>,</sup><xref rid="bb0660" ref-type="bibr"><sup>132</sup></xref><sup>,</sup><xref rid="bb0670" ref-type="bibr"><sup>134</sup></xref><sup>,</sup><xref rid="bb0690" ref-type="bibr"><sup>138</sup></xref><sup>,</sup><xref rid="bb0700" ref-type="bibr">140</xref>, <xref rid="bb0705" ref-type="bibr">141</xref>, <xref rid="bb0710" ref-type="bibr">142</xref>, <xref rid="bb0715" ref-type="bibr">143</xref>, <xref rid="bb0720" ref-type="bibr">144.</xref><sup>,</sup><xref rid="bb0735" ref-type="bibr">147</xref>, <xref rid="bb0740" ref-type="bibr">148</xref>, <xref rid="bb0745" ref-type="bibr">149.</xref> and zolpidem (<italic toggle="yes">n</italic>&#160;=&#160;16)<xref rid="bb0335" ref-type="bibr"><sup>67</sup></xref><sup>,</sup><xref rid="bb0355" ref-type="bibr"><sup>71</sup></xref><sup>,</sup><xref rid="bb0360" ref-type="bibr"><sup>72</sup></xref><sup>,</sup><xref rid="bb0485" ref-type="bibr"><sup>97</sup></xref><sup>,</sup><xref rid="bb0495" ref-type="bibr"><sup>99</sup></xref><sup>,</sup><xref rid="bb0525" ref-type="bibr"><sup>105</sup></xref><sup>,</sup><xref rid="bb0535" ref-type="bibr"><sup>107</sup></xref><sup>,</sup><xref rid="bb0590" ref-type="bibr"><sup>118</sup></xref><sup>,</sup><xref rid="bb0600" ref-type="bibr"><sup>120</sup></xref><sup>,</sup><xref rid="bb0670" ref-type="bibr"><sup>134</sup></xref><sup>,</sup><xref rid="bb0685" ref-type="bibr"><sup>137</sup></xref><sup>,</sup><xref rid="bb0705" ref-type="bibr"><sup>141</sup></xref><sup>,</sup><xref rid="bb0725" ref-type="bibr"><sup>145</sup></xref><sup>,</sup><xref rid="bb0735" ref-type="bibr">147</xref>, <xref rid="bb0740" ref-type="bibr">148</xref>, <xref rid="bb0745" ref-type="bibr">149.</xref> were studied more often compared to zaleplon (<italic toggle="yes">n</italic>&#160;=&#160;5).<xref rid="bb0690" ref-type="bibr"><sup>138</sup></xref><sup>,</sup><xref rid="bb0700" ref-type="bibr"><sup>140</sup></xref><sup>,</sup><xref rid="bb0725" ref-type="bibr"><sup>145</sup></xref><sup>,</sup><xref rid="bb0735" ref-type="bibr"><sup>147</sup></xref><sup>,</sup><xref rid="bb0740" ref-type="bibr"><sup>148</sup></xref> When any one of the Z-drugs was a medication being investigated, 18<xref rid="bb0485" ref-type="bibr">97</xref>, <xref rid="bb0490" ref-type="bibr">98</xref>, <xref rid="bb0495" ref-type="bibr">99</xref>, <xref rid="bb0500" ref-type="bibr">100</xref><sup>,</sup><xref rid="bb0540" ref-type="bibr"><sup>108</sup></xref><sup>,</sup><xref rid="bb0565" ref-type="bibr"><sup>113</sup></xref><sup>,</sup><xref rid="bb0605" ref-type="bibr"><sup>121</sup></xref><sup>,</sup><xref rid="bb0670" ref-type="bibr"><sup>134</sup></xref><sup>,</sup><xref rid="bb0685" ref-type="bibr"><sup>137</sup></xref><sup>,</sup><xref rid="bb0690" ref-type="bibr"><sup>138</sup></xref><sup>,</sup><xref rid="bb0700" ref-type="bibr">140</xref>, <xref rid="bb0705" ref-type="bibr">141</xref>, <xref rid="bb0710" ref-type="bibr">142</xref><sup>,</sup><xref rid="bb0720" ref-type="bibr"><sup>144</sup></xref><sup>,</sup><xref rid="bb0725" ref-type="bibr"><sup>145</sup></xref><sup>,</sup><xref rid="bb0735" ref-type="bibr">147</xref>, <xref rid="bb0740" ref-type="bibr">148</xref>, <xref rid="bb0745" ref-type="bibr">149.</xref> were conducted in the Netherlands. Diazepam (<italic toggle="yes">n</italic>&#160;=&#160;24)<xref rid="bb0350" ref-type="bibr"><sup>70</sup></xref><sup>,</sup><xref rid="bb0400" ref-type="bibr"><sup>80</sup></xref><sup>,</sup><xref rid="bb0405" ref-type="bibr"><sup>81</sup></xref><sup>,</sup><xref rid="bb0415" ref-type="bibr"><sup>83</sup></xref><sup>,</sup><xref rid="bb0450" ref-type="bibr"><sup>90</sup></xref><sup>,</sup><xref rid="bb0465" ref-type="bibr"><sup>93</sup></xref><sup>,</sup><xref rid="bb0505" ref-type="bibr">101</xref>, <xref rid="bb0510" ref-type="bibr">102</xref>, <xref rid="bb0515" ref-type="bibr">103</xref><sup>,</sup><xref rid="bb0525" ref-type="bibr"><sup>105</sup></xref><sup>,</sup><xref rid="bb0555" ref-type="bibr"><sup>111</sup></xref><sup>,</sup><xref rid="bb0570" ref-type="bibr"><sup>114</sup></xref><sup>,</sup><xref rid="bb0585" ref-type="bibr"><sup>117</sup></xref><sup>,</sup><xref rid="bb0595" ref-type="bibr"><sup>119</sup></xref><sup>,</sup><xref rid="bb0625" ref-type="bibr"><sup>125</sup></xref><sup>,</sup><xref rid="bb0645" ref-type="bibr"><sup>129</sup></xref><sup>,</sup><xref rid="bb0665" ref-type="bibr">133</xref>, <xref rid="bb0670" ref-type="bibr">134.</xref>, <xref rid="bb0675" ref-type="bibr">135</xref><sup>,</sup><xref rid="bb0745" ref-type="bibr"><sup>149</sup></xref><sup>,</sup><xref rid="bb0755" ref-type="bibr"><sup>151</sup></xref><sup>,</sup><xref rid="bb0765" ref-type="bibr"><sup>153</sup></xref><sup>,</sup><xref rid="bb0770" ref-type="bibr"><sup>154</sup></xref> was the most studied non-Z-drug BZRA, followed by lorazepam (<italic toggle="yes">n</italic>&#160;=&#160;13)<xref rid="bb0395" ref-type="bibr"><sup>79</sup></xref><sup>,</sup><xref rid="bb0425" ref-type="bibr"><sup>85</sup></xref><sup>,</sup><xref rid="bb0495" ref-type="bibr"><sup>99</sup></xref><sup>,</sup><xref rid="bb0530" ref-type="bibr"><sup>106</sup></xref><sup>,</sup><xref rid="bb0550" ref-type="bibr"><sup>110</sup></xref><sup>,</sup><xref rid="bb0560" ref-type="bibr"><sup>112</sup></xref><sup>,</sup><xref rid="bb0580" ref-type="bibr"><sup>116</sup></xref><sup>,</sup><xref rid="bb0585" ref-type="bibr"><sup>117</sup></xref><sup>,</sup><xref rid="bb0640" ref-type="bibr"><sup>128</sup></xref><sup>,</sup><xref rid="bb0670" ref-type="bibr"><sup>134</sup></xref><sup>,</sup><xref rid="bb0680" ref-type="bibr"><sup>136</sup></xref><sup>,</sup><xref rid="bb0745" ref-type="bibr"><sup>149</sup></xref> and alprazolam (<italic toggle="yes">n</italic>&#160;=&#160;10).<xref rid="bb0380" ref-type="bibr"><sup>76</sup></xref><sup>,</sup><xref rid="bb0430" ref-type="bibr"><sup>86</sup></xref><sup>,</sup><xref rid="bb0435" ref-type="bibr"><sup>87</sup></xref><sup>,</sup><xref rid="bb0475" ref-type="bibr"><sup>95</sup></xref><sup>,</sup><xref rid="bb0630" ref-type="bibr">126</xref>, <xref rid="bb0635" ref-type="bibr">127</xref>, <xref rid="bb0640" ref-type="bibr">128</xref><sup>,</sup><xref rid="bb0670" ref-type="bibr"><sup>134</sup></xref><sup>,</sup><xref rid="bb0730" ref-type="bibr"><sup>146</sup></xref><sup>,</sup><xref rid="bb0745" ref-type="bibr"><sup>149</sup></xref> Overall, zopiclone was the most frequently studied of all drugs.</p><p id="p0135">Some studies compared different BZRAs or used the BZRA as a comparator, including studies that had another non-BZRA being researched. For example, Vermeeren et al.<xref rid="bb0685" ref-type="bibr"><sup>137</sup></xref> compared zolpidem, flunitrazepam, and placebo in a double-blind crossover trial. Mercier-Guyonx et al.<xref rid="bb0530" ref-type="bibr"><sup>106</sup></xref> examined lorazepam versus an antihistamine.</p></sec><sec id="s0105"><label>4.4</label><title>Driving impairment setting and measures overview</title><p id="p0140">When examining the study design and methods of experimental studies, we found that two defining features are important: where the study takes place, denoted as the driving impairment assessment setting (<xref rid="t0010" ref-type="table">Table 2</xref>); and driving impairment measures (<xref rid="t0015" ref-type="table">Table 3</xref>). These two features appeared to guide how studies are conducted.<table-wrap position="float" id="t0010" orientation="portrait"><label>Table 2</label><caption><p>Driving setting, description, and approximation of actual driving conditions in experimental studies.</p></caption><alt-text id="al0025">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Driving Setting</th><th colspan="1" rowspan="1">Description</th><th colspan="1" rowspan="1">Approximation of driving conditions</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Road traffic driving</td><td colspan="1" rowspan="1">Participants drive a real car on roads with other drivers.</td><td colspan="1" rowspan="1">Highest fidelity</td></tr><tr><td colspan="1" rowspan="1">Driving course (non-traffic)</td><td colspan="1" rowspan="1">Participants drive a real car on closed roads with no other drivers.</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Simulated car driving</td><td colspan="1" rowspan="1">Participants are placed in a specially instrumented car indoors that mimics real road driving.</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Simulated computer driving</td><td colspan="1" rowspan="1">Participants use a computer to simulate driving.</td><td colspan="1" rowspan="1">Lowest fidelity</td></tr></tbody></table></table-wrap><table-wrap position="float" id="t0015" orientation="portrait"><label>Table 3</label><caption><p>Four most common measures to assess driving performance and impairment in experimental studies.</p></caption><alt-text id="al0030">Table 3</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Measure of driving impairment</th><th colspan="1" rowspan="1">Description</th><th colspan="1" rowspan="1">Interpretation</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Standard Deviation of Lateral Position (SDLP)<xref rid="bb0450" ref-type="bibr"><sup>90</sup></xref><sup>,</sup><xref rid="bb0710" ref-type="bibr"><sup>142</sup></xref></td><td colspan="1" rowspan="1">The participants' task is to drive in the center of the designated traffic lane while maintaining a constant speed. Deviations from the center of the lane are recorded.</td><td colspan="1" rowspan="1">Higher SDLP values are associated with a greater degree of driving impairment.</td></tr><tr><td colspan="1" rowspan="1">Standard Deviation of Speed (SDS)<xref rid="bb0710" ref-type="bibr"><sup>142</sup></xref></td><td colspan="1" rowspan="1">The participants' task is to drive at a constant predetermined speed. Deviations from the instructed driving speed are recorded.</td><td colspan="1" rowspan="1">Higher SDS values are associated with a greater degree of driving impairment.</td></tr><tr><td colspan="1" rowspan="1">Number of Road Exits (#RE)<xref rid="bb0740" ref-type="bibr"><sup>148</sup></xref></td><td colspan="1" rowspan="1">Road exits are events where the participant driving leaves the lane unintentionally, either to another traffic lane or the shoulder of the road.</td><td colspan="1" rowspan="1">Higher number of road exits are associated with a greater degree of driving impairment.</td></tr><tr><td colspan="1" rowspan="1">Brake Reaction Time (BRT)<xref rid="bb0365" ref-type="bibr"><sup>73</sup></xref></td><td colspan="1" rowspan="1">The participants' task is to brake when instructed. The participants reaction time is recorded.</td><td colspan="1" rowspan="1">Longer brake reaction times are associated with a greater degree of driving impairment.</td></tr></tbody></table></table-wrap></p><p id="p0145">With respect to Standard Deviation of Lateral Position (SDLP; weaving of the car) and Standard Deviation of Speed (SDS), the mean lateral position and the mean speed are continuously recorded and SDLP and the SDS are computed, respectively. The SDLP test has been shown to demonstrate dose-dependent impairment for alcohol, illicit drugs, as well as some sedative-hypnotic medications, antidepressants, and antihistamines.<xref rid="bb0210" ref-type="bibr"><sup>42</sup></xref> The Number of Road Exits (#RE) are counts of the events where those driving leave the lane unintentionally, either to another traffic lane or the shoulder of the road.<xref rid="bb0740" ref-type="bibr"><sup>148</sup></xref> This may represent loss of control of the vehicle. Other commonly used and related terminology includes excursions out-of-lane<xref rid="bb0740" ref-type="bibr"><sup>148</sup></xref> and inappropriate line crossings.<xref rid="bb0395" ref-type="bibr"><sup>79</sup></xref><sup>,</sup><xref rid="bb0445" ref-type="bibr"><sup>89</sup></xref></p><p id="p0150">Within driving setting, it was noted that there was use of two broad categories: real road driving, and simulated driving. Nuances exist within these categories. For example, road driving could occur in real traffic or on a driving course. Studies using simulated driving could include a simulated car or a computer-based mechanism to simulate the driving experience. Driving simulators range from fully interactive systems using instrumented vehicles with 360-degree view to computer desktop systems. They are capable of assessing performance in a safe and controlled manner, however, are criticized for limited realism.<xref rid="bb0200" ref-type="bibr"><sup>40</sup></xref> Lastly, laboratory cognitive tasks permit an assessment of a single isolated aspect of driving performance in a controlled environment. However, these are limited in their validity to compare to real-life driving and are questionable in whether they can be accurately used to predict accident risk.<xref rid="bb0200" ref-type="bibr"><sup>40</sup></xref> Other assessments used infrequently in the studies were varied (e.g., gap estimation/acceptance task, weaving task, parking task, speed exceedances, mean speed, etc.)</p></sec><sec id="s0110"><label>4.5</label><title>Driving impairment setting</title><p id="p0155">Except for three studies by Daurat et al.<xref rid="bb0395" ref-type="bibr"><sup>79</sup></xref> and Volkerts et al.,<xref rid="bb0750" ref-type="bibr"><sup>150</sup></xref> both of which used road driving (traffic) and simulated driving (car), and Laurell and Tornros<xref rid="bb0470" ref-type="bibr"><sup>94</sup></xref> who used driving course (non-traffic) and simulated driving (car), all experimental studies used only one driving setting. Nontraffic driving course was used in eight studies,<xref rid="bb0340" ref-type="bibr"><sup>68</sup></xref><sup>,</sup><xref rid="bb0345" ref-type="bibr"><sup>69</sup></xref><sup>,</sup><xref rid="bb0365" ref-type="bibr"><sup>73</sup></xref><sup>,</sup><xref rid="bb0420" ref-type="bibr">84</xref>, <xref rid="bb0425" ref-type="bibr">85</xref>, <xref rid="bb0430" ref-type="bibr">86</xref><sup>,</sup><xref rid="bb0530" ref-type="bibr"><sup>106</sup></xref><sup>,</sup><xref rid="bb0755" ref-type="bibr"><sup>151</sup></xref> and simulated driving with a computer was used in nine.<xref rid="bb0335" ref-type="bibr"><sup>67</sup></xref><sup>,</sup><xref rid="bb0385" ref-type="bibr"><sup>77</sup></xref><sup>,</sup><xref rid="bb0390" ref-type="bibr"><sup>78</sup></xref><sup>,</sup><xref rid="bb0440" ref-type="bibr"><sup>88</sup></xref><sup>,</sup><xref rid="bb0465" ref-type="bibr"><sup>93</sup></xref><sup>,</sup><xref rid="bb0525" ref-type="bibr"><sup>105</sup></xref><sup>,</sup><xref rid="bb0620" ref-type="bibr"><sup>124</sup></xref><sup>,</sup><xref rid="bb0640" ref-type="bibr"><sup>128</sup></xref><sup>,</sup><xref rid="bb0760" ref-type="bibr"><sup>152</sup></xref> Simulated driving in a car and road driving in traffic were most used with 36 studies each (Appendix III). Most driving course studies (nontraffic) have been conducted in the UK.<xref rid="bb0340" ref-type="bibr"><sup>68</sup></xref><sup>,</sup><xref rid="bb0345" ref-type="bibr"><sup>69</sup></xref><sup>,</sup><xref rid="bb0365" ref-type="bibr"><sup>73</sup></xref><sup>,</sup><xref rid="bb0420" ref-type="bibr">84</xref>, <xref rid="bb0425" ref-type="bibr">85</xref>, <xref rid="bb0430" ref-type="bibr">86</xref><sup>,</sup><xref rid="bb0755" ref-type="bibr"><sup>151</sup></xref> Simulated car driving tests and simulated computer driving tests have been conducted in multiple countries without a clear trend.</p></sec><sec id="s0115"><label>4.6</label><title>Driving impairment measures</title><p id="p0160">The ways in which driving impairment were measured or quantified differed across the experimental studies. Most employed multiple driving impairment measures (Appendix III). For example, SDLP was most commonly used in 54 of 92 (62&#160;%) trials of which 12 used it as the sole measure.<xref rid="bb0370" ref-type="bibr"><sup>74</sup></xref><sup>,</sup><xref rid="bb0435" ref-type="bibr"><sup>87</sup></xref><sup>,</sup><xref rid="bb0450" ref-type="bibr"><sup>90</sup></xref><sup>,</sup><xref rid="bb0575" ref-type="bibr">115</xref>, <xref rid="bb0580" ref-type="bibr">116</xref>, <xref rid="bb0585" ref-type="bibr">117</xref><sup>,</sup><xref rid="bb0605" ref-type="bibr"><sup>121</sup></xref><sup>,</sup><xref rid="bb0670" ref-type="bibr"><sup>134</sup></xref><sup>,</sup><xref rid="bb0685" ref-type="bibr"><sup>137</sup></xref><sup>,</sup><xref rid="bb0705" ref-type="bibr"><sup>141</sup></xref><sup>,</sup><xref rid="bb0720" ref-type="bibr"><sup>144</sup></xref> All were conducted in the Netherlands (Appendix IV). Country trends were less clear regarding some measures used to assess performance. For example, in driving course studies (nontraffic) from the UK,<xref rid="bb0340" ref-type="bibr"><sup>68</sup></xref><sup>,</sup><xref rid="bb0345" ref-type="bibr"><sup>69</sup></xref><sup>,</sup><xref rid="bb0365" ref-type="bibr"><sup>73</sup></xref><sup>,</sup><xref rid="bb0420" ref-type="bibr">84</xref>, <xref rid="bb0425" ref-type="bibr">85</xref>, <xref rid="bb0430" ref-type="bibr">86</xref><sup>,</sup><xref rid="bb0755" ref-type="bibr"><sup>151</sup></xref> three used an individual measure such as Brake Reaction Time (BRT)<xref rid="bb0365" ref-type="bibr"><sup>73</sup></xref><sup>,</sup><xref rid="bb0430" ref-type="bibr"><sup>86</sup></xref> and gap estimation/acceptance task,<xref rid="bb0755" ref-type="bibr"><sup>151</sup></xref> while the remainder used combinations of methods.</p><p id="p0165">There were other patterns of measures co-occurring frequently together (Appendix IV). For example, SDS was almost exclusively used alongside SDLP. Only one study was conducted by Otmani et al.,<xref rid="bb0590" ref-type="bibr"><sup>118</sup></xref> employing SDS without SDLP. Other measures were used with SDS including mean speed and number of collisions.<xref rid="bb0590" ref-type="bibr"><sup>118</sup></xref></p></sec><sec id="s0120"><label>4.7</label><title>Driving impairment settings' and measures' trends</title><p id="p0170">Certain driving impairment measures were used more commonly in specific driving impairment assessment settings. For example, SDLP and SDS are heavily used in road traffic driving and simulated car driving (Appendix III), while they are less frequently used in driving course or simulated computer driving settings. Conversely, other measures such as number of Road Exits (#REs) were used in 19 studies<xref rid="bb0355" ref-type="bibr"><sup>71</sup></xref><sup>,</sup><xref rid="bb0380" ref-type="bibr"><sup>76</sup></xref><sup>,</sup><xref rid="bb0395" ref-type="bibr"><sup>79</sup></xref><sup>,</sup><xref rid="bb0415" ref-type="bibr"><sup>83</sup></xref><sup>,</sup><xref rid="bb0445" ref-type="bibr"><sup>89</sup></xref><sup>,</sup><xref rid="bb0455" ref-type="bibr"><sup>91</sup></xref><sup>,</sup><xref rid="bb0460" ref-type="bibr"><sup>92</sup></xref><sup>,</sup><xref rid="bb0505" ref-type="bibr">101</xref>, <xref rid="bb0510" ref-type="bibr">102</xref>, <xref rid="bb0515" ref-type="bibr">103</xref><sup>,</sup><xref rid="bb0545" ref-type="bibr"><sup>109</sup></xref><sup>,</sup><xref rid="bb0555" ref-type="bibr"><sup>111</sup></xref><sup>,</sup><xref rid="bb0560" ref-type="bibr"><sup>112</sup></xref><sup>,</sup><xref rid="bb0630" ref-type="bibr"><sup>126</sup></xref><sup>,</sup><xref rid="bb0635" ref-type="bibr"><sup>127</sup></xref><sup>,</sup><xref rid="bb0660" ref-type="bibr"><sup>132</sup></xref><sup>,</sup><xref rid="bb0680" ref-type="bibr"><sup>136</sup></xref><sup>,</sup><xref rid="bb0730" ref-type="bibr"><sup>146</sup></xref><sup>,</sup><xref rid="bb0740" ref-type="bibr"><sup>148</sup></xref> and infrequently used in road traffic driving or driving course settings. Number of road exits was more commonly used in both car and computer simulated driving setting (Appendix III). The metric #REs was never used as the sole measure of impairment.</p><p id="p0175">Brake reaction time was used as the sole metric in four studies<xref rid="bb0330" ref-type="bibr"><sup>66</sup></xref><sup>,</sup><xref rid="bb0365" ref-type="bibr"><sup>73</sup></xref><sup>,</sup><xref rid="bb0430" ref-type="bibr"><sup>86</sup></xref><sup>,</sup><xref rid="bb0650" ref-type="bibr"><sup>130</sup></xref> and used for assessment on a driving course (non-traffic)<xref rid="bb0365" ref-type="bibr"><sup>73</sup></xref><sup>,</sup><xref rid="bb0430" ref-type="bibr"><sup>86</sup></xref> and in two studies with simulated driving in a car.<xref rid="bb0330" ref-type="bibr"><sup>66</sup></xref><sup>,</sup><xref rid="bb0650" ref-type="bibr"><sup>130</sup></xref> Eighteen studies used BRT in combination with other measures, and most (<italic toggle="yes">n</italic>&#160;=&#160;11) studies<xref rid="bb0330" ref-type="bibr"><sup>66</sup></xref><sup>,</sup><xref rid="bb0405" ref-type="bibr">81</xref>, <xref rid="bb0410" ref-type="bibr">82</xref>, <xref rid="bb0415" ref-type="bibr">83</xref><sup>,</sup><xref rid="bb0445" ref-type="bibr"><sup>89</sup></xref><sup>,</sup><xref rid="bb0510" ref-type="bibr"><sup>102</sup></xref><sup>,</sup><xref rid="bb0545" ref-type="bibr"><sup>109</sup></xref><sup>,</sup><xref rid="bb0610" ref-type="bibr"><sup>122</sup></xref><sup>,</sup><xref rid="bb0645" ref-type="bibr">129</xref>, <xref rid="bb0650" ref-type="bibr">130</xref>, <xref rid="bb0655" ref-type="bibr">131.</xref> used the measure to assess performance in simulated driving (car). Three studies used a non-traffic driving course.<xref rid="bb0365" ref-type="bibr"><sup>73</sup></xref><sup>,</sup><xref rid="bb0425" ref-type="bibr"><sup>85</sup></xref> Laurell and Tornros<xref rid="bb0470" ref-type="bibr"><sup>94</sup></xref> used both driving course (non-traffic) and simulated driving in a car with the BRT, whilst road driving was used by Leufkens et al.<xref rid="bb0500" ref-type="bibr"><sup>100</sup></xref> Two studies by Carter et al.<xref rid="bb0385" ref-type="bibr"><sup>77</sup></xref><sup>,</sup><xref rid="bb0390" ref-type="bibr"><sup>78</sup></xref> used simulated driving with a computer.</p><p id="p0180">Similarly, certain BZRAs have been studied more frequently using driving settings and driving impairment measures (<xref rid="f0010" ref-type="fig">Fig. 2</xref>, <xref rid="f0015" ref-type="fig">Fig. 3</xref>, Appendix IV). For example, zopiclone has been studied most using road traffic driving and the SDLP.<fig id="f0010" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Driving impairment measures and benzodiazepine receptor agonists in experimental studies.</p><p>SDLP: Standard Deviation of Lateral Position; SDS: Standard Deviation of Speed; BRT: Brake Reaction Time; #RE: Number of Road Exits.</p></caption><alt-text id="al0010">Fig. 2</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="lk0010" position="float" orientation="portrait" xlink:href="gr2.jpg"/></fig><fig id="f0015" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>Driving settings and benzodiazepine receptor agonists in experimental studies.</p></caption><alt-text id="al0015">Fig. 3</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="lk0015" position="float" orientation="portrait" xlink:href="gr3.jpg"/></fig></p></sec><sec id="s0125"><label>4.8</label><title>Impairment</title><p id="p0185">Authors' interpretation related to driving impairment, focusing on primary outcomes, was grouped into three categories: 1) no driving impairment identified; 2) driving impairment identified; and 3) mixed results &#8211; driving impairment identified with some measures. Seventy-eight of the 92 (85&#160;%) studies had at least one measure that identified impairment. Forty-one studies found impairment in the study measures and 37 studies (Appendix III) were categorized as having mixed results, with impairment identified at least one or more, but not all measures. There were multiple measures used, except for four studies,<xref rid="bb0365" ref-type="bibr"><sup>73</sup></xref><sup>,</sup><xref rid="bb0650" ref-type="bibr"><sup>130</sup></xref><sup>,</sup><xref rid="bb0685" ref-type="bibr"><sup>137</sup></xref><sup>,</sup><xref rid="bb0755" ref-type="bibr"><sup>151</sup></xref> where driving impairment was found.</p><p id="p0190">No driving impairment was reported by the authors for the primary endpoint in 14 studies in a total of 2529 people.<xref rid="bb0365" ref-type="bibr"><sup>73</sup></xref><sup>,</sup><xref rid="bb0385" ref-type="bibr"><sup>77</sup></xref><sup>,</sup><xref rid="bb0390" ref-type="bibr"><sup>78</sup></xref><sup>,</sup><xref rid="bb0405" ref-type="bibr">81</xref>, <xref rid="bb0410" ref-type="bibr">82</xref>, <xref rid="bb0415" ref-type="bibr">83</xref>, <xref rid="bb0420" ref-type="bibr">84</xref><sup>,</sup><xref rid="bb0440" ref-type="bibr"><sup>88</sup></xref><sup>,</sup><xref rid="bb0495" ref-type="bibr"><sup>99</sup></xref><sup>,</sup><xref rid="bb0515" ref-type="bibr"><sup>103</sup></xref><sup>,</sup><xref rid="bb0600" ref-type="bibr"><sup>120</sup></xref><sup>,</sup><xref rid="bb0650" ref-type="bibr"><sup>130</sup></xref><sup>,</sup><xref rid="bb0685" ref-type="bibr"><sup>137</sup></xref><sup>,</sup><xref rid="bb0755" ref-type="bibr"><sup>151</sup></xref> Six<xref rid="bb0365" ref-type="bibr"><sup>73</sup></xref><sup>,</sup><xref rid="bb0385" ref-type="bibr"><sup>77</sup></xref><sup>,</sup><xref rid="bb0390" ref-type="bibr"><sup>78</sup></xref><sup>,</sup><xref rid="bb0495" ref-type="bibr"><sup>99</sup></xref><sup>,</sup><xref rid="bb0600" ref-type="bibr"><sup>120</sup></xref><sup>,</sup><xref rid="bb0710" ref-type="bibr"><sup>142</sup></xref> of these studies explored <italic toggle="yes">Z</italic>-drugs. Diazepam<xref rid="bb0415" ref-type="bibr"><sup>83</sup></xref><sup>,</sup><xref rid="bb0515" ref-type="bibr"><sup>103</sup></xref><sup>,</sup><xref rid="bb0755" ref-type="bibr"><sup>151</sup></xref> and zolpidem<xref rid="bb0495" ref-type="bibr"><sup>99</sup></xref><sup>,</sup><xref rid="bb0600" ref-type="bibr"><sup>120</sup></xref><sup>,</sup><xref rid="bb0685" ref-type="bibr"><sup>137</sup></xref> were the most common individual drugs studied in three studies each (Appendix IV).</p></sec><sec id="s0130"><label>4.9</label><title>BZRA dosing, dose timing, and duration of therapy</title><p id="p0195">In experimental studies, the BZRA dosing compared to placebo (Appendix V) varied from 5&#160;mg to 30&#160;mg diazepam-equivalents, and the time between administration and impairment testing ranged from 0.5&#160;h to 36&#160;h among studies. The consecutive days of dosing was most often one (<italic toggle="yes">n</italic>&#160;=&#160;34<xref rid="bb0330" ref-type="bibr"><sup>66</sup></xref><sup>,</sup><xref rid="bb0340" ref-type="bibr"><sup>68</sup></xref><sup>,</sup><xref rid="bb0365" ref-type="bibr"><sup>73</sup></xref><sup>,</sup><xref rid="bb0380" ref-type="bibr"><sup>76</sup></xref><sup>,</sup><xref rid="bb0390" ref-type="bibr">78.</xref>, <xref rid="bb0395" ref-type="bibr">79</xref>, <xref rid="bb0400" ref-type="bibr">80</xref><sup>,</sup><xref rid="bb0435" ref-type="bibr"><sup>87</sup></xref><sup>,</sup><xref rid="bb0445" ref-type="bibr"><sup>89</sup></xref><sup>,</sup><xref rid="bb0455" ref-type="bibr"><sup>91</sup></xref><sup>,</sup><xref rid="bb0460" ref-type="bibr"><sup>92</sup></xref><sup>,</sup><xref rid="bb0490" ref-type="bibr"><sup>98</sup></xref><sup>,</sup><xref rid="bb0500" ref-type="bibr"><sup>100</sup></xref><sup>,</sup><xref rid="bb0510" ref-type="bibr">102</xref>, <xref rid="bb0515" ref-type="bibr">103</xref>, <xref rid="bb0520" ref-type="bibr">104</xref><sup>,</sup><xref rid="bb0540" ref-type="bibr">108</xref>, <xref rid="bb0545" ref-type="bibr">109</xref>, <xref rid="bb0550" ref-type="bibr">110</xref><sup>,</sup><xref rid="bb0560" ref-type="bibr"><sup>112</sup></xref><sup>,</sup><xref rid="bb0565" ref-type="bibr"><sup>113</sup></xref><sup>,</sup><xref rid="bb0605" ref-type="bibr"><sup>121</sup></xref><sup>,</sup><xref rid="bb0610" ref-type="bibr"><sup>122</sup></xref><sup>,</sup><xref rid="bb0630" ref-type="bibr"><sup>126</sup></xref><sup>,</sup><xref rid="bb0635" ref-type="bibr"><sup>127</sup></xref><sup>,</sup><xref rid="bb0645" ref-type="bibr"><sup>129</sup></xref><sup>,</sup><xref rid="bb0655" ref-type="bibr">131.</xref>, <xref rid="bb0660" ref-type="bibr">132</xref>, <xref rid="bb0665" ref-type="bibr">133</xref><sup>,</sup><xref rid="bb0710" ref-type="bibr">142</xref>, <xref rid="bb0715" ref-type="bibr">143</xref>, <xref rid="bb0720" ref-type="bibr">144.</xref><sup>,</sup><xref rid="bb0730" ref-type="bibr"><sup>146</sup></xref>) and up to 30&#160;days.<xref rid="bb0385" ref-type="bibr"><sup>77</sup></xref></p><p id="p0200">For studies comparing BZRAs to active comparators and placebo (Appendix VI), dosing of diazepam-equivalents ranged from 1.75&#160;mg up to 30&#160;mg. T&#246;rnros et al.<xref rid="bb0655" ref-type="bibr"><sup>131</sup></xref> included one participant with 60&#160;mg diazepam-equivalents, but data were grouped and not presented for individual BZRAs in their analyses. The time between BZRA administration and impairment testing varied (e.g., 0.5 to 17&#160;h), and similar to placebo-only comparative studies, the number of consecutive days of dosing was most often one (Appendix VI). Several studies (e.g., T&#246;rnros et al.,<xref rid="bb0655" ref-type="bibr"><sup>131</sup></xref> van der Sluiszen et al.,<xref rid="bb0670" ref-type="bibr"><sup>134</sup></xref> Vinckenbosch et al.<xref rid="bb0745" ref-type="bibr"><sup>149</sup></xref>) included people who had been prescribed BZRAs for lengthy time periods (e.g. more than 6&#160;months to &#8220;years&#8221;).</p></sec></sec><sec id="s0135"><label>5</label><title>Review findings &#8211; Observational studies</title><sec id="s0140"><label>5.1</label><title>Country and date of publication</title><p id="p0205">Observational studies (Appendix VII) were conducted in 24 different countries from around the world with the majority being in Norway (<xref rid="t0020" ref-type="table">Table 4</xref>).<table-wrap position="float" id="t0020" orientation="portrait"><label>Table 4</label><caption><p>Country of publication and number of observational studies<xref rid="tf0010" ref-type="table-fn">a</xref>.</p></caption><alt-text id="al0035">Table 4</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Country</th><th colspan="1" rowspan="1">Number of Observational Studies</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">United States, Sweden</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">Canada</td><td colspan="1" rowspan="1">9</td></tr><tr><td colspan="1" rowspan="1">Australia</td><td colspan="1" rowspan="1">8</td></tr><tr><td colspan="1" rowspan="1">Finland</td><td colspan="1" rowspan="1">7</td></tr><tr><td colspan="1" rowspan="1">Denmark</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Italy, Netherlands</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">Poland, UK<xref rid="tf0015" ref-type="table-fn">b</xref></td><td colspan="1" rowspan="1">4</td></tr><tr><td colspan="1" rowspan="1">Belgium, Spain, Taiwan</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Slovakia, Switzerland, Jordan, Brazil, France, New Zealand, Greece, Iceland, Lithuania, Portugal</td><td colspan="1" rowspan="1">1</td></tr></tbody></table><table-wrap-foot><fn id="tf0010"><label>a</label><p id="np0010">The numbers do not sum to 91 because some studies involved more than one country.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0015"><label>b</label><p id="np0015">United Kingdom was used as the code for studies from Scotland, England, Wales, and/or Northern Ireland.</p></fn></table-wrap-foot></table-wrap></p><p id="p0210">Trends in publications per decade were similar to experimental studies. There were 33/91 (36&#160;%) published between 2010 and 2019 inclusive (<italic toggle="yes">n</italic>&#160;=&#160;26, 2000s; <italic toggle="yes">n</italic>&#160;=&#160;13, 1990s; <italic toggle="yes">n</italic>&#160;=&#160;4, 1980s; <italic toggle="yes">n</italic>&#160;=&#160;3, 1970s) (Appendix V). Since 2020 to the time of the search, there were 12 observational studies published.</p></sec><sec id="s0145"><label>5.2</label><title>Population demographics</title><p id="p0215">There was a total of 14,968,248 people in the observational studies. The sex was known for 11,483,838 participants with females comprising 44&#160;% of participants and males were 56&#160;%. Ages of participants in the observational studies ranged from 16 to 93&#160;years old with a mean age of 35.9&#160;years. There were eight analyses that included drivers 50&#160;years of age and older.<xref rid="bb0825" ref-type="bibr"><sup>165</sup></xref><sup>,</sup><xref rid="bb0925" ref-type="bibr"><sup>185</sup></xref><sup>,</sup><xref rid="bb0965" ref-type="bibr"><sup>193</sup></xref><sup>,</sup><xref rid="bb0975" ref-type="bibr"><sup>195</sup></xref><sup>,</sup><xref rid="bb0995" ref-type="bibr"><sup>199</sup></xref><sup>,</sup><xref rid="bb1100" ref-type="bibr"><sup>220</sup></xref><sup>,</sup><xref rid="bb1135" ref-type="bibr"><sup>227</sup></xref></p></sec><sec id="s0150"><label>5.3</label><title>Study design</title><p id="p0220">There were 21 case-control,<xref rid="bb0795" ref-type="bibr"><sup>159</sup></xref><sup>,</sup><xref rid="bb0820" ref-type="bibr"><sup>164</sup></xref><sup>,</sup><xref rid="bb0845" ref-type="bibr"><sup>169</sup></xref><sup>,</sup><xref rid="bb0875" ref-type="bibr"><sup>175</sup></xref><sup>,</sup><xref rid="bb0900" ref-type="bibr">180</xref>, <xref rid="bb0905" ref-type="bibr">181</xref>, <xref rid="bb0910" ref-type="bibr">182.</xref>, <xref rid="bb0915" ref-type="bibr">183</xref><sup>,</sup><xref rid="bb0925" ref-type="bibr"><sup>185</sup></xref><sup>,</sup><xref rid="bb0940" ref-type="bibr"><sup>188</sup></xref><sup>,</sup><xref rid="bb0950" ref-type="bibr"><sup>190</sup></xref><sup>,</sup><xref rid="bb0965" ref-type="bibr"><sup>193</sup></xref><sup>,</sup><xref rid="bb0985" ref-type="bibr">197</xref>, <xref rid="bb0990" ref-type="bibr">198.</xref>, <xref rid="bb0995" ref-type="bibr">199</xref><sup>,</sup><xref rid="bb1055" ref-type="bibr"><sup>211</sup></xref><sup>,</sup><xref rid="bb1065" ref-type="bibr"><sup>213</sup></xref><sup>,</sup><xref rid="bb1075" ref-type="bibr"><sup>215</sup></xref><sup>,</sup><xref rid="bb1080" ref-type="bibr"><sup>216</sup></xref><sup>,</sup><xref rid="bb1100" ref-type="bibr"><sup>220</sup></xref><sup>,</sup><xref rid="bb1105" ref-type="bibr"><sup>221</sup></xref> 12 cohort,<xref rid="bb0115" ref-type="bibr"><sup>23</sup></xref><sup>,</sup><xref rid="bb0825" ref-type="bibr">165</xref>, <xref rid="bb0830" ref-type="bibr">166</xref>, <xref rid="bb0835" ref-type="bibr">167</xref><sup>,</sup><xref rid="bb0955" ref-type="bibr"><sup>191</sup></xref><sup>,</sup><xref rid="bb0975" ref-type="bibr"><sup>195</sup></xref><sup>,</sup><xref rid="bb1055" ref-type="bibr"><sup>211</sup></xref><sup>,</sup><xref rid="bb1085" ref-type="bibr">217</xref>, <xref rid="bb1090" ref-type="bibr">218</xref>, <xref rid="bb1095" ref-type="bibr">219.</xref><sup>,</sup><xref rid="bb1115" ref-type="bibr"><sup>223</sup></xref><sup>,</sup><xref rid="bb1135" ref-type="bibr"><sup>227</sup></xref> 4 case-crossover<xref rid="bb0800" ref-type="bibr"><sup>160</sup></xref><sup>,</sup><xref rid="bb1100" ref-type="bibr"><sup>220</sup></xref><sup>,</sup><xref rid="bb1115" ref-type="bibr"><sup>223</sup></xref><sup>,</sup><xref rid="bb1205" ref-type="bibr"><sup>241</sup></xref> studies, and the remainder were non-comparative (Appendix VII).</p></sec><sec id="s0155"><label>5.4</label><title>BZRAs studied</title><p id="p0225">Most studies had multiple BZRAs represented in the data, prescription drugs, or alcohol as part of the assessment. When examining <italic toggle="yes">Z</italic>-drugs specifically, there were 18 publications with 20 studies.<xref rid="bb0115" ref-type="bibr"><sup>23</sup></xref><sup>,</sup><xref rid="bb0795" ref-type="bibr"><sup>159</sup></xref><sup>,</sup><xref rid="bb0820" ref-type="bibr"><sup>164</sup></xref><sup>,</sup><xref rid="bb0825" ref-type="bibr"><sup>165</sup></xref><sup>,</sup><xref rid="bb0845" ref-type="bibr"><sup>169</sup></xref><sup>,</sup><xref rid="bb0875" ref-type="bibr"><sup>175</sup></xref><sup>,</sup><xref rid="bb0890" ref-type="bibr"><sup>178</sup></xref><sup>,</sup><xref rid="bb0950" ref-type="bibr"><sup>190</sup></xref><sup>,</sup><xref rid="bb0955" ref-type="bibr"><sup>191</sup></xref><sup>,</sup><xref rid="bb0980" ref-type="bibr"><sup>196</sup></xref><sup>,</sup><xref rid="bb0990" ref-type="bibr"><sup>198</sup></xref><sup>,</sup><xref rid="bb1005" ref-type="bibr"><sup>201</sup></xref><sup>,</sup><xref rid="bb1040" ref-type="bibr">208</xref>, <xref rid="bb1045" ref-type="bibr">209</xref>, <xref rid="bb1050" ref-type="bibr">210</xref><sup>,</sup><xref rid="bb1100" ref-type="bibr"><sup>220</sup></xref><sup>,</sup><xref rid="bb1115" ref-type="bibr"><sup>223</sup></xref><sup>,</sup><xref rid="bb1205" ref-type="bibr"><sup>241</sup></xref></p></sec><sec id="s0160"><label>5.5</label><title>Driving impairment measures</title><p id="p0230">The most common method reported in the observational studies was biological detection (e.g., urine, blood) (<italic toggle="yes">n</italic>&#160;=&#160;73) (Appendix VII) followed by prescription drug records (e.g., dispensing records for prescriptions) (<italic toggle="yes">n</italic>&#160;=&#160;17).<xref rid="bb0115" ref-type="bibr"><sup>23</sup></xref><sup>,</sup><xref rid="bb0800" ref-type="bibr"><sup>160</sup></xref><sup>,</sup><xref rid="bb0845" ref-type="bibr"><sup>169</sup></xref><sup>,</sup><xref rid="bb0875" ref-type="bibr"><sup>175</sup></xref><sup>,</sup><xref rid="bb0925" ref-type="bibr"><sup>185</sup></xref><sup>,</sup><xref rid="bb0965" ref-type="bibr"><sup>193</sup></xref><sup>,</sup><xref rid="bb0995" ref-type="bibr"><sup>199</sup></xref><sup>,</sup><xref rid="bb1085" ref-type="bibr">217</xref>, <xref rid="bb1090" ref-type="bibr">218</xref>, <xref rid="bb1095" ref-type="bibr">219.</xref>, <xref rid="bb1100" ref-type="bibr">220.</xref>, <xref rid="bb1105" ref-type="bibr">221</xref><sup>,</sup><xref rid="bb1115" ref-type="bibr"><sup>223</sup></xref><sup>,</sup><xref rid="bb1135" ref-type="bibr"><sup>227</sup></xref><sup>,</sup><xref rid="bb1205" ref-type="bibr"><sup>241</sup></xref> A pill bottle review occurred in one study.<xref rid="bb0825" ref-type="bibr"><sup>165</sup></xref></p></sec><sec id="s0165"><label>5.6</label><title>Driving impairment measures' and outcomes' trends</title><p id="p0235">Unlike experimental studies, impairment was described in observational studies (Appendix VII) in multiple ways, and with many studies including multiple different outcomes. For example, motor vehicle accidents (<italic toggle="yes">n</italic>&#160;=&#160;59), driving while impaired (DWI) suspected (<italic toggle="yes">n</italic>&#160;=&#160;42), fatal MVA (<italic toggle="yes">n</italic>&#160;=&#160;23)<xref rid="bb0775" ref-type="bibr">155</xref>, <xref rid="bb0780" ref-type="bibr">156</xref>, <xref rid="bb0785" ref-type="bibr">157.</xref>, <xref rid="bb0790" ref-type="bibr">158</xref><sup>,</sup><xref rid="bb0865" ref-type="bibr"><sup>173</sup></xref><sup>,</sup><xref rid="bb0895" ref-type="bibr">179</xref>, <xref rid="bb0900" ref-type="bibr">180</xref>, <xref rid="bb0905" ref-type="bibr">181</xref><sup>,</sup><xref rid="bb0915" ref-type="bibr"><sup>183</sup></xref><sup>,</sup><xref rid="bb0935" ref-type="bibr">187</xref>, <xref rid="bb0940" ref-type="bibr">188.</xref>, <xref rid="bb0945" ref-type="bibr">189</xref>, <xref rid="bb0950" ref-type="bibr">190</xref><sup>,</sup><xref rid="bb1045" ref-type="bibr"><sup>209</sup></xref><sup>,</sup><xref rid="bb1065" ref-type="bibr"><sup>213</sup></xref><sup>,</sup><xref rid="bb1070" ref-type="bibr"><sup>214</sup></xref><sup>,</sup><xref rid="bb1130" ref-type="bibr">226</xref>, <xref rid="bb1135" ref-type="bibr">227</xref>, <xref rid="bb1140" ref-type="bibr">228.</xref><sup>,</sup><xref rid="bb1150" ref-type="bibr"><sup>230</sup></xref><sup>,</sup><xref rid="bb1155" ref-type="bibr"><sup>231</sup></xref><sup>,</sup><xref rid="bb1190" ref-type="bibr"><sup>238</sup></xref><sup>,</sup><xref rid="bb1195" ref-type="bibr"><sup>239</sup></xref> and 10 or fewer studies having others (e.g., accessing emergency services, hospitalization, injuries, etc). Of the 17<xref rid="bb0115" ref-type="bibr"><sup>23</sup></xref><sup>,</sup><xref rid="bb0800" ref-type="bibr"><sup>160</sup></xref><sup>,</sup><xref rid="bb0845" ref-type="bibr"><sup>169</sup></xref><sup>,</sup><xref rid="bb0875" ref-type="bibr"><sup>175</sup></xref><sup>,</sup><xref rid="bb0925" ref-type="bibr"><sup>185</sup></xref><sup>,</sup><xref rid="bb0965" ref-type="bibr"><sup>193</sup></xref><sup>,</sup><xref rid="bb0995" ref-type="bibr"><sup>199</sup></xref><sup>,</sup><xref rid="bb1085" ref-type="bibr">217</xref>, <xref rid="bb1090" ref-type="bibr">218</xref>, <xref rid="bb1095" ref-type="bibr">219.</xref>, <xref rid="bb1100" ref-type="bibr">220.</xref>, <xref rid="bb1105" ref-type="bibr">221</xref><sup>,</sup><xref rid="bb1115" ref-type="bibr"><sup>223</sup></xref><sup>,</sup><xref rid="bb1135" ref-type="bibr"><sup>227</sup></xref><sup>,</sup><xref rid="bb1205" ref-type="bibr"><sup>241</sup></xref> studies using prescription records, all had MVA involvement (e.g., MVA, MVA with injury, fatal MVA, etc.). Of all the studies that used suspected DWI as at least one of their measures (n&#160;=&#160;42), all but four<xref rid="bb0800" ref-type="bibr"><sup>160</sup></xref><sup>,</sup><xref rid="bb0845" ref-type="bibr"><sup>169</sup></xref><sup>,</sup><xref rid="bb1100" ref-type="bibr"><sup>220</sup></xref> used biological detection.</p></sec></sec><sec id="s0170"><label>6</label><title>Discussion</title><p id="p0240">Driving performance has been assessed with 20 unique BZRAs across 183 studies in 178 publications based on the findings of this scoping review. The methods to assess driving impairment differed whether the study design was experimental or observational, which was expected. In experimental studies, the SDLP was the most used measure alone or in combination with other measures to examine BZRA impact on performance, whilst in observational studies, biological detection through analysis of bodily fluids was most common. The Netherlands was the country where the SDLP was most frequently used as at least one of the assessment measures. Generally, most experimental studies occurred in the Netherlands and observational studies were from Norway. Road driving in traffic and simulated car driving were used more often as the setting in experimental studies than alternatives. Most studies reported driving impairment with BZRAs.</p><sec id="s0175"><label>6.1</label><title>BZRAs studied and prevalence of use in practice</title><p id="p0245">Zopiclone was the most studied medication in experimental studies and investigated using the SDLP method. The representation of zopiclone in the literature is beneficial given it is commonly prescribed.<xref rid="bb0020" ref-type="bibr"><sup>4</sup></xref><sup>,</sup><xref rid="bb0025" ref-type="bibr"><sup>5</sup></xref><sup>,</sup><xref rid="bb1210" ref-type="bibr"><sup>242</sup></xref><sup>,</sup><xref rid="bb1215" ref-type="bibr"><sup>243</sup></xref> However, the number of times a BZRA was investigated for driving impairment was not always consistent with its frequency of clinical use in various regions representing a gap in the literature. For example, in Canada's largest province (Ontario; population over 14.7 million in 2020<xref rid="bb1220" ref-type="bibr"><sup>244</sup></xref>), 14.5&#160;% of patients who were prescribed a new BZRA in 2019 were given clonazepam.<xref rid="bb1225" ref-type="bibr"><sup>245</sup></xref> Clonazepam impairment was reported in two people in the included experimental studies.<xref rid="bb0495" ref-type="bibr"><sup>99</sup></xref><sup>,</sup><xref rid="bb0745" ref-type="bibr"><sup>149</sup></xref> Further, 71&#160;% of Ontarians prescribed a new BZRA in 2019 received lorazepam, and in our review, the number of studies (13 of 92) for lorazepam was limited compared to its prescribing prevalence. Similarly, temazepam remains one of the most commonly prescribed medications for insomnia in Australia<xref rid="bb1230" ref-type="bibr"><sup>246</sup></xref> and yet it was studied in only eight experimental papers.</p></sec><sec id="s0180"><label>6.2</label><title>Heterogeneity of BZRA dosing and timing in protocols</title><p id="p0250">There was considerable heterogeneity in the experimental study designs with respect to dosing protocols including the dose amount and diazepam dosing equivalency, timing of BZRA dose with respect to the timing of the assessments, variability in the type of assessment, and duration of therapy in relation to driving assessments. Each of these factors are important considerations in study design when considering whether medications were compared equally and when considering the pharmacodynamics and pharmacokinetics of individual BZRAs.</p><p id="p0255">For dosing, the diazepam equivalents were different within and across many experimental studies thus limiting direct comparisons among agents and across studies. The amount given is relevant as sedative effects can be dose dependent. With respect to timing of the dose and the driving assessment, there was also considerable variability ranging from under an hour to more than a day for experimental studies. It was unclear in many of these studies as to whether relevant pharmacokinetic parameters such as time to peak drug concentration, peak drug concentration, elimination half-life, and other factors (e.g., active metabolites and their respective pharmacokinetic parameters) were considered when choosing the interval between dosing and time to conduct driving assessments. With observational studies, timing of dosing in relation to measuring outcomes was uncontrolled due to the nature of their design.</p><p id="p0260">Most of the experimental studies did not have consecutive days of dosing (i.e., single dose studies), and very few were of longer duration (e.g., 30&#160;days with Carter et al.,<xref rid="bb0385" ref-type="bibr"><sup>77</sup></xref> 6&#160;months with van der Sluiszen et al.<xref rid="bb0670" ref-type="bibr"><sup>134</sup></xref>). Therefore, considerations related to pharmacodynamic tolerance from repeated administration and its impact on driving ability is relatively understudied.</p><p id="p0265">Additionally, there are also considerations with respect to pharmacokinetic and pharmacodynamic inter- and intra-subject variability in responses to medications. Partinen et al.,<xref rid="bb0600" ref-type="bibr"><sup>120</sup></xref> for example, found no difference with mean time to collision in the primary outcome, and the general conclusion was that no impairment was found. However, there were considerable interindividual differences in the driving performance in the study. For example, there were numerous off-road accidents with one patient having five accidents after ingesting zolpidem and another patient had five accidents after taking temazepam.</p><p id="p0270">For observational studies, similar issues of heterogeneity among studies were found with respect to doses, lengths of therapy, reliability of dosing, and the timing of reported outcomes in relation to dosing. Using the length of the exposure period to demonstrate, Gustavsen et al.<xref rid="bb0115" ref-type="bibr"><sup>23</sup></xref> examined injuries during an exposure period of one week from dispensation of specific BZRAs (i.e., zopiclone, zolpidem, flunitrazepam, and nitrazepam), whereas Neutel et al.<xref rid="bb1095" ref-type="bibr"><sup>219</sup></xref> reported injuries due to traffic accidents within 28&#160;days of the index BZRA prescription for one of triazolam, flurazepam, oxazepam, lorazepam, or diazepam.</p></sec></sec><sec id="s0185"><label>7</label><title>Knowledge translation and practical application</title><sec id="s0190"><label>7.1</label><title>Measures of impairment</title><p id="p0275">Through this scoping review process, the review team discussed the challenges with whether health care providers can readily understand and interpret the various measures and settings in which BZRA-related impairment is explored given the number of tests and measures. It also raised questions about how information from the various measures can translate to shared decision making with patients regarding the effects of BZRAs on driving. Specifically, how can results from measures, such as SDLP, SDS, BRT, and #REs, be translated into language and advice that is relevant to both health care providers and patients? The practicalities of knowledge translation become important when health care providers must advise and counsel patients on medication use. Notably, organizations like the Canadian Council of Motor Transport Administrators acknowledge that physicians, pharmacists, and nurses can play key roles in the education regarding medications' effects on driving performance.<xref rid="bb1235" ref-type="bibr"><sup>247</sup></xref> Within the profession of pharmacy, the International Pharmaceutical Federation (FIP) has published guidelines on medications affecting driving performance<xref rid="bb1240" ref-type="bibr"><sup>248</sup></xref> and indicate, among several recommendations, that clarifications on manufacturers' warnings about any impacts on driving performance is conveyed and patients' experiences of driving while taking the medication are monitored. Additionally, FIP indicates patients should be informed by pharmacists of how to detect side effects such as psychomotor impairment. No information is provided on when and how this assessment should be completed in terms of factors that may be related to psychomotor impairment. Aside from limited information available from research published using simulated patients and pharmacy encounters, the advice given to patients by pharmacists is not adequately documented. Similarly, there is little to no objective evidence that reports other health care prescribers' advice giving. Health care providers cannot conduct tests that were encountered in this review with patients, and a referral pathway to such services would be required. It is unlikely that access to such services that conduct these tests would be readily available to match the prevalence of BZRA prescribing across the population.</p></sec><sec id="s0195"><label>7.2</label><title>Comparison to alcohol</title><p id="p0280">One approach that has been used to describe BZRA impairment with extrapolating from various measures in studies, is to relate or compare impairment caused by BZRAs against alcohol. Alcohol impairment as a concept is likely more recognizable by health care providers and patients; although for patients, inquiring about their alcohol use is important as alcohol patterns of consumption can change with age and time.<xref rid="bb1245" ref-type="bibr"><sup>249</sup></xref><sup>,</sup><xref rid="bb1250" ref-type="bibr"><sup>250</sup></xref> The International Council on Alcohol, Drugs and Traffic Safety (ICADTS) System for Medicinal Drugs Affecting Driving Performance,<xref rid="bb1255" ref-type="bibr"><sup>251</sup></xref> categories can be leveraged in this area. The ICADTS,<xref rid="bb1255" ref-type="bibr"><sup>251</sup></xref> published in 2007, has categories for medications based on experiments using on-the-road driving tests in the Netherlands and makes comparisons with alcohol. These categories include category I as equivalent to blood alcohol concentration (BAC) of &lt;0.5&#160;g/L (0.05&#160;%), category II with 0.5&#8211;0.8&#160;g/L (0.05&#8211;0.08&#160;%), and III as BAC &gt;0.8&#160;g/L (&gt;0.08&#160;%). Per Verster and Mets,<xref rid="bb0210" ref-type="bibr"><sup>42</sup></xref> Category I drugs are, &#8220;presumed to be safe or unlikely to produce an effect&#8221;, with advice to patients to, &#8220;be careful not to drive before having read the warnings in the package insert&#8221;; Category II are, &#8220;likely to produce minor or moderate effects&#8221;, with advice to the patient as, &#8220;do not drive without consulting a healthcare professional about the possible impairing effects&#8221;; and lastly, Category III are, &#8220;likely to produce severe effects or presumed to be potentially dangerous&#8221;, with advice to the patient including, &#8220;do not drive when this drug is taken and consult a healthcare professional when to start driving again after evaluation of the treatment outcomes.&#8221;<xref rid="bb0210" ref-type="bibr"><sup>42</sup></xref> Verster and Mets<xref rid="bb0210" ref-type="bibr"><sup>42</sup></xref> provided additional information incorporating SDLP measures alongside levels of impairment based on BAC using the work of Louwerens presented at the International Conference on Alcohol, Drugs and Traffic Safety.<xref rid="bb1260" ref-type="bibr"><sup>252</sup></xref> The SDLP increments after alcohol consumption (BAC) were&#160;+&#160;2.4&#160;cm (0.05&#160;%), +4.1&#160;cm (0.08&#160;%), and&#160;+&#160;5.3&#160;cm (0.10&#160;%). Some publications in our scoping review applied these comparisons to enhance their interpretation of their results. For example, Jongen et al. 2018<xref rid="bb0450" ref-type="bibr"><sup>90</sup></xref> used the same information from Louwerens et al.<xref rid="bb1260" ref-type="bibr"><sup>252</sup></xref> and related their SDLP results to BACs in their discussion of their results. They indicated that after administration of oxazepam 10&#160;mg, there was a significant SDLP increase of 1.83&#160;cm, which would correspond to minor impairment (i.e. a BAC of &lt;0.5&#160;g/L). After diazepam 10&#160;mg, the SDLP increased with 3.03&#160;cm, corresponding to moderate impairment (i.e. BAC 0.5&#8211;0.8&#160;g/L), and after oxazepam 30&#160;mg, SDLP increased with 7.57&#160;cm, corresponding to severe impairment (i.e. BAC of &gt;1.0&#160;g/L).<xref rid="bb0450" ref-type="bibr"><sup>90</sup></xref> Further, Verster and Mets<xref rid="bb0210" ref-type="bibr"><sup>42</sup></xref> also report the various BZRAs as per the ICADTS categories, with the majority falling in category III, which would indicate that studies of road tests produce results of a BAC &gt;0.08&#160;% for most BZRAs. Only three medications (zolpidem, medazepam, clobazam) were listed in category II. Based on the observational studies retrieved from this scoping review, there is prevalent use of category II and III medications while driving. While the advice to patients in these categories provides clear guidance to avoid driving without consultation of a healthcare providers, the onus is on the health care provider to determine when driving may be safe again. Using knowledge related to BAC, ICADTS categories, and measures such as SDLP may be an appropriate reference for prescribers with patients to explain impairment. These comparisons to SDLP are useful, but as seen in this review, it is not the only measure of assessing impairment extracted from studies, and although it was common, it was not used in all experimental studies.</p></sec></sec><sec id="s0200"><label>8</label><title>Conclusion</title><p id="p0285">The effects of individual benzodiazepine receptor agonists (BZRAs) on people's motor vehicle driving performance have been assessed using heterogenous protocols with multiple approaches to dosing and timing of testing, measures, and settings that ranged from simulated to authentic traffic situations. The scoping review findings indicate that many BZRAs were studied but representation in the studies does not always match with prevalence in prescribing patterns. The interpretation and contextualization of results for use in clinical practice is challenging due to the complexity of protocols, measures, and variety of settings used to assess performance. Comparisons to other substances such as alcohol may be valuable, but challenges remain with limited driving assessments compared against BAC. Future work in this area should seek to improve knowledge translation of results so that the information is more readily accessible and applicable to health care providers and patients in shared decision-making processes. The findings will also serve to inform future syntheses regarding BZRA-related impairment assessments and driving.</p></sec><sec id="s0205"><title>Funding</title><p id="p0290">The research is unfunded. Student research support was provided to K.S. by the Drug Evaluation Alliance of Nova Scotia (DEANS). The funder providing the student research support was not involved in the design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></sec><sec id="s0210"><title>CRediT authorship contribution statement</title><p id="p0295"><bold>Andrea L. Murphy:</bold> Writing &#8211; review &amp; editing, Writing &#8211; original draft, Visualization, Validation, Supervision, Software, Resources, Project administration, Methodology, Investigation, Funding acquisition, Formal analysis, Data curation, Conceptualization. <bold>Korolos Sawires:</bold> Writing &#8211; review &amp; editing, Writing &#8211; original draft, Visualization, Validation, Software, Methodology, Formal analysis, Data curation. <bold>Sophie M. Peltekian:</bold> Writing &#8211; review &amp; editing, Writing &#8211; original draft, Visualization, Validation, Investigation, Formal analysis, Data curation. <bold>Melissa Helwig:</bold> Writing &#8211; review &amp; editing, Writing &#8211; original draft, Visualization, Validation, Software, Methodology, Formal analysis, Data curation. <bold>Marilyn Macdonald:</bold> Writing &#8211; review &amp; editing, Writing &#8211; original draft, Methodology, Formal analysis, Data curation. <bold>Ruth Martin-Misener:</bold> Writing &#8211; review &amp; editing, Writing &#8211; original draft, Methodology, Data curation. <bold>Bandana Saini:</bold> Writing &#8211; review &amp; editing, Writing &#8211; original draft, Methodology, Data curation. <bold>Heather Neyedli:</bold> Writing &#8211; review &amp; editing, Writing &#8211; original draft, Methodology, Data curation. <bold>Chris Giacomantonio:</bold> Writing &#8211; review &amp; editing, Writing &#8211; original draft, Methodology, Data curation. <bold>David M. Gardner:</bold> Writing &#8211; review &amp; editing, Writing &#8211; original draft, Visualization, Validation, Supervision, Software, Resources, Project administration, Methodology, Investigation, Funding acquisition, Formal analysis, Data curation, Conceptualization.</p></sec><sec sec-type="COI-statement"><title>Declaration of competing interest</title><p id="p0300">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></sec></body><back><ref-list id="bi0005"><title>References</title><ref id="bb0005"><label>1</label><element-citation publication-type="journal" id="rf0005"><person-group person-group-type="author"><name name-style="western"><surname>Kassam</surname><given-names>A.</given-names></name><name name-style="western"><surname>Patten</surname><given-names>S.B.</given-names></name></person-group><article-title>Hypnotic use in a population-based sample of over thirty-five thousand interviewed Canadians</article-title><source>Popul Health Metrics</source><volume>4</volume><year>2006</year><fpage>15</fpage><pub-id pub-id-type="doi">10.1186/1478-7954-4-15</pub-id><pub-id pub-id-type="pmcid">PMC1687202</pub-id><pub-id pub-id-type="pmid">17125509</pub-id></element-citation></ref><ref id="bb0010"><label>2.</label><element-citation publication-type="journal" id="rf0010"><person-group person-group-type="author"><name name-style="western"><surname>Olfson</surname><given-names>M.</given-names></name><name name-style="western"><surname>King</surname><given-names>M.</given-names></name><name name-style="western"><surname>Schoenbaum</surname><given-names>M.</given-names></name></person-group><article-title>Benzodiazepine use in the United States</article-title><source>JAMA Psychiatry</source><volume>72</volume><year>2015</year><fpage>136</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.1763</pub-id><pub-id pub-id-type="pmid">25517224</pub-id></element-citation></ref><ref id="bb0015"><label>3</label><element-citation publication-type="journal" id="rf0015"><person-group person-group-type="author"><name name-style="western"><surname>Cunningham</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Hanley</surname><given-names>G.E.</given-names></name><name name-style="western"><surname>Morgan</surname><given-names>S.</given-names></name></person-group><article-title>Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use</article-title><source>Health Policy Amst Neth</source><volume>97</volume><year>2010</year><fpage>122</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.healthpol.2010.03.008</pub-id><pub-id pub-id-type="pmid">20413177</pub-id></element-citation></ref><ref id="bb0020"><label>4</label><element-citation publication-type="journal" id="rf0020"><person-group person-group-type="author"><name name-style="western"><surname>Brett</surname><given-names>J.</given-names></name><name name-style="western"><surname>Maust</surname><given-names>D.T.</given-names></name><name name-style="western"><surname>Bouck</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Benzodiazepine use in older adults in the United States, Ontario, and Australia from 2010 to 2016</article-title><source>J Am Geriatr Soc</source><volume>66</volume><year>2018</year><fpage>1180</fpage><lpage>1185</lpage><pub-id pub-id-type="doi">10.1111/jgs.15292</pub-id><pub-id pub-id-type="pmid">29430639</pub-id><pub-id pub-id-type="pmcid">PMC6087688</pub-id></element-citation></ref><ref id="bb0025"><label>5</label><element-citation publication-type="journal" id="rf0025"><person-group person-group-type="author"><name name-style="western"><surname>Alessi-Severini</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bolton</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Enns</surname><given-names>M.W.</given-names></name><etal/></person-group><article-title>Use of benzodiazepines and related drugs in Manitoba: a population-based study</article-title><source>CMAJ Open</source><volume>2</volume><year>2014</year><fpage>E208</fpage><lpage>E216</lpage><pub-id pub-id-type="other">10.9778/cmajo.20130076 [doi]</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.9778/cmajo.20130076</pub-id><pub-id pub-id-type="pmcid">PMC4251517</pub-id><pub-id pub-id-type="pmid">25485245</pub-id></element-citation></ref><ref id="bb0030"><label>6</label><element-citation publication-type="journal" id="rf0030"><person-group person-group-type="author"><name name-style="western"><surname>Kurko</surname><given-names>T.A.T.</given-names></name><name name-style="western"><surname>Saastamoinen</surname><given-names>L.K.</given-names></name><name name-style="western"><surname>T&#228;hk&#228;p&#228;&#228;</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Long-term use of benzodiazepines: Definitions, prevalence and usage patterns &#8211; a systematic review of register-based studies</article-title><source>Eur Psychiatry</source><volume>30</volume><year>2015</year><fpage>1037</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1016/j.eurpsy.2015.09.003</pub-id><pub-id pub-id-type="pmid">26545257</pub-id></element-citation></ref><ref id="bb0035"><label>7</label><element-citation publication-type="journal" id="rf0035"><person-group person-group-type="author"><name name-style="western"><surname>Taipale</surname><given-names>H.</given-names></name><name name-style="western"><surname>S&#228;rkil&#228;</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tanskanen</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Incidence of and Characteristics Associated With Long-term Benzodiazepine Use in Finland</article-title><source>JAMA Netw Open</source><volume>3</volume><year>2020</year><object-id pub-id-type="publisher-id">e2019029</object-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.19029</pub-id><pub-id pub-id-type="pmcid">PMC7596584</pub-id><pub-id pub-id-type="pmid">33119104</pub-id></element-citation></ref><ref id="bb0040"><label>8</label><element-citation publication-type="journal" id="rf0040"><person-group person-group-type="author"><name name-style="western"><surname>Maust</surname><given-names>D.T.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Blow</surname><given-names>F.C.</given-names></name></person-group><article-title>Benzodiazepine Use and Misuse Among Adults in the United States</article-title><source>Psychiatr Serv</source><volume>70</volume><year>2019</year><fpage>97</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1176/appi.ps.201800321</pub-id><pub-id pub-id-type="pmid">30554562</pub-id><pub-id pub-id-type="pmcid">PMC6358464</pub-id></element-citation></ref><ref id="bb0045"><label>9.</label><element-citation publication-type="journal" id="rf0045"><person-group person-group-type="author"><name name-style="western"><surname>Katzman</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Bleau</surname><given-names>P.</given-names></name><name name-style="western"><surname>Blier</surname><given-names>P.</given-names></name><name name-style="western"><surname>Chokka</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kjernisted</surname><given-names>K.</given-names></name><name name-style="western"><surname>Van Ameringen</surname><given-names>M.</given-names></name></person-group><article-title>M.U. the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and, Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders</article-title><source>BMC Psychiatry</source><volume>14</volume><year>2014</year><fpage>S1</fpage><pub-id pub-id-type="doi">10.1186/1471-244X-14-S1-S1</pub-id><pub-id pub-id-type="pmid">25081580</pub-id><pub-id pub-id-type="pmcid">PMC4120194</pub-id></element-citation></ref><ref id="bb0050"><label>10</label><element-citation publication-type="journal" id="rf0050"><person-group person-group-type="author"><name name-style="western"><surname>Qaseem</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kansagara</surname><given-names>D.</given-names></name><name name-style="western"><surname>Forciea</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Cooke</surname><given-names>M.</given-names></name><name name-style="western"><surname>Denberg</surname><given-names>T.D.</given-names></name></person-group><article-title>for the clinical guidelines committee of the american college of physicians, management of chronic insomnia disorder in adults: A clinical practice guideline from the American College of Physicians</article-title><source>Ann Intern Med</source><volume>165</volume><year>2016</year><fpage>125</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.7326/M15-2175</pub-id><pub-id pub-id-type="pmid">27136449</pub-id></element-citation></ref><ref id="bb0055"><label>11</label><element-citation publication-type="journal" id="rf0055"><person-group person-group-type="author"><name name-style="western"><surname>Berry</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dore</surname><given-names>D.D.</given-names></name></person-group><article-title>Nonbenzodiazepine sleep medication use and hip fractures in nursing home residents</article-title><source>JAMA Intern Med</source><volume>173</volume><year>2013</year><fpage>754</fpage><lpage>761</lpage><pub-id pub-id-type="doi">10.1001/jamainternmed.2013.3795</pub-id><pub-id pub-id-type="pmid">23460413</pub-id><pub-id pub-id-type="pmcid">PMC3676706</pub-id></element-citation></ref><ref id="bb0060"><label>12</label><element-citation publication-type="journal" id="rf0060"><person-group person-group-type="author"><name name-style="western"><surname>Victorri-Vigneau</surname><given-names>C.</given-names></name><name name-style="western"><surname>Dailly</surname><given-names>E.</given-names></name><name name-style="western"><surname>Veyrac</surname><given-names>G.</given-names></name><name name-style="western"><surname>Jolliet</surname><given-names>P.</given-names></name></person-group><article-title>Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey</article-title><source>Br J Clin Pharmacol</source><volume>64</volume><year>2007</year><fpage>198</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2125.2007.02861.x</pub-id><pub-id pub-id-type="pmid">17324242</pub-id><pub-id pub-id-type="pmcid">PMC2000636</pub-id></element-citation></ref><ref id="bb0065"><label>13</label><element-citation publication-type="journal" id="rf0065"><person-group person-group-type="author"><name name-style="western"><surname>Gomm</surname><given-names>W.</given-names></name><name name-style="western"><surname>von Holt</surname><given-names>K.</given-names></name><name name-style="western"><surname>Thome</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Regular benzodiazepine and Z-substance use and risk of dementia: An analysis of German Claims Data</article-title><source>J Alzheimers Dis JAD</source><volume>54</volume><year>2016</year><fpage>801</fpage><lpage>808</lpage><pub-id pub-id-type="doi">10.3233/JAD-151006</pub-id><pub-id pub-id-type="pmid">27567804</pub-id></element-citation></ref><ref id="bb0070"><label>14</label><element-citation publication-type="journal" id="rf0070"><person-group person-group-type="author"><name name-style="western"><surname>Nakafero</surname><given-names>G.</given-names></name><name name-style="western"><surname>Sanders</surname><given-names>R.D.</given-names></name><name name-style="western"><surname>Nguyen-Van-Tam</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Myles</surname><given-names>P.R.</given-names></name></person-group><article-title>The association between benzodiazepines and influenza-like illness-related pneumonia and mortality: a survival analysis using UK Primary Care data</article-title><source>Pharmacoepidemiol Drug Saf</source><volume>25</volume><year>2016</year><fpage>1263</fpage><lpage>1273</lpage><pub-id pub-id-type="doi">10.1002/pds.4028</pub-id><pub-id pub-id-type="pmid">27215827</pub-id></element-citation></ref><ref id="bb0075"><label>15</label><element-citation publication-type="journal" id="rf0075"><person-group person-group-type="author"><name name-style="western"><surname>Gunja</surname><given-names>N.</given-names></name></person-group><article-title>In the Zzz zone: the effects of Z-drugs on human performance and driving</article-title><source>J Med Toxicol Off J Am Coll Med Toxicol</source><volume>9</volume><year>2013</year><fpage>163</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1007/s13181-013-0294-y</pub-id><pub-id pub-id-type="pmcid">PMC3657033</pub-id><pub-id pub-id-type="pmid">23456542</pub-id></element-citation></ref><ref id="bb0080"><label>16.</label><element-citation publication-type="book" id="rf0080"><person-group person-group-type="author"><name name-style="western"><surname>OECD</surname></name></person-group><part-title>Drugs and Driving</part-title><year>2010</year><pub-id pub-id-type="doi">10.1787/9789282102763-en</pub-id></element-citation></ref><ref id="bb0085"><label>17.</label><element-citation publication-type="book" id="rf0085"><person-group person-group-type="author"><name name-style="western"><surname>Forman-Hoffman</surname><given-names>V.</given-names></name><name name-style="western"><surname>Cook Middleton</surname><given-names>J.</given-names></name><name name-style="western"><surname>Feltner</surname><given-names>C.</given-names></name><etal/></person-group><part-title>Psychological and pharmacological treatments for adults with posttraumatic stress disorder: a systematic review update</part-title><year>2018</year><publisher-name>Agency for Healthcare Research and Quality (AHRQ)</publisher-name><pub-id pub-id-type="doi">10.23970/AHRQEPCCER207</pub-id><pub-id pub-id-type="pmid">30204376</pub-id></element-citation></ref><ref id="bb0090"><label>18</label><element-citation publication-type="journal" id="rf0090"><person-group person-group-type="author"><name name-style="western"><surname>Yatham</surname><given-names>L.N.</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Schaffer</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009</article-title><source>Bipolar Disord</source><volume>11</volume><year>2009</year><fpage>225</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1111/j.1399-5618.2009.00672.x</pub-id><pub-id pub-id-type="pmid">19419382</pub-id></element-citation></ref><ref id="bb0095"><label>19</label><element-citation publication-type="journal" id="rf0095"><person-group person-group-type="author"><name name-style="western"><surname>Shaw</surname><given-names>J.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Turner</surname><given-names>J.P.</given-names></name><etal/></person-group><article-title>Policies for deprescribing: an international scan of intended and unintended outcomes of limiting sedative-hypnotic use in community-dwelling older adults</article-title><source>Healthc Policy Polit Sante</source><volume>14</volume><year>2019</year><fpage>39</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.12927/hcpol.2019.25857</pub-id><pub-id pub-id-type="pmcid">PMC7008681</pub-id><pub-id pub-id-type="pmid">31322113</pub-id></element-citation></ref><ref id="bb0100"><label>20.</label><element-citation publication-type="journal" id="rf0100"><person-group person-group-type="author"><name name-style="western"><surname>Evrard</surname><given-names>P.</given-names></name><name name-style="western"><surname>P&#233;tein</surname><given-names>C.</given-names></name><name name-style="western"><surname>Beuscart</surname><given-names>J.</given-names></name><name name-style="western"><surname>Spinewine</surname><given-names>A.</given-names></name></person-group><article-title>Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework</article-title><source>Implement Sci</source><volume>17</volume><year>2022</year><fpage>41</fpage><pub-id pub-id-type="pmid">35804428</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13012-022-01206-7</pub-id><pub-id pub-id-type="pmcid">PMC9264665</pub-id></element-citation></ref><ref id="bb0105"><label>21.</label><element-citation publication-type="journal" id="rf0105"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Le Couteur</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Hilmer</surname><given-names>S.N.</given-names></name></person-group><article-title>Deprescribing Benzodiazepines in Older Patients: Impact of Interventions Targeting Physicians, Pharmacists, and Patients</article-title><source>Drugs Aging</source><volume>35</volume><year>2018</year><fpage>493</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1007/s40266-018-0544-4</pub-id><pub-id pub-id-type="pmid">29705831</pub-id></element-citation></ref><ref id="bb0110"><label>22.</label><element-citation publication-type="journal" id="rf0110"><person-group person-group-type="author"><name name-style="western"><surname>Barker</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Greenwood</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Crowe</surname><given-names>S.F.</given-names></name></person-group><article-title>Cognitive effects of long-term benzodiazepine use: a meta-analysis</article-title><source>CNS Drugs</source><volume>18</volume><year>2004</year><fpage>37</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.2165/00023210-200418010-00004</pub-id><pub-id pub-id-type="pmid">14731058</pub-id></element-citation></ref><ref id="bb0115"><label>23</label><element-citation publication-type="journal" id="rf0115"><person-group person-group-type="author"><name name-style="western"><surname>Gustavsen</surname><given-names>I.</given-names></name><name name-style="western"><surname>Bramness</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Skurtveit</surname><given-names>S.</given-names></name><name name-style="western"><surname>Engeland</surname><given-names>A.</given-names></name><name name-style="western"><surname>Neutel</surname><given-names>I.</given-names></name><name name-style="western"><surname>M&#248;rland</surname><given-names>J.</given-names></name></person-group><article-title>Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam</article-title><source>Sleep Med</source><volume>9</volume><year>2008</year><fpage>818</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1016/j.sleep.2007.11.011</pub-id><pub-id pub-id-type="pmid">18226959</pub-id></element-citation></ref><ref id="bb0120"><label>24</label><element-citation publication-type="journal" id="rf0120"><person-group person-group-type="author"><name name-style="western"><surname>Picton</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Marino</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Nealy</surname><given-names>K.L.</given-names></name></person-group><article-title>Benzodiazepine use and cognitive decline in the elderly</article-title><source>Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm</source><volume>75</volume><year>2018</year><fpage>e6</fpage><lpage>e12</lpage><pub-id pub-id-type="doi">10.2146/ajhp160381</pub-id><pub-id pub-id-type="pmid">29273607</pub-id></element-citation></ref><ref id="bb0125"><label>25</label><element-citation publication-type="journal" id="rf0125"><person-group person-group-type="author"><name name-style="western"><surname>Ravera</surname><given-names>S.</given-names></name><name name-style="western"><surname>Monteiro</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>de Gier</surname><given-names>J.J.</given-names></name><etal/></person-group><article-title>A European approach to categorizing medicines for fitness to drive: outcomes of the DRUID project</article-title><source>Br J Clin Pharmacol</source><volume>74</volume><year>2012</year><fpage>920</fpage><lpage>931</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2125.2012.04279.x</pub-id><pub-id pub-id-type="pmid">22452358</pub-id><pub-id pub-id-type="pmcid">PMC3522805</pub-id></element-citation></ref><ref id="bb0130"><label>26</label><element-citation publication-type="journal" id="rf0130"><person-group person-group-type="author"><name name-style="western"><surname>Rhee</surname><given-names>T.G.</given-names></name></person-group><article-title>Coprescribing of benzodiazepines and opioids in older adults: rates, correlates, and national trends</article-title><source>J Gerontol A Biol Sci Med Sci</source><volume>74</volume><year>2019</year><fpage>1910</fpage><lpage>1915</lpage><pub-id pub-id-type="doi">10.1093/gerona/gly283</pub-id><pub-id pub-id-type="pmid">30561526</pub-id><pub-id pub-id-type="pmcid">PMC6853668</pub-id></element-citation></ref><ref id="bb0135"><label>27</label><element-citation publication-type="journal" id="rf0135"><person-group person-group-type="author"><name name-style="western"><surname>Aitken</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hayley</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Shiferaw</surname><given-names>B.</given-names></name><name name-style="western"><surname>Downey</surname><given-names>L.A.</given-names></name></person-group><article-title>The combined effects of alcohol and benzodiazepines on driving-related neurocognitive skills: a systematic review</article-title><source>J Stud Alcohol Drugs</source><volume>82</volume><year>2021</year><fpage>553</fpage><lpage>563</lpage><pub-id pub-id-type="pmid">34546901</pub-id></element-citation></ref><ref id="bb0140"><label>28.</label><element-citation publication-type="other" id="rf0140"><person-group person-group-type="author"><name name-style="western"><surname>Department of Justice</surname></name></person-group><article-title>Offenses relating to conveyances, 320.14 (1)</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://laws-lois.justice.gc.ca/eng/annualstatutes/2018_21/page-3.html" id="ir0005">https://laws-lois.justice.gc.ca/eng/annualstatutes/2018_21/page-3.html</ext-link><year>2018</year></element-citation></ref><ref id="bb0145"><label>29.</label><element-citation publication-type="book" id="rf0145"><person-group person-group-type="author"><name name-style="western"><surname>Norwegian Ministry of Transport and Communications</surname></name></person-group><part-title>Driving under the influence of non-alcohol drugs</part-title><year>2014</year><publisher-name>Norwegian Ministry of Transport and Communications</publisher-name><publisher-loc>Norway</publisher-loc><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.regjeringen.no/contentassets/61d8bf75d02e4b64ab0bfbea244b78d9/sd_ruspavirket_kjoring_net.pdf" id="ir0010">https://www.regjeringen.no/contentassets/61d8bf75d02e4b64ab0bfbea244b78d9/sd_ruspavirket_kjoring_net.pdf</ext-link></element-citation></ref><ref id="bb0150"><label>30.</label><element-citation publication-type="book" id="rf0150"><person-group person-group-type="author"><name name-style="western"><surname>Canadian Pharmacists Association</surname></name></person-group><part-title>Zopiclone, Hypnotic-Sedative, CPhA Monograph, RxTx</part-title><year>2019</year><comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://myrxtx-ca.ezproxy.library.dal.ca/search" id="ir0015">https://myrxtx-ca.ezproxy.library.dal.ca/search</ext-link> (accessed January 23, 2023)</comment></element-citation></ref><ref id="bb0155"><label>31.</label><element-citation publication-type="book" id="rf0155"><person-group person-group-type="author"><name name-style="western"><surname>sanofi-aventis Canada Inc</surname></name></person-group><part-title>Patient Medication Information: Pr IMOVANE&#174;, zopiclone, Hypnotic-Sedative, CPS Myrxtx</part-title><year>2022</year><comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://myrxtx-ca.ezproxy.library.dal.ca/search" id="ir0020">https://myrxtx-ca.ezproxy.library.dal.ca/search</ext-link> (accessed June 12, 2023)</comment></element-citation></ref><ref id="bb0160"><label>32.</label><element-citation publication-type="book" id="rf0160"><person-group person-group-type="author"><name name-style="western"><surname>sanofi-aventis Canada Inc</surname></name></person-group><part-title>PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION Pr IMOVANE&#174; Zopiclone Tablets, 5.0 mg and 7.5 mg, Oral Administration Hypnotic and Sedative</part-title><year>2022</year><comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pdf.hres.ca/dpd_pm/00065357.PDF" id="ir0025">https://pdf.hres.ca/dpd_pm/00065357.PDF</ext-link> (accessed April 6, 2023)</comment></element-citation></ref><ref id="bb0165"><label>33.</label><element-citation publication-type="book" id="rf0165"><person-group person-group-type="author"><name name-style="western"><surname>First Databank Inc</surname></name></person-group><part-title>Kroll Care: Apo-Lorazepam 1mg (DIN: 00655759)</part-title><year>2019</year></element-citation></ref><ref id="bb0170"><label>34.</label><element-citation publication-type="other" id="rf0170"><article-title>Royal Pharmaceutical Society, Drugs and Driving Legislation: Quick Reference Guide</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.rpharms.com/resources/quick-reference-guides/new-drugs-and-driving-legislation" id="ir0030">https://www.rpharms.com/resources/quick-reference-guides/new-drugs-and-driving-legislation</ext-link><year>2015</year></element-citation></ref><ref id="bb0175"><label>35</label><element-citation publication-type="journal" id="rf0175"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Gardner</surname><given-names>D.M.</given-names></name></person-group><article-title>A simulated patient evaluation of pharmacist&#8217;s performance in a men&#8217;s mental health program</article-title><source>BMC Res Notes</source><volume>11</volume><year>2018</year><fpage>765</fpage><pub-id pub-id-type="doi">10.1186/s13104-018-3869-5</pub-id><pub-id pub-id-type="pmid">30367674</pub-id><pub-id pub-id-type="pmcid">PMC6204042</pub-id></element-citation></ref><ref id="bb0180"><label>36</label><element-citation publication-type="journal" id="rf0180"><person-group person-group-type="author"><name name-style="western"><surname>Kippist</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bartlett</surname><given-names>D.</given-names></name><name name-style="western"><surname>Saini</surname><given-names>B.</given-names></name></person-group><article-title>How do pharmacists respond to complaints of acute insomnia? A simulated patient study</article-title><source>Int J Clin Pharm</source><volume>33</volume><year>2011</year><fpage>237</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1007/s11096-011-9482-5</pub-id><pub-id pub-id-type="pmid">21394573</pub-id></element-citation></ref><ref id="bb0185"><label>37.</label><element-citation publication-type="journal" id="rf0185"><person-group person-group-type="author"><name name-style="western"><surname>Khojah</surname><given-names>H.M.</given-names></name></person-group><article-title>Do pharmacists counsel customers about the effects of sedating antihistamines on driving skills? A survey of community pharmacies in Saudi Arabia</article-title><source>J Int Med Res</source><volume>47</volume><year>2019</year><fpage>2018</fpage><lpage>2025</lpage><pub-id pub-id-type="doi">10.1177/0300060519838953</pub-id><pub-id pub-id-type="pmid">30885078</pub-id><pub-id pub-id-type="pmcid">PMC6567744</pub-id></element-citation></ref><ref id="bb0190"><label>38</label><element-citation publication-type="journal" id="rf0190"><person-group person-group-type="author"><name name-style="western"><surname>Jomaa</surname><given-names>I.</given-names></name><name name-style="western"><surname>Odisho</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cheung</surname><given-names>J.M.Y.</given-names></name><etal/></person-group><article-title>Pharmacists&#8217; perceptions and communication of risk for alertness impairing medications</article-title><source>Res Soc Adm Pharm</source><volume>14</volume><year>2018</year><fpage>31</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.sapharm.2016.12.010</pub-id><pub-id pub-id-type="pmid">28118967</pub-id></element-citation></ref><ref id="bb0195"><label>39</label><element-citation publication-type="journal" id="rf0195"><person-group person-group-type="author"><name name-style="western"><surname>Sake</surname><given-names>F.-T.-N.</given-names></name><name name-style="western"><surname>Wong</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bartlett</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Saini</surname><given-names>B.</given-names></name></person-group><article-title>Benzodiazepine use risk: Understanding patient specific risk perceptions and medication beliefs</article-title><source>Res Soc Adm Pharm</source><volume>15</volume><year>2019</year><fpage>1317</fpage><lpage>1325</lpage><pub-id pub-id-type="doi">10.1016/j.sapharm.2018.12.007</pub-id><pub-id pub-id-type="pmid">30639048</pub-id></element-citation></ref><ref id="bb0200"><label>40.</label><element-citation publication-type="book" id="rf0200"><source>J.C. Joris C. Verster, Drugs, driving, and traffic safety, Basel; Boston&#160;: Birkhauser, Basel; Boston</source><year>2009</year></element-citation></ref><ref id="bb0205"><label>41.</label><element-citation publication-type="journal" id="rf0205"><person-group person-group-type="author"><name name-style="western"><surname>Verster</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Roth</surname><given-names>T.</given-names></name></person-group><article-title>Excursions out-of-lane versus standard deviation of lateral position as outcome measure of the on-the-road driving test</article-title><source>Hum Psychopharmacol</source><volume>29</volume><year>2014</year><fpage>322</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1002/hup.2406</pub-id><pub-id pub-id-type="pmid">24753058</pub-id></element-citation></ref><ref id="bb0210"><label>42</label><element-citation publication-type="journal" id="rf0210"><person-group person-group-type="author"><name name-style="western"><surname>Verster</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Mets</surname><given-names>M.A.J.</given-names></name></person-group><article-title>Psychoactive medication and traffic safety</article-title><source>Int J Environ Res Public Health</source><volume>6</volume><year>2009</year><fpage>1041</fpage><lpage>1054</lpage><pub-id pub-id-type="doi">10.3390/ijerph6031041</pub-id><pub-id pub-id-type="pmid">19440432</pub-id><pub-id pub-id-type="pmcid">PMC2672393</pub-id></element-citation></ref><ref id="bb0215"><label>43</label><element-citation publication-type="journal" id="rf0215"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Peltekian</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Helwig</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Driving performance assessments for benzodiazepine receptor agonist&#8211;related impairment: a scoping review protocol</article-title><source>JBI Evid Synth</source><volume>19</volume><year>2021</year><fpage>242</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.11124/JBISRIR-D-19-00420</pub-id><pub-id pub-id-type="pmid">33165178</pub-id></element-citation></ref><ref id="bb0220"><label>44</label><element-citation publication-type="journal" id="rf0220"><person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Godfrey</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Khalil</surname><given-names>H.</given-names></name><name name-style="western"><surname>McInerney</surname><given-names>P.</given-names></name><name name-style="western"><surname>Parker</surname><given-names>D.</given-names></name><name name-style="western"><surname>Soares</surname><given-names>C.B.</given-names></name></person-group><article-title>Guidance for conducting systematic scoping reviews</article-title><source>Int J Evid Based Healthc</source><volume>13</volume><year>2015</year><fpage>141</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1097/XEB.0000000000000050</pub-id><pub-id pub-id-type="pmid">26134548</pub-id></element-citation></ref><ref id="bb0225"><label>45</label><element-citation publication-type="journal" id="rf0225"><person-group person-group-type="author"><name name-style="western"><surname>Tricco</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Lillie</surname><given-names>E.</given-names></name><name name-style="western"><surname>Zarin</surname><given-names>W.</given-names></name><etal/></person-group><article-title>PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and ExplanationThe PRISMA-ScR Statement</article-title><source>Ann Intern Med</source><volume>169</volume><year>2018</year><fpage>467</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.7326/M18-0850</pub-id><pub-id pub-id-type="pmid">30178033</pub-id></element-citation></ref><ref id="bb0230"><label>46.</label><element-citation publication-type="journal" id="rf0230"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>R.</given-names></name><name name-style="western"><surname>Minor</surname><given-names>B.L.</given-names></name><etal/></person-group><article-title>The REDCap consortium: building an international community of software platform partners</article-title><source>J Biomed Inform</source><volume>95</volume><year>2019</year><pub-id pub-id-type="doi">10.1016/j.jbi.2019.103208</pub-id><comment>Article 103208</comment><pub-id pub-id-type="pmcid">PMC7254481</pub-id><pub-id pub-id-type="pmid">31078660</pub-id></element-citation></ref><ref id="bb0235"><label>47</label><element-citation publication-type="journal" id="rf0235"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>R.</given-names></name><name name-style="western"><surname>Thielke</surname><given-names>R.</given-names></name><name name-style="western"><surname>Payne</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>N.</given-names></name><name name-style="western"><surname>Conde</surname><given-names>J.G.</given-names></name></person-group><article-title>Research electronic data capture (REDCap) &#8211; a metadata-driven methodology and workflow process for providing translational research informatics support</article-title><source>J Biomed Inform</source><volume>42</volume><year>2009</year><fpage>377</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1016/j.jbi.2008.08.010</pub-id><pub-id pub-id-type="pmid">18929686</pub-id><pub-id pub-id-type="pmcid">PMC2700030</pub-id></element-citation></ref><ref id="bb0240"><label>48</label><element-citation publication-type="journal" id="rf0240"><person-group person-group-type="author"><name name-style="western"><surname>Verster</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Veldhuijzen</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Volkerts</surname><given-names>E.R.</given-names></name></person-group><article-title>Is it safe to drive a car when treated with anxiolytics? Evidence from on-the-road driving studies during normal traffic</article-title><source>Curr Psychiatr Rev</source><volume>1</volume><year>2005</year><fpage>215</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.2174/1573400054065613</pub-id></element-citation></ref><ref id="bb0245"><label>49</label><element-citation publication-type="journal" id="rf0245"><person-group person-group-type="author"><name name-style="western"><surname>Verster</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Spence</surname><given-names>D.W.</given-names></name><name name-style="western"><surname>Shahid</surname><given-names>A.</given-names></name><name name-style="western"><surname>Pandi-Perumal</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Roth</surname><given-names>T.</given-names></name></person-group><article-title>Zopiclone as positive control in studies examining the residual effects of hypnotic drugs on driving ability</article-title><source>Curr Drug Saf</source><volume>6</volume><year>2011</year><fpage>209</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">22129315</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/157488611798280933</pub-id></element-citation></ref><ref id="bb0250"><label>50</label><element-citation publication-type="journal" id="rf0250"><person-group person-group-type="author"><name name-style="western"><surname>Verster</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Roth</surname><given-names>T.</given-names></name></person-group><article-title>Blood drug concentrations of benzodiazepines correlate poorly with actual driving impairment</article-title><source>Sleep Med Rev</source><volume>17</volume><year>2013</year><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1016/j.smrv.2012.05.004</pub-id><pub-id pub-id-type="pmid">22884949</pub-id></element-citation></ref><ref id="bb0255"><label>51.</label><element-citation publication-type="journal" id="rf0255"><person-group person-group-type="author"><name name-style="western"><surname>Verster</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Roth</surname><given-names>T.</given-names></name></person-group><article-title>The prevalence and nature of stopped on-the-road driving tests and the relationship with objective performance impairment</article-title><source>Accid Anal Prev</source><volume>45</volume><year>2012</year><fpage>498</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1016/j.aap.2011.09.003</pub-id><pub-id pub-id-type="pmid">22269535</pub-id></element-citation></ref><ref id="bb0260"><label>52</label><element-citation publication-type="journal" id="rf0260"><person-group person-group-type="author"><name name-style="western"><surname>Verster</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>van de Loo</surname><given-names>A.J.A.E.</given-names></name><name name-style="western"><surname>Moline</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Roth</surname><given-names>T.</given-names></name></person-group><article-title>Middle-of-the-night administration of sleep medication: a critical review of the effects on next morning driving ability</article-title><source>Curr Drug Saf</source><volume>9</volume><year>2014</year><fpage>205</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">24909576</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/1574886309666140601210422</pub-id></element-citation></ref><ref id="bb0265"><label>53</label><element-citation publication-type="journal" id="rf0265"><person-group person-group-type="author"><name name-style="western"><surname>Verster</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Veldhuijzen</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Volkerts</surname><given-names>E.R.</given-names></name></person-group><article-title>Residual effects of sleep medication on driving ability</article-title><source>Sleep Med Rev</source><volume>8</volume><year>2004</year><fpage>309</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">15233958</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.smrv.2004.02.001</pub-id></element-citation></ref><ref id="bb0270"><label>54</label><element-citation publication-type="journal" id="rf0270"><person-group person-group-type="author"><name name-style="western"><surname>Verster</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Veldhuijzen</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Patat</surname><given-names>A.</given-names></name><name name-style="western"><surname>Olivier</surname><given-names>B.</given-names></name><name name-style="western"><surname>Volkerts</surname><given-names>E.R.</given-names></name></person-group><article-title>Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test</article-title><source>Curr Drug Saf</source><volume>1</volume><year>2006</year><fpage>63</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">18690916</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/157488606775252674</pub-id></element-citation></ref><ref id="bb0275"><label>55</label><element-citation publication-type="journal" id="rf0275"><person-group person-group-type="author"><name name-style="western"><surname>Brunnauer</surname><given-names>A.</given-names></name><name name-style="western"><surname>Herpich</surname><given-names>F.</given-names></name><name name-style="western"><surname>Zwanzger</surname><given-names>P.</given-names></name><name name-style="western"><surname>Laux</surname><given-names>G.</given-names></name></person-group><article-title>Driving performance under treatment of most frequently prescribed drugs for mental disorders: a systematic review of patient studies</article-title><source>Int J Neuropsychopharmacol</source><volume>24</volume><year>2021</year><fpage>679</fpage><lpage>693</lpage><pub-id pub-id-type="doi">10.1093/ijnp/pyab031</pub-id><pub-id pub-id-type="pmid">34038545</pub-id><pub-id pub-id-type="pmcid">PMC8453274</pub-id></element-citation></ref><ref id="bb0280"><label>56</label><element-citation publication-type="journal" id="rf0280"><person-group person-group-type="author"><name name-style="western"><surname>Dassanayake</surname><given-names>T.</given-names></name><name name-style="western"><surname>Michie</surname><given-names>P.</given-names></name><name name-style="western"><surname>Carter</surname><given-names>G.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>A.</given-names></name></person-group><article-title>Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence</article-title><source>Drug Saf</source><volume>34</volume><year>2011</year><fpage>125</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.2165/11539050-000000000-00000</pub-id><pub-id pub-id-type="pmid">21247221</pub-id></element-citation></ref><ref id="bb0285"><label>57</label><element-citation publication-type="journal" id="rf0285"><person-group person-group-type="author"><name name-style="western"><surname>Elvik</surname><given-names>R.</given-names></name></person-group><article-title>Risk of road accident associated with the use of drugs: a systematic review and meta-analysis of evidence from epidemiological studies</article-title><source>Accid Anal Prev</source><volume>60</volume><year>2013</year><fpage>254</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1016/j.aap.2012.06.017</pub-id><pub-id pub-id-type="pmid">22785089</pub-id></element-citation></ref><ref id="bb0290"><label>58</label><element-citation publication-type="journal" id="rf0290"><person-group person-group-type="author"><name name-style="western"><surname>McElroy</surname><given-names>H.</given-names></name><name name-style="western"><surname>O&#8217;Leary</surname><given-names>B.</given-names></name><name name-style="western"><surname>Adena</surname><given-names>M.</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>R.</given-names></name><name name-style="western"><surname>Tahami Monfared</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Meier</surname><given-names>G.</given-names></name></person-group><article-title>Comparison of the effect of lemborexant and other insomnia treatments on driving performance: a systematic review and meta-analysis</article-title><source>SLEEP Adv</source><volume>2</volume><year>2021</year><fpage>zpab010</fpage><pub-id pub-id-type="doi">10.1093/sleepadvances/zpab010</pub-id><pub-id pub-id-type="pmid">37193564</pub-id><pub-id pub-id-type="pmcid">PMC10104353</pub-id></element-citation></ref><ref id="bb0295"><label>59</label><element-citation publication-type="journal" id="rf0295"><person-group person-group-type="author"><name name-style="western"><surname>Moline</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zammit</surname><given-names>G.</given-names></name><name name-style="western"><surname>Yardley</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Lack of residual morning effects of lemborexant treatment for insomnia: summary of findings across 9 clinical trials</article-title><source>Postgrad Med</source><volume>133</volume><year>2021</year><fpage>71</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1080/00325481.2020.1823724</pub-id><pub-id pub-id-type="pmid">33119423</pub-id></element-citation></ref><ref id="bb0300"><label>60</label><element-citation publication-type="journal" id="rf0300"><person-group person-group-type="author"><name name-style="western"><surname>Orriols</surname><given-names>L.</given-names></name><name name-style="western"><surname>Salmi</surname><given-names>L.-R.</given-names></name><name name-style="western"><surname>Philip</surname><given-names>P.</given-names></name><etal/></person-group><article-title>The impact of medicinal drugs on traffic safety: a systematic review of epidemiological studies</article-title><source>Pharmacoepidemiol Drug Saf</source><volume>18</volume><year>2009</year><fpage>647</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1002/pds.1763</pub-id><pub-id pub-id-type="pmid">19418468</pub-id><pub-id pub-id-type="pmcid">PMC2780583</pub-id></element-citation></ref><ref id="bb0305"><label>61</label><element-citation publication-type="journal" id="rf0305"><person-group person-group-type="author"><name name-style="western"><surname>Rapoport</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Lanctot</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Streiner</surname><given-names>D.L.</given-names></name><etal/></person-group><article-title>Benzodiazepine use and driving: a meta-analysis</article-title><source>J Clin Psychiatry</source><volume>70</volume><year>2009</year><fpage>663</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.4088/JCP.08m04325</pub-id><pub-id pub-id-type="pmid">19389334</pub-id></element-citation></ref><ref id="bb0310"><label>62.</label><element-citation publication-type="journal" id="rf0310"><person-group person-group-type="author"><name name-style="western"><surname>Roth</surname><given-names>T.</given-names></name><name name-style="western"><surname>Eklov</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Drake</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Verster</surname><given-names>J.C.</given-names></name></person-group><article-title>Meta-Analysis of On-the-Road Experimental Studies of Hypnotics: Effects of Time After Intake, Dose, and Half-Life</article-title><source>Traffic Inj Prev</source><volume>15</volume><year>2014</year><fpage>439</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1080/15389588.2013.830211</pub-id><pub-id pub-id-type="pmid">24678565</pub-id></element-citation></ref><ref id="bb0315"><label>63.</label><element-citation publication-type="journal" id="rf0315"><person-group person-group-type="author"><name name-style="western"><surname>Rudisill</surname><given-names>T.M.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kelley</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Pilkerton</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rudisill</surname><given-names>B.R.</given-names></name></person-group><article-title>Medication use and the risk of motor vehicle collisions among licensed drivers: A systematic review</article-title><source>Accid Anal Prev</source><volume>96</volume><year>2016</year><fpage>255</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1016/j.aap.2016.08.001</pub-id><pub-id pub-id-type="pmid">27569655</pub-id><pub-id pub-id-type="pmcid">PMC5045819</pub-id></element-citation></ref><ref id="bb0320"><label>64</label><element-citation publication-type="journal" id="rf0320"><person-group person-group-type="author"><name name-style="western"><surname>Smink</surname><given-names>B.E.</given-names></name><name name-style="western"><surname>Egberts</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Lusthof</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Uges</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>de Gier</surname><given-names>J.J.</given-names></name></person-group><article-title>The Relationship between Benzodiazepine Use and Traffic Accidents: A Systematic Literature Review</article-title><source>CNS Drugs</source><volume>24</volume><year>2010</year><fpage>639</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.2165/11533170-000000000-00000</pub-id><pub-id pub-id-type="pmid">20658797</pub-id></element-citation></ref><ref id="bb0325"><label>65</label><element-citation publication-type="journal" id="rf0325"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>R.E.</given-names></name></person-group><article-title>Benzodiazepine use and motor vehicle accidents. Systematic review of reported association</article-title><source>Can Fam Physician Med Fam Can</source><volume>44</volume><year>1998</year><fpage>799</fpage><lpage>808</lpage><pub-id pub-id-type="pmcid">PMC2277821</pub-id><pub-id pub-id-type="pmid">9585853</pub-id></element-citation></ref><ref id="bb0330"><label>66</label><element-citation publication-type="journal" id="rf0330"><person-group person-group-type="author"><name name-style="western"><surname>Berry</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Grubb</surname><given-names>D.J.</given-names></name></person-group><article-title>Effects of oxypertine and chlordiazepoxide on human motor coordination</article-title><source>J Int Med Res</source><volume>2</volume><year>1974</year><fpage>177</fpage><lpage>188</lpage></element-citation></ref><ref id="bb0335"><label>67</label><element-citation publication-type="journal" id="rf0335"><person-group person-group-type="author"><name name-style="western"><surname>Berthelon</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bocca</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Denise</surname><given-names>P.</given-names></name><name name-style="western"><surname>Pottier</surname><given-names>A.</given-names></name></person-group><article-title>Do zopiclone, zolpidem and flunitrazepam have residual effects on simulated task of collision anticipation?</article-title><source>J Psychopharmacol Oxf Engl</source><volume>17</volume><year>2003</year><fpage>324</fpage><lpage>331</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/02698811030173015</pub-id><pub-id pub-id-type="pmid">14513925</pub-id></element-citation></ref><ref id="bb0340"><label>68</label><element-citation publication-type="journal" id="rf0340"><person-group person-group-type="author"><name name-style="western"><surname>Betts</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Clayton</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Mackay</surname><given-names>G.M.</given-names></name></person-group><article-title>Effects of four commonly-used tranquillizers on low-speed driving performance tests</article-title><source>Br Med J</source><volume>4</volume><year>1972</year><fpage>580</fpage><lpage>584</lpage><pub-id pub-id-type="pmid">4566100</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.4.5840.580</pub-id><pub-id pub-id-type="pmcid">PMC1786808</pub-id></element-citation></ref><ref id="bb0345"><label>69.</label><element-citation publication-type="journal" id="rf0345"><person-group person-group-type="author"><name name-style="western"><surname>Betts</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Birtle</surname><given-names>J.</given-names></name></person-group><article-title>Effect of two hypnotic drugs on actual driving performance next morning</article-title><source>Br Med J (Clin Res Ed)</source><volume>285</volume><year>1982</year><fpage>852</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.285.6345.852</pub-id><pub-id pub-id-type="pmcid">PMC1499736</pub-id><pub-id pub-id-type="pmid">6126244</pub-id></element-citation></ref><ref id="bb0350"><label>70</label><element-citation publication-type="journal" id="rf0350"><person-group person-group-type="author"><name name-style="western"><surname>Biehl</surname><given-names>B.</given-names></name></person-group><article-title>Studies of clobazam and car-driving</article-title><source>Br J Clin Pharmacol</source><volume>7</volume><issue>suppl 1</issue><year>1979</year><fpage>85S</fpage><lpage>90S</lpage><pub-id pub-id-type="pmid">35213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2125.1979.tb04671.x</pub-id><pub-id pub-id-type="pmcid">PMC1429513</pub-id></element-citation></ref><ref id="bb0355"><label>71</label><element-citation publication-type="journal" id="rf0355"><person-group person-group-type="author"><name name-style="western"><surname>Bocca</surname><given-names>M.-L.</given-names></name><name name-style="western"><surname>Marie</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lelong-Boulouard</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Zolpidem and zopiclone impair similarly monotonous driving performance after a single nighttime intake in aged subjects</article-title><source>Psychopharmacology</source><volume>214</volume><year>2011</year><fpage>699</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1007/s00213-010-2075-5</pub-id><pub-id pub-id-type="pmid">21086117</pub-id></element-citation></ref><ref id="bb0360"><label>72</label><element-citation publication-type="journal" id="rf0360"><person-group person-group-type="author"><name name-style="western"><surname>Bocca</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Le Doze</surname><given-names>F.</given-names></name><name name-style="western"><surname>Etard</surname><given-names>O.</given-names></name><name name-style="western"><surname>Pottier</surname><given-names>M.</given-names></name><name name-style="western"><surname>L&#8217;Hoste</surname><given-names>J.</given-names></name><name name-style="western"><surname>Denise</surname><given-names>P.</given-names></name></person-group><article-title>Residual effects of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades</article-title><source>Psychopharmacology</source><volume>143</volume><year>1999</year><fpage>373</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1007/s002130050961</pub-id><pub-id pub-id-type="pmid">10367554</pub-id></element-citation></ref><ref id="bb0365"><label>73</label><element-citation publication-type="journal" id="rf0365"><person-group person-group-type="author"><name name-style="western"><surname>Boyle</surname><given-names>J.</given-names></name><name name-style="western"><surname>Trick</surname><given-names>L.</given-names></name><name name-style="western"><surname>Johnsen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Roach</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rubens</surname><given-names>R.</given-names></name></person-group><article-title>Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone</article-title><source>Hum Psychopharmacol</source><volume>23</volume><year>2008</year><fpage>385</fpage><lpage>397</lpage><pub-id pub-id-type="doi">10.1002/hup.936</pub-id><pub-id pub-id-type="pmid">18350566</pub-id></element-citation></ref><ref id="bb0370"><label>74</label><element-citation publication-type="journal" id="rf0370"><person-group person-group-type="author"><name name-style="western"><surname>Brookhuis</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Volkerts</surname><given-names>E.R.</given-names></name><name name-style="western"><surname>O&#8217;Hanlon</surname><given-names>J.F.</given-names></name></person-group><article-title>Repeated dose effects of lormetazepam and flurazepam upon driving performance</article-title><source>Eur J Clin Pharmacol</source><volume>39</volume><year>1990</year><fpage>83</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">1980464</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF02657065</pub-id></element-citation></ref><ref id="bb0375"><label>75</label><element-citation publication-type="journal" id="rf0375"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>T.</given-names></name><name name-style="western"><surname>Milavetz</surname><given-names>G.</given-names></name><name name-style="western"><surname>Murry</surname><given-names>D.J.</given-names></name></person-group><article-title>Alcohol, drugs and driving: implications for evaluating driver impairment</article-title><source>Ann Adv Automot Med Assoc Adv Automot Med Annu Sci Conf</source><volume>57</volume><year>2013</year><fpage>23</fpage><lpage>32</lpage><pub-id pub-id-type="pmcid">PMC3861813</pub-id><pub-id pub-id-type="pmid">24406943</pub-id></element-citation></ref><ref id="bb0380"><label>76.</label><element-citation publication-type="journal" id="rf0380"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>T.L.</given-names></name><name name-style="western"><surname>Milavetz</surname><given-names>G.</given-names></name><name name-style="western"><surname>Gaffney</surname><given-names>G.</given-names></name><name name-style="western"><surname>Spurgin</surname><given-names>A.</given-names></name></person-group><article-title>Evaluating drugged driving: Effects of exemplar pain and anxiety medications</article-title><source>Traffic Inj Prev</source><volume>19</volume><year>2018</year><fpage>S97</fpage><lpage>S103</lpage><pub-id pub-id-type="doi">10.1080/15389588.2017.1378814</pub-id><pub-id pub-id-type="pmid">29584496</pub-id></element-citation></ref><ref id="bb0385"><label>77</label><element-citation publication-type="journal" id="rf0385"><person-group person-group-type="author"><name name-style="western"><surname>Carter</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Carberry</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Cho</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Effects of one month of nightly zopiclone on obstructive sleep apnea severity and symptoms: A randomized, double-blind, placebo-controlled trial</article-title><source>Am J Respir Crit Care Med</source><volume>195</volume><year>2017</year><pub-id pub-id-type="doi">10.1164/ajrccmconference.2017.C109</pub-id></element-citation></ref><ref id="bb0390"><label>78.</label><element-citation publication-type="journal" id="rf0390"><person-group person-group-type="author"><name name-style="western"><surname>Carter</surname><given-names>S.G.</given-names></name><name name-style="western"><surname>Carberry</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Grunstein</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>Eckert</surname><given-names>D.J.</given-names></name></person-group><article-title>Randomized trial on the effects of high-dose zopiclone on osa severity, upper airway physiology, and alertness</article-title><source>Chest</source><year>2020</year><pub-id pub-id-type="doi">10.1016/j.chest.2020.02.057</pub-id><pub-id pub-id-type="pmid">32197956</pub-id></element-citation></ref><ref id="bb0395"><label>79</label><element-citation publication-type="journal" id="rf0395"><person-group person-group-type="author"><name name-style="western"><surname>Daurat</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sagaspe</surname><given-names>P.</given-names></name><name name-style="western"><surname>Motak</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Lorazepam impairs highway driving performance more than heavy alcohol consumption</article-title><source>Accid Anal Prev</source><volume>60</volume><year>2013</year><fpage>31</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.aap.2013.08.004</pub-id><pub-id pub-id-type="pmid">24007754</pub-id></element-citation></ref><ref id="bb0400"><label>80</label><element-citation publication-type="journal" id="rf0400"><person-group person-group-type="author"><name name-style="western"><surname>de Gier</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>&#8217;t Hart</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Nelemans</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>Bergman</surname><given-names>H.</given-names></name></person-group><article-title>Psychomotor performance and real driving performance of outpatients receiving diazepam</article-title><source>Psychopharmacology</source><volume>73</volume><year>1981</year><fpage>340</fpage><lpage>344</lpage><pub-id pub-id-type="pmid">6789355</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF00426462</pub-id></element-citation></ref><ref id="bb0405"><label>81</label><element-citation publication-type="journal" id="rf0405"><person-group person-group-type="author"><name name-style="western"><surname>Dureman</surname><given-names>I.</given-names></name><name name-style="western"><surname>Norrman</surname><given-names>B.</given-names></name></person-group><article-title>Clinical and experimental comparison of diazepam, chlorazepate and placebo</article-title><source>Psychopharmacologia</source><volume>40</volume><year>1975</year><fpage>279</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">238256</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF00421465</pub-id></element-citation></ref><ref id="bb0410"><label>82</label><element-citation publication-type="journal" id="rf0410"><person-group person-group-type="author"><name name-style="western"><surname>Dureman</surname><given-names>I.</given-names></name><name name-style="western"><surname>Malmgren</surname><given-names>H.</given-names></name><name name-style="western"><surname>Norrman</surname><given-names>B.</given-names></name></person-group><article-title>Comparison studies of chlorazepate administered as a divided daily dose and as a single dose at night</article-title><source>Psychopharmacology</source><volume>57</volume><year>1978</year><fpage>123</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1007/BF00426875</pub-id><pub-id pub-id-type="pmid">26099</pub-id></element-citation></ref><ref id="bb0415"><label>83</label><element-citation publication-type="journal" id="rf0415"><person-group person-group-type="author"><name name-style="western"><surname>Friedel</surname><given-names>B.</given-names></name><name name-style="western"><surname>Sjoo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Reker</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hartmann</surname><given-names>R.</given-names></name></person-group><article-title>Testing drivers taking diazepam in the Daimler-Benz driving simulator</article-title><source>J Traffic Med</source><volume>19</volume><year>1991</year><fpage>15</fpage><lpage>27</lpage></element-citation></ref><ref id="bb0420"><label>84</label><element-citation publication-type="journal" id="rf0420"><person-group person-group-type="author"><name name-style="western"><surname>Hindmarch</surname><given-names>I.</given-names></name><name name-style="western"><surname>Hanks</surname><given-names>G.W.</given-names></name><name name-style="western"><surname>Hewett</surname><given-names>A.J.</given-names></name></person-group><article-title>Clobazam, a 1,5-benzodiazepine, and car-driving ability</article-title><source>Br J Clin Pharmacol</source><volume>4</volume><year>1977</year><fpage>573</fpage><lpage>578</lpage><pub-id pub-id-type="pmid">20918</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2125.1977.tb00788.x</pub-id><pub-id pub-id-type="pmcid">PMC1429166</pub-id></element-citation></ref><ref id="bb0425"><label>85</label><element-citation publication-type="journal" id="rf0425"><person-group person-group-type="author"><name name-style="western"><surname>Hindmarch</surname><given-names>I.</given-names></name><name name-style="western"><surname>Gudgeon</surname><given-names>A.C.</given-names></name></person-group><article-title>The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability</article-title><source>Br J Clin Pharmacol</source><volume>10</volume><year>1980</year><fpage>145</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2125.1980.tb01731.x</pub-id><pub-id pub-id-type="pmid">6107116</pub-id><pub-id pub-id-type="pmcid">PMC1430040</pub-id></element-citation></ref><ref id="bb0430"><label>86</label><element-citation publication-type="journal" id="rf0430"><person-group person-group-type="author"><name name-style="western"><surname>Hindmarch</surname><given-names>I.</given-names></name><name name-style="western"><surname>Trick</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ridout</surname><given-names>F.</given-names></name></person-group><article-title>A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers</article-title><source>Psychopharmacology</source><volume>183</volume><year>2005</year><fpage>133</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">16205916</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00213-005-0172-7</pub-id></element-citation></ref><ref id="bb0435"><label>87</label><element-citation publication-type="journal" id="rf0435"><person-group person-group-type="author"><name name-style="western"><surname>Huizinga</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Zuiker</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>de Kam</surname><given-names>M.L.</given-names></name><etal/></person-group><article-title>Evaluation of simulated driving in comparison to laboratory-based tests to assess the pharmacodynamics of alprazolam and alcohol</article-title><source>J Psychopharmacol Oxf Engl</source><volume>33</volume><year>2019</year><fpage>791</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1177/0269881119836198</pub-id><pub-id pub-id-type="pmid">30912701</pub-id></element-citation></ref><ref id="bb0440"><label>88</label><element-citation publication-type="journal" id="rf0440"><person-group person-group-type="author"><name name-style="western"><surname>Iudice</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bonanni</surname><given-names>E.</given-names></name><name name-style="western"><surname>Maestri</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Lormetazepam effects on daytime vigilance, psychomotor performance and simulated driving in young adult healthy volunteers</article-title><source>Int J Clin Pharmacol Ther</source><volume>40</volume><year>2002</year><fpage>304</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">12139207</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5414/cpp40304</pub-id></element-citation></ref><ref id="bb0445"><label>89</label><element-citation publication-type="journal" id="rf0445"><person-group person-group-type="author"><name name-style="western"><surname>Iwamoto</surname><given-names>K.</given-names></name><name name-style="western"><surname>Iwata</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kambe</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Residual effects of zopiclone on driving performance using a standardized driving simulator among healthy volunteers</article-title><source>Psychopharmacology</source><volume>239</volume><year>2022</year><fpage>841</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1007/s00213-022-06075-y</pub-id><pub-id pub-id-type="pmid">35106620</pub-id></element-citation></ref><ref id="bb0450"><label>90</label><element-citation publication-type="journal" id="rf0450"><person-group person-group-type="author"><name name-style="western"><surname>Jongen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Vuurman</surname><given-names>E.F.P.M.</given-names></name><name name-style="western"><surname>Ramaekers</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name></person-group><article-title>Comparing the effects of oxazepam and diazepam in actual highway driving and neurocognitive test performance: a validation study</article-title><source>Psychopharmacology</source><volume>235</volume><year>2018</year><fpage>1283</fpage><lpage>1294</lpage><pub-id pub-id-type="doi">10.1007/s00213-018-4844-5</pub-id><pub-id pub-id-type="pmid">29500585</pub-id><pub-id pub-id-type="pmcid">PMC5869943</pub-id></element-citation></ref><ref id="bb0455"><label>91</label><element-citation publication-type="journal" id="rf0455"><person-group person-group-type="author"><name name-style="western"><surname>Kay</surname><given-names>G.G.</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>H.I.</given-names></name><name name-style="western"><surname>Wingertzahn</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Jayawardena</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rosenberg</surname><given-names>R.P.</given-names></name></person-group><article-title>Next-day residual effects of gabapentin, diphenhydramine, and triazolam on simulated driving performance in healthy volunteers: a phase 3, randomized, double-blind, placebo-controlled, crossover trial</article-title><source>Hum Psychopharmacol</source><volume>31</volume><year>2016</year><fpage>217</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1002/hup.2530</pub-id><pub-id pub-id-type="pmid">27018419</pub-id></element-citation></ref><ref id="bb0460"><label>92.</label><element-citation publication-type="journal" id="rf0460"><person-group person-group-type="author"><name name-style="western"><surname>Kay</surname><given-names>G.G.</given-names></name><name name-style="western"><surname>Hochadel</surname><given-names>T.</given-names></name><name name-style="western"><surname>Sicard</surname><given-names>E.</given-names></name><name name-style="western"><surname>Natarajan</surname><given-names>K.K.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>N.N.</given-names></name></person-group><article-title>Next-day residual effects of flibanserin on simulated driving performance in premenopausal women</article-title><source>Hum Psychopharmacol</source><volume>32</volume><year>2017</year><pub-id pub-id-type="doi">10.1002/hup.2603</pub-id><pub-id pub-id-type="pmcid">PMC5697607</pub-id><pub-id pub-id-type="pmid">28568608</pub-id></element-citation></ref><ref id="bb0465"><label>93</label><element-citation publication-type="journal" id="rf0465"><person-group person-group-type="author"><name name-style="western"><surname>Kuitunen</surname><given-names>T.</given-names></name></person-group><article-title>Drug and ethanol effects on the clinical test for drunkenness: single doses of ethanol, hypnotic drugs and antidepressant drugs</article-title><source>Pharmacol Toxicol</source><volume>75</volume><year>1994</year><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">7971743</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0773.1994.tb00329.x</pub-id></element-citation></ref><ref id="bb0470"><label>94</label><element-citation publication-type="journal" id="rf0470"><person-group person-group-type="author"><name name-style="western"><surname>Laurell</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tornros</surname><given-names>J.</given-names></name></person-group><article-title>The carry-over effects of triazolam compared with nitrazepam and placebo in acute emergency driving situations and in monotonous simulated driving</article-title><source>Acta Pharmacol Toxicol (Copenh)</source><volume>58</volume><year>1986</year><fpage>182</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">3716812</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0773.1986.tb00092.x</pub-id></element-citation></ref><ref id="bb0475"><label>95</label><element-citation publication-type="journal" id="rf0475"><person-group person-group-type="author"><name name-style="western"><surname>Leufkens</surname><given-names>T.R.M.</given-names></name><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name><name name-style="western"><surname>Smink</surname><given-names>B.E.</given-names></name><name name-style="western"><surname>van Ruitenbeek</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ramaekers</surname><given-names>J.G.</given-names></name></person-group><article-title>Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg</article-title><source>Psychopharmacology</source><volume>191</volume><year>2007</year><fpage>951</fpage><lpage>959</lpage><pub-id pub-id-type="pmid">17219217</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00213-006-0669-8</pub-id></element-citation></ref><ref id="bb0480"><label>96</label><element-citation publication-type="journal" id="rf0480"><person-group person-group-type="author"><name name-style="western"><surname>Leufkens</surname><given-names>T.R.M.</given-names></name><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name></person-group><article-title>Highway driving in the elderly the morning after bedtime use of hypnotics: a comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo</article-title><source>J Clin Psychopharmacol</source><volume>29</volume><year>2009</year><fpage>432</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1097/JCP.0b013e3181b57b43</pub-id><pub-id pub-id-type="pmid">19745642</pub-id></element-citation></ref><ref id="bb0485"><label>97</label><element-citation publication-type="journal" id="rf0485"><person-group person-group-type="author"><name name-style="western"><surname>Leufkens</surname><given-names>T.R.M.</given-names></name><name name-style="western"><surname>Lund</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name></person-group><article-title>Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem</article-title><source>J Sleep Res</source><volume>18</volume><year>2009</year><fpage>387</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2869.2009.00746.x</pub-id><pub-id pub-id-type="pmid">19552733</pub-id></element-citation></ref><ref id="bb0490"><label>98</label><element-citation publication-type="journal" id="rf0490"><person-group person-group-type="author"><name name-style="western"><surname>Leufkens</surname><given-names>T.R.M.</given-names></name><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name></person-group><article-title>Zopiclone&#8217;s residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies</article-title><source>Clin Ther</source><volume>36</volume><year>2014</year><fpage>141</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1016/j.clinthera.2013.11.005</pub-id><pub-id pub-id-type="pmid">24360801</pub-id></element-citation></ref><ref id="bb0495"><label>99</label><element-citation publication-type="journal" id="rf0495"><person-group person-group-type="author"><name name-style="western"><surname>Leufkens</surname><given-names>T.R.M.</given-names></name><name name-style="western"><surname>Ramaekers</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>de Weerd</surname><given-names>A.W.</given-names></name><name name-style="western"><surname>Riedel</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name></person-group><article-title>On-the-road driving performance and driving-related skills in older untreated insomnia patients and chronic users of hypnotics</article-title><source>Psychopharmacology</source><volume>231</volume><year>2014</year><fpage>2851</fpage><lpage>2865</lpage><pub-id pub-id-type="doi">10.1007/s00213-014-3455-z</pub-id><pub-id pub-id-type="pmid">24488406</pub-id><pub-id pub-id-type="pmcid">PMC4072063</pub-id></element-citation></ref><ref id="bb0500"><label>100</label><element-citation publication-type="journal" id="rf0500"><person-group person-group-type="author"><name name-style="western"><surname>Leufkens</surname><given-names>T.R.M.</given-names></name><name name-style="western"><surname>Ramaekers</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>de Weerd</surname><given-names>A.W.</given-names></name><name name-style="western"><surname>Riedel</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name></person-group><article-title>Residual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study</article-title><source>Psychopharmacology</source><volume>231</volume><year>2014</year><fpage>2785</fpage><lpage>2798</lpage><pub-id pub-id-type="doi">10.1007/s00213-014-3447-z</pub-id><pub-id pub-id-type="pmid">24458443</pub-id><pub-id pub-id-type="pmcid">PMC4072058</pub-id></element-citation></ref><ref id="bb0505"><label>101</label><element-citation publication-type="journal" id="rf0505"><person-group person-group-type="author"><name name-style="western"><surname>Linnoila</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mattila</surname><given-names>M.J.</given-names></name></person-group><article-title>Proceedings: Drug interaction on driving skills as evaluated by laboratory tests and by a driving simulator</article-title><source>Pharmakopsychiatr Neuropsychopharmakol</source><volume>6</volume><year>1973</year><fpage>127</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">4153017</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-0028-1094375</pub-id></element-citation></ref><ref id="bb0510"><label>102</label><element-citation publication-type="journal" id="rf0510"><person-group person-group-type="author"><name name-style="western"><surname>Linnoila</surname><given-names>M.</given-names></name><name name-style="western"><surname>H&#228;kkinen</surname><given-names>S.</given-names></name></person-group><article-title>Effects of diazepam and codeine, alone and in combination with alcohol, on simulated driving</article-title><source>Clin Pharmacol Ther</source><volume>15</volume><year>1974</year><fpage>368</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1002/cpt1974154368</pub-id><pub-id pub-id-type="pmid">4595291</pub-id></element-citation></ref><ref id="bb0515"><label>103</label><element-citation publication-type="journal" id="rf0515"><person-group person-group-type="author"><name name-style="western"><surname>Mattila</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Aranko</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kuitunen</surname><given-names>T.</given-names></name></person-group><article-title>Diazepam effects on the performance of healthy subjects are not enhanced by treatment with the antihistamine ebastine</article-title><source>Br J Clin Pharmacol</source><volume>35</volume><year>1993</year><fpage>272</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">8097102</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2125.1993.tb05694.x</pub-id><pub-id pub-id-type="pmcid">PMC1381574</pub-id></element-citation></ref><ref id="bb0520"><label>104</label><element-citation publication-type="journal" id="rf0520"><person-group person-group-type="author"><name name-style="western"><surname>Mattila</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Vanakoski</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mattila-Evenden</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Karonen</surname><given-names>S.L.</given-names></name></person-group><article-title>Suriclone enhances the actions of chlorpromazine on human psychomotor performance but not on memory or plasma prolactin in healthy subjects</article-title><source>Eur J Clin Pharmacol</source><volume>46</volume><year>1994</year><fpage>215</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">7915235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF00192551</pub-id></element-citation></ref><ref id="bb0525"><label>105</label><element-citation publication-type="journal" id="rf0525"><person-group person-group-type="author"><name name-style="western"><surname>Mattila</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Vanakoski</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kalska</surname><given-names>H.</given-names></name><name name-style="western"><surname>Seppala</surname><given-names>T.</given-names></name></person-group><article-title>Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory</article-title><source>Pharmacol Biochem Behav</source><volume>59</volume><year>1998</year><fpage>917</fpage><lpage>923</lpage><pub-id pub-id-type="pmid">9586849</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0091-3057(97)00506-6</pub-id></element-citation></ref><ref id="bb0530"><label>106</label><element-citation publication-type="journal" id="rf0530"><person-group person-group-type="author"><name name-style="western"><surname>Mercier-Guyon</surname><given-names>C.</given-names></name><name name-style="western"><surname>Lejay</surname><given-names>J.</given-names></name><name name-style="western"><surname>Choay</surname><given-names>P.</given-names></name></person-group><article-title>Comparative study of the effects of captodiamine and lorazepam on car driving ability</article-title><source>Clin Drug Investig</source><volume>17</volume><year>1999</year><fpage>451</fpage><lpage>459</lpage></element-citation></ref><ref id="bb0535"><label>107</label><element-citation publication-type="journal" id="rf0535"><person-group person-group-type="author"><name name-style="western"><surname>Meskali</surname><given-names>M.</given-names></name><name name-style="western"><surname>Berthelon</surname><given-names>C.</given-names></name><name name-style="western"><surname>Marie</surname><given-names>S.</given-names></name><name name-style="western"><surname>Denise</surname><given-names>P.</given-names></name><name name-style="western"><surname>Bocca</surname><given-names>M.-L.</given-names></name></person-group><article-title>Residual effects of hypnotic drugs in aging drivers submitted to simulated accident scenarios: an exploratory study</article-title><source>Psychopharmacology</source><volume>207</volume><year>2009</year><fpage>461</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1007/s00213-009-1677-2</pub-id><pub-id pub-id-type="pmid">19798483</pub-id></element-citation></ref><ref id="bb0540"><label>108</label><element-citation publication-type="journal" id="rf0540"><person-group person-group-type="author"><name name-style="western"><surname>Mets</surname><given-names>M.A.J.</given-names></name><name name-style="western"><surname>de Vries</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>de Senerpont Domis</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Volkerts</surname><given-names>E.R.</given-names></name><name name-style="western"><surname>Olivier</surname><given-names>B.</given-names></name><name name-style="western"><surname>Verster</surname><given-names>J.C.</given-names></name></person-group><article-title>Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects</article-title><source>Sleep</source><volume>34</volume><year>2011</year><fpage>1327</fpage><lpage>1334</lpage><pub-id pub-id-type="doi">10.5665/SLEEP.1272</pub-id><pub-id pub-id-type="pmid">21966064</pub-id><pub-id pub-id-type="pmcid">PMC3173578</pub-id></element-citation></ref><ref id="bb0545"><label>109</label><element-citation publication-type="journal" id="rf0545"><person-group person-group-type="author"><name name-style="western"><surname>Miyata</surname><given-names>A.</given-names></name><name name-style="western"><surname>Iwamoto</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kawano</surname><given-names>N.</given-names></name><etal/></person-group><article-title>The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers</article-title><source>Psychopharmacology</source><year>2014</year><pub-id pub-id-type="doi">10.1007/s00213-014-3843-4</pub-id><pub-id pub-id-type="pmid">25533998</pub-id></element-citation></ref><ref id="bb0550"><label>110</label><element-citation publication-type="journal" id="rf0550"><person-group person-group-type="author"><name name-style="western"><surname>Moller</surname><given-names>H.-J.</given-names></name><name name-style="western"><surname>Volz</surname><given-names>H.-P.</given-names></name><name name-style="western"><surname>Seifritz</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Silexan does not affect driving performance after single and multiple dose applications: Results from a double-blind, placebo and reference-controlled study in healthy volunteers</article-title><source>J Psychiatr Res</source><volume>136</volume><year>2021</year><fpage>543</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1016/j.jpsychires.2020.10.028</pub-id><pub-id pub-id-type="pmid">33221027</pub-id></element-citation></ref><ref id="bb0555"><label>111.</label><element-citation publication-type="journal" id="rf0555"><person-group person-group-type="author"><name name-style="western"><surname>Moskowitz</surname><given-names>H.</given-names></name><name name-style="western"><surname>Smiley</surname><given-names>A.</given-names></name></person-group><article-title>Effects of chronically administered buspirone and diazepam on driving-related skills performance</article-title><source>J Clin Psychiatry</source><volume>43</volume><year>1982</year><fpage>45</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">6130073</pub-id></element-citation></ref><ref id="bb0560"><label>112</label><element-citation publication-type="journal" id="rf0560"><person-group person-group-type="author"><name name-style="western"><surname>Motak</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bayssac</surname><given-names>L.</given-names></name><name name-style="western"><surname>Taillard</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Naturalistic conversation improves daytime motorway driving performance under a benzodiazepine: a randomised, crossover, double-blind, placebo-controlled study</article-title><source>Accid Anal Prev</source><volume>67</volume><year>2014</year><fpage>61</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.aap.2014.02.009</pub-id><pub-id pub-id-type="pmid">24631977</pub-id></element-citation></ref><ref id="bb0565"><label>113</label><element-citation publication-type="journal" id="rf0565"><person-group person-group-type="author"><name name-style="western"><surname>Muehlan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Brooks</surname><given-names>S.</given-names></name><name name-style="western"><surname>Vaillant</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Driving performance after bedtime administration of daridorexant, assessed in a sensitive simulator</article-title><source>Clin Pharmacol Ther</source><year>2022</year><pub-id pub-id-type="doi">10.1002/cpt.2592</pub-id><pub-id pub-id-type="pmcid">PMC9320895</pub-id><pub-id pub-id-type="pmid">35426136</pub-id></element-citation></ref><ref id="bb0570"><label>114</label><element-citation publication-type="journal" id="rf0570"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Hanlon</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Haak</surname><given-names>T.W.</given-names></name><name name-style="western"><surname>Blaauw</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Riemersma</surname><given-names>J.B.</given-names></name></person-group><article-title>Diazepam impairs lateral position control in highway driving</article-title><source>Science</source><volume>217</volume><year>1982</year><fpage>79</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">7089544</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.7089544</pub-id></element-citation></ref><ref id="bb0575"><label>115</label><element-citation publication-type="journal" id="rf0575"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Hanlon</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Volkerts</surname><given-names>E.R.</given-names></name></person-group><article-title>Hypnotics and actual driving performance</article-title><source>Acta Psychiatr Scand</source><volume>74</volume><year>1986</year><fpage>95</fpage><lpage>104</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0447.1986.tb08985.x</pub-id><pub-id pub-id-type="pmid">3554901</pub-id></element-citation></ref><ref id="bb0580"><label>116</label><element-citation publication-type="book" id="rf0580"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Hanlon</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Swijgman</surname><given-names>H.F.</given-names></name><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name></person-group><part-title>Comparison of alpidem, lorazepam, and placebo effects in a combined clinical/psychometric study: A new approach for assessing the behavioral costs and benefits of anxiolytic drug therapy</part-title><source>Imidazopyridines Anxiety Disord. Nov. Exp. Ther</source><year>1993</year><publisher-name>Approach, Raven Press</publisher-name><publisher-loc>New York, NY</publisher-loc><fpage>143</fpage><lpage>153</lpage><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ezproxy.library.dal.ca/login?url=http://search.ebscohost.com/login.aspx?direct=true&amp;db=psyh&amp;AN=1993-98553-005&amp;site=ehost-live" id="ir0035">http://ezproxy.library.dal.ca/login?url=http://search.ebscohost.com/login.aspx?direct=true&amp;db=psyh&amp;AN=1993-98553-005&amp;site=ehost-live</ext-link></element-citation></ref><ref id="bb0585"><label>117</label><element-citation publication-type="journal" id="rf0585"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Hanlon</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name><name name-style="western"><surname>Uiterwijk</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>van Veggel</surname><given-names>L.M.</given-names></name><name name-style="western"><surname>Swijgman</surname><given-names>H.F.</given-names></name></person-group><article-title>Anxiolytics&#8217; effects on the actual driving performance of patients and healthy volunteers in a standardized test. An integration of three studies</article-title><source>Neuropsychobiology</source><volume>31</volume><year>1995</year><fpage>81</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">7760989</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000119177</pub-id></element-citation></ref><ref id="bb0590"><label>118.</label><element-citation publication-type="journal" id="rf0590"><person-group person-group-type="author"><name name-style="western"><surname>Otmani</surname><given-names>S.</given-names></name><name name-style="western"><surname>Demazieres</surname><given-names>A.</given-names></name><name name-style="western"><surname>Staner</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers</article-title><source>Hum Psychopharmacol</source><volume>23</volume><year>2008</year><fpage>693</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1002/hup.980</pub-id><pub-id pub-id-type="pmid">18763235</pub-id></element-citation></ref><ref id="bb0595"><label>119</label><element-citation publication-type="journal" id="rf0595"><person-group person-group-type="author"><name name-style="western"><surname>Palva</surname><given-names>E.S.</given-names></name><name name-style="western"><surname>Linnoila</surname><given-names>M.</given-names></name></person-group><article-title>Effect of active metabolites of chlordiazepoxide and diazepam, alone or in combination with alcohol, on psychomotor skills related to driving</article-title><source>Eur J Clin Pharmacol</source><volume>13</volume><year>1978</year><fpage>345</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">352710</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF00644607</pub-id></element-citation></ref><ref id="bb0600"><label>120</label><element-citation publication-type="journal" id="rf0600"><person-group person-group-type="author"><name name-style="western"><surname>Partinen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hirvonen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hublin</surname><given-names>C.</given-names></name><name name-style="western"><surname>Halavaara</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hiltunen</surname><given-names>H.</given-names></name></person-group><article-title>Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia</article-title><source>Sleep Med</source><volume>4</volume><year>2003</year><fpage>553</fpage><lpage>561</lpage><pub-id pub-id-type="pmid">14607350</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.sleep.2003.06.005</pub-id></element-citation></ref><ref id="bb0605"><label>121</label><element-citation publication-type="journal" id="rf0605"><person-group person-group-type="author"><name name-style="western"><surname>Ramaekers</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Conen</surname><given-names>S.</given-names></name><name name-style="western"><surname>de Kam</surname><given-names>P.J.</given-names></name><etal/></person-group><article-title>Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype</article-title><source>Psychopharmacology</source><volume>215</volume><year>2011</year><fpage>321</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1007/s00213-010-2149-4</pub-id><pub-id pub-id-type="pmid">21246188</pub-id><pub-id pub-id-type="pmcid">PMC3083504</pub-id></element-citation></ref><ref id="bb0610"><label>122</label><element-citation publication-type="journal" id="rf0610"><person-group person-group-type="author"><name name-style="western"><surname>Sarris</surname><given-names>J.</given-names></name><name name-style="western"><surname>Laporte</surname><given-names>E.</given-names></name><name name-style="western"><surname>Scholey</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Does a medicinal dose of kava impair driving? A randomized, placebo-controlled, double-blind study</article-title><source>Traffic Inj Prev</source><volume>14</volume><year>2013</year><fpage>13</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1080/15389588.2012.682233</pub-id><pub-id pub-id-type="pmid">23259514</pub-id></element-citation></ref><ref id="bb0615"><label>123</label><element-citation publication-type="journal" id="rf0615"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>U.</given-names></name><name name-style="western"><surname>Brendemuhl</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ruther</surname><given-names>E.</given-names></name></person-group><article-title>Aspects of driving after hypnotic therapy with particular reference to temazepam</article-title><source>Acta Psychiatr Scand</source><volume>74</volume><year>1986</year><fpage>112</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">2883818</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0447.1986.tb08987.x</pub-id></element-citation></ref><ref id="bb0620"><label>124</label><element-citation publication-type="journal" id="rf0620"><person-group person-group-type="author"><name name-style="western"><surname>Seppala</surname><given-names>T.</given-names></name><name name-style="western"><surname>Saario</surname><given-names>I.</given-names></name><name name-style="western"><surname>Mattila</surname><given-names>M.J.</given-names></name></person-group><article-title>Two weeks&#8217; treatment with chlorpromazine, thioridazine, sulpiride, or bromazepam: actions and interactions with alcohol on psychomotor skills related to driving</article-title><source>Mod Probl Pharmacopsychiatry</source><volume>11</volume><year>1976</year><fpage>85</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">9581</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000399456</pub-id></element-citation></ref><ref id="bb0625"><label>125</label><element-citation publication-type="journal" id="rf0625"><person-group person-group-type="author"><name name-style="western"><surname>Smiley</surname><given-names>A.</given-names></name><name name-style="western"><surname>Moskowitz</surname><given-names>H.</given-names></name></person-group><article-title>Effects of long-term administration of buspirone and diazepam on driver steering control</article-title><source>Am J Med</source><volume>80</volume><year>1986</year><fpage>22</fpage><lpage>29</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0002-9343(86)90328-1</pub-id><pub-id pub-id-type="pmid">3963031</pub-id></element-citation></ref><ref id="bb0630"><label>126</label><element-citation publication-type="journal" id="rf0630"><person-group person-group-type="author"><name name-style="western"><surname>Stone</surname><given-names>B.T.</given-names></name><name name-style="western"><surname>Correa</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>T.L.</given-names></name><etal/></person-group><article-title>Behavioral and neurophysiological signatures of benzodiazepine-related driving impairments</article-title><source>Front Psychol</source><volume>6</volume><year>2015</year><fpage>1799</fpage><pub-id pub-id-type="doi">10.3389/fpsyg.2015.01799</pub-id><pub-id pub-id-type="pmid">26635697</pub-id><pub-id pub-id-type="pmcid">PMC4659917</pub-id></element-citation></ref><ref id="bb0635"><label>127</label><element-citation publication-type="journal" id="rf0635"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kay</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hochadel</surname><given-names>T.</given-names></name><etal/></person-group><article-title>A randomized, multicenter trial assessing the effects of rapastinel compared to ketamine, alprazolam, and placebo on simulated driving performance</article-title><source>Clin Transl Sci</source><volume>15</volume><year>2022</year><fpage>255</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1111/cts.13145</pub-id><pub-id pub-id-type="pmid">34423904</pub-id><pub-id pub-id-type="pmcid">PMC8742651</pub-id></element-citation></ref><ref id="bb0640"><label>128</label><element-citation publication-type="journal" id="rf0640"><person-group person-group-type="author"><name name-style="western"><surname>Subhan</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hindmarch</surname><given-names>I.</given-names></name></person-group><article-title>Alprazolam and lorazepam single and multiple-dose effects on psychomotor skills and sleep</article-title><source>Eur J Clin Pharmacol</source><volume>29</volume><year>1986</year><fpage>709</fpage><lpage>712</lpage><pub-id pub-id-type="pmid">3709614</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF00615963</pub-id></element-citation></ref><ref id="bb0645"><label>129</label><element-citation publication-type="journal" id="rf0645"><person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Iwamoto</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kawamura</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>The effects of acute treatment with tandospirone, diazepam, and placebo on driving performance and cognitive function in healthy volunteers</article-title><source>Hum Psychopharmacol</source><volume>25</volume><year>2010</year><fpage>260</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1002/hup.1105</pub-id><pub-id pub-id-type="pmid">20373478</pub-id></element-citation></ref><ref id="bb0650"><label>130</label><element-citation publication-type="journal" id="rf0650"><person-group person-group-type="author"><name name-style="western"><surname>Tornros</surname><given-names>J.</given-names></name><name name-style="western"><surname>Laurell</surname><given-names>H.</given-names></name></person-group><article-title>Acute and carry-over effects of brotizolam compared to nitrazepam and placebo in monotonous simulated driving</article-title><source>Pharmacol Toxicol</source><volume>67</volume><year>1990</year><fpage>77</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">2395820</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0773.1990.tb00786.x</pub-id></element-citation></ref><ref id="bb0655"><label>131.</label><element-citation publication-type="journal" id="rf0655"><person-group person-group-type="author"><name name-style="western"><surname>T&#246;rnros</surname><given-names>J.</given-names></name><name name-style="western"><surname>Vikander</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ahlner</surname><given-names>J.</given-names></name><name name-style="western"><surname>J&#246;nsson</surname><given-names>K.-&#197;.</given-names></name></person-group><article-title>Simulated driving performance of benzodiazepine users</article-title><source>J Traffic Med</source><volume>29</volume><year>2001</year><fpage>4</fpage><lpage>15</lpage></element-citation></ref><ref id="bb0660"><label>132</label><element-citation publication-type="journal" id="rf0660"><person-group person-group-type="author"><name name-style="western"><surname>Torres</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>M.</given-names></name><name name-style="western"><surname>Birznieks</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Simulated driving performance in healthy adults after night-time administration of 20 mg tasimelteon</article-title><source>J Sleep Res</source><volume>31</volume><year>2022</year><object-id pub-id-type="publisher-id">e13430</object-id><pub-id pub-id-type="doi">10.1111/jsr.13430</pub-id><pub-id pub-id-type="pmcid">PMC9285441</pub-id><pub-id pub-id-type="pmid">34152055</pub-id></element-citation></ref><ref id="bb0665"><label>133</label><element-citation publication-type="journal" id="rf0665"><person-group person-group-type="author"><name name-style="western"><surname>Vanakoski</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mattila</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Seppala</surname><given-names>T.</given-names></name></person-group><article-title>Driving under light and dark conditions: effects of alcohol and diazepam in young and older subjects</article-title><source>Eur J Clin Pharmacol</source><volume>56</volume><year>2000</year><fpage>453</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">11049006</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s002280000167</pub-id></element-citation></ref><ref id="bb0670"><label>134.</label><element-citation publication-type="journal" id="rf0670"><person-group person-group-type="author"><name name-style="western"><surname>van der Sluiszen</surname><given-names>N.N.J.J.M.</given-names></name><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name><name name-style="western"><surname>Verster</surname><given-names>J.C.</given-names></name><etal/></person-group><article-title>Driving performance and neurocognitive skills of long-term users of benzodiazepine anxiolytics and hypnotics</article-title><source>Hum Psychopharmacol</source><volume>34</volume><year>2019</year><object-id pub-id-type="publisher-id">e2715</object-id><pub-id pub-id-type="doi">10.1002/hup.2715</pub-id><pub-id pub-id-type="pmcid">PMC7003498</pub-id><pub-id pub-id-type="pmid">31837049</pub-id></element-citation></ref><ref id="bb0675"><label>135</label><element-citation publication-type="journal" id="rf0675"><person-group person-group-type="author"><name name-style="western"><surname>van Laar</surname><given-names>M.W.</given-names></name><name name-style="western"><surname>Volkerts</surname><given-names>E.R.</given-names></name><name name-style="western"><surname>van Willigenburg</surname><given-names>A.P.</given-names></name></person-group><article-title>Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients</article-title><source>J Clin Psychopharmacol</source><volume>12</volume><year>1992</year><fpage>86</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">1573045</pub-id></element-citation></ref><ref id="bb0680"><label>136</label><element-citation publication-type="journal" id="rf0680"><person-group person-group-type="author"><name name-style="western"><surname>van Laar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Volkerts</surname><given-names>E.</given-names></name><name name-style="western"><surname>Verbaten</surname><given-names>M.</given-names></name></person-group><article-title>Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers</article-title><source>Psychopharmacology</source><volume>154</volume><year>2001</year><fpage>189</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">11314681</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s002130000633</pub-id></element-citation></ref><ref id="bb0685"><label>137</label><element-citation publication-type="journal" id="rf0685"><person-group person-group-type="author"><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name><name name-style="western"><surname>O&#8217;Hanlon</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Declerck</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Kho</surname><given-names>L.</given-names></name></person-group><article-title>Acute effects of zolpidem and flunitrazepam on sleep, memory and driving performance, compared to those of partial sleep deprivation and placebo</article-title><source>Acta Ther</source><volume>21</volume><year>1995</year><fpage>47</fpage><lpage>64</lpage></element-citation></ref><ref id="bb0690"><label>138</label><element-citation publication-type="journal" id="rf0690"><person-group person-group-type="author"><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name><name name-style="western"><surname>Danjou</surname><given-names>P.E.</given-names></name><name name-style="western"><surname>O&#8217;Hanlon</surname><given-names>J.F.</given-names></name></person-group><article-title>Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance</article-title><source>Hum Psychopharmacol</source><volume>13</volume><year>1998</year><fpage>S98</fpage><lpage>S107</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1099-1077(1998110)13:2+3.0.CO;2-1</pub-id></element-citation></ref><ref id="bb0695"><label>139</label><element-citation publication-type="journal" id="rf0695"><person-group person-group-type="author"><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ramaekers</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Van Leeuwen</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>O&#8217;Hanlon</surname><given-names>J.F.</given-names></name></person-group><article-title>Residual effects on actual car driving of evening dosing of chlorpheniramine 8 and 12 mg when use with terfenadine 60 mg in the morning</article-title><source>Hum Psychopharmacol Clin Exp</source><volume>13</volume><year>1998</year><fpage>S79</fpage><lpage>S86</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1099-1077(1998110)13:2+3.0.CO;2-C</pub-id></element-citation></ref><ref id="bb0700"><label>140</label><element-citation publication-type="journal" id="rf0700"><person-group person-group-type="author"><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name><name name-style="western"><surname>Riedel</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>van Boxtel</surname><given-names>M.P.J.</given-names></name><name name-style="western"><surname>Darwish</surname><given-names>M.</given-names></name><name name-style="western"><surname>Paty</surname><given-names>I.</given-names></name><name name-style="western"><surname>Patat</surname><given-names>A.</given-names></name></person-group><article-title>Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol</article-title><source>Sleep</source><volume>25</volume><year>2002</year><fpage>224</fpage><lpage>231</lpage><pub-id pub-id-type="pmid">11905433</pub-id></element-citation></ref><ref id="bb0705"><label>141</label><element-citation publication-type="journal" id="rf0705"><person-group person-group-type="author"><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name><name name-style="western"><surname>Leufkens</surname><given-names>T.R.M.</given-names></name><name name-style="western"><surname>Van Leeuwen</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Effect of middle-of-the-night doses of zolpidemsublingual tablet 3.5 mg on next-morning driving performance</article-title><source>Sleep Med</source><volume>12</volume><year>2011</year><fpage>S7</fpage></element-citation></ref><ref id="bb0710"><label>142</label><element-citation publication-type="journal" id="rf0710"><person-group person-group-type="author"><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>H.</given-names></name><name name-style="western"><surname>Vuurman</surname><given-names>E.F.P.M.</given-names></name><etal/></person-group><article-title>On-the-road driving performance the morning after bedtime use of suvorexant 20 and 40 mg: A study in non-elderly healthy volunteers</article-title><source>Sleep</source><volume>38</volume><year>2015</year><fpage>1803</fpage><lpage>1813</lpage><pub-id pub-id-type="doi">10.5665/sleep.5168</pub-id><pub-id pub-id-type="pmid">26039969</pub-id><pub-id pub-id-type="pmcid">PMC4813357</pub-id></element-citation></ref><ref id="bb0715"><label>143</label><element-citation publication-type="journal" id="rf0715"><person-group person-group-type="author"><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vets</surname><given-names>E.</given-names></name><name name-style="western"><surname>Vuurman</surname><given-names>E.F.P.M.</given-names></name><etal/></person-group><article-title>On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly</article-title><source>Psychopharmacology</source><volume>233</volume><year>2016</year><fpage>3341</fpage><lpage>3351</lpage><pub-id pub-id-type="doi">10.1007/s00213-016-4375-x</pub-id><pub-id pub-id-type="pmid">27424295</pub-id><pub-id pub-id-type="pmcid">PMC4989000</pub-id></element-citation></ref><ref id="bb0720"><label>144.</label><element-citation publication-type="journal" id="rf0720"><person-group person-group-type="author"><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name><name name-style="western"><surname>Jongen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>P.</given-names></name><etal/></person-group><article-title>On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers</article-title><source>Sleep</source><volume>42</volume><year>2019</year><pub-id pub-id-type="doi">10.1093/sleep/zsy260</pub-id><pub-id pub-id-type="pmcid">PMC6448281</pub-id><pub-id pub-id-type="pmid">30597112</pub-id></element-citation></ref><ref id="bb0725"><label>145</label><element-citation publication-type="journal" id="rf0725"><person-group person-group-type="author"><name name-style="western"><surname>Verster</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Volkerts</surname><given-names>E.R.</given-names></name><name name-style="western"><surname>Schreuder</surname><given-names>A.H.C.M.L.</given-names></name><etal/></person-group><article-title>Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance</article-title><source>J Clin Psychopharmacol</source><volume>22</volume><year>2002</year><fpage>576</fpage><lpage>583</lpage><pub-id pub-id-type="pmid">12454557</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00004714-200212000-00007</pub-id></element-citation></ref><ref id="bb0730"><label>146</label><element-citation publication-type="journal" id="rf0730"><person-group person-group-type="author"><name name-style="western"><surname>Verster</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Volkerts</surname><given-names>E.R.</given-names></name><name name-style="western"><surname>Verbaten</surname><given-names>M.N.</given-names></name></person-group><article-title>Effects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled study</article-title><source>Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol</source><volume>27</volume><year>2002</year><fpage>260</fpage><lpage>269</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0893-133X(02)00310-X</pub-id><pub-id pub-id-type="pmid">12093599</pub-id></element-citation></ref><ref id="bb0735"><label>147</label><element-citation publication-type="journal" id="rf0735"><person-group person-group-type="author"><name name-style="western"><surname>Verster</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Bervoets</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>de Klerk</surname><given-names>S.</given-names></name><name name-style="western"><surname>Roth</surname><given-names>T.</given-names></name></person-group><article-title>Lapses of attention as outcome measure of the on-the-road driving test</article-title><source>Psychopharmacology</source><volume>231</volume><year>2014</year><fpage>283</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1007/s00213-013-3236-0</pub-id><pub-id pub-id-type="pmid">23975036</pub-id></element-citation></ref><ref id="bb0740"><label>148</label><element-citation publication-type="journal" id="rf0740"><person-group person-group-type="author"><name name-style="western"><surname>Verster</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Mooren</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bervoets</surname><given-names>A.C.</given-names></name><name name-style="western"><surname>Roth</surname><given-names>T.</given-names></name></person-group><article-title>Highway driving safety the day after using sleep medication: the direction of lapses and excursions out-of-lane in drowsy drivers</article-title><source>J Sleep Res</source><volume>27</volume><year>2018</year><object-id pub-id-type="publisher-id">e12622</object-id><pub-id pub-id-type="doi">10.1111/jsr.12622</pub-id><pub-id pub-id-type="pmid">29063632</pub-id></element-citation></ref><ref id="bb0745"><label>149.</label><element-citation publication-type="journal" id="rf0745"><person-group person-group-type="author"><name name-style="western"><surname>Vinckenbosch</surname><given-names>F.R.J.</given-names></name><name name-style="western"><surname>Vermeeren</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vuurman</surname><given-names>E.F.P.M.</given-names></name><etal/></person-group><article-title>An explorative approach to understanding individual differences in driving performance and neurocognition in long-term benzodiazepine users</article-title><source>Hum Psychopharmacol</source><volume>36</volume><year>2021</year><object-id pub-id-type="publisher-id">e2778</object-id><pub-id pub-id-type="doi">10.1002/hup.2778</pub-id><pub-id pub-id-type="pmcid">PMC8365705</pub-id><pub-id pub-id-type="pmid">33547849</pub-id></element-citation></ref><ref id="bb0750"><label>150.</label><element-citation publication-type="journal" id="rf0750"><person-group person-group-type="author"><name name-style="western"><surname>Volkerts</surname><given-names>E.R.</given-names></name><name name-style="western"><surname>Van Laar</surname><given-names>M.W.</given-names></name><name name-style="western"><surname>Van Willigenburg</surname><given-names>A.P.P.</given-names></name><name name-style="western"><surname>Plomp</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Maes</surname><given-names>R.A.A.</given-names></name></person-group><article-title>A comparative study of on-the-road and simulated driving performance after nocturnal treatment with lormetazepam 1 mg and oxazepam 50 mg</article-title><source>Hum Psychopharmacol</source><volume>7</volume><year>1992</year><fpage>297</fpage><lpage>309</lpage></element-citation></ref><ref id="bb0755"><label>151</label><element-citation publication-type="journal" id="rf0755"><person-group person-group-type="author"><name name-style="western"><surname>Wetherell</surname><given-names>A.</given-names></name></person-group><article-title>Individual and group effect of 10 mg diazepam on drivers&#8217; ability, confidence and willingness to act in a gap-judging task</article-title><source>Psychopharmacology</source><volume>63</volume><year>1979</year><fpage>259</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1007/BF00433559</pub-id><pub-id pub-id-type="pmid">113812</pub-id></element-citation></ref><ref id="bb0760"><label>152</label><element-citation publication-type="journal" id="rf0760"><person-group person-group-type="author"><name name-style="western"><surname>Willumeit</surname><given-names>H.P.</given-names></name><name name-style="western"><surname>Neubert</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ott</surname><given-names>H.</given-names></name><name name-style="western"><surname>Hemmerling</surname><given-names>K.G.</given-names></name></person-group><article-title>Driving ability following the subchronic application of lormetazepam, flurazepam and placebo</article-title><source>Ergonomics</source><volume>26</volume><year>1983</year><fpage>1055</fpage><lpage>1061</lpage><pub-id pub-id-type="pmid">6662099</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/00140138308963438</pub-id></element-citation></ref><ref id="bb0765"><label>153.</label><element-citation publication-type="journal" id="rf0765"><person-group person-group-type="author"><name name-style="western"><surname>Willumeit</surname><given-names>H.P.</given-names></name><name name-style="western"><surname>Ott</surname><given-names>H.</given-names></name><name name-style="western"><surname>Neubert</surname><given-names>W.</given-names></name><name name-style="western"><surname>Hemmerling</surname><given-names>K.G.</given-names></name><name name-style="western"><surname>Schratzer</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fichte</surname><given-names>K.</given-names></name></person-group><article-title>Alcohol interaction of lormetazepam, mepindolol sulphate and diazepam measured by performance on the driving simulator</article-title><source>Pharmacopsychiatry</source><volume>17</volume><year>1984</year><fpage>36</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">6145169</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-2007-1017405</pub-id></element-citation></ref><ref id="bb0770"><label>154</label><element-citation publication-type="journal" id="rf0770"><person-group person-group-type="author"><name name-style="western"><surname>Willumeit</surname><given-names>H.P.</given-names></name><name name-style="western"><surname>Ott</surname><given-names>H.</given-names></name><name name-style="western"><surname>Neubert</surname><given-names>W.</given-names></name></person-group><article-title>Simulated car driving as a useful technique for the determination of residual effects and alcohol interaction after short- and long-acting benzodiazepines</article-title><source>Psychopharmacol Suppl</source><volume>1</volume><year>1984</year><fpage>182</fpage><lpage>192</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/978-3-642-69659-6_16</pub-id><pub-id pub-id-type="pmid">6147840</pub-id></element-citation></ref><ref id="bb0775"><label>155</label><element-citation publication-type="journal" id="rf0775"><person-group person-group-type="author"><name name-style="western"><surname>Al-Abdallat</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>Al Ali</surname><given-names>R.</given-names></name><name name-style="western"><surname>Hudaib</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Salameh</surname><given-names>G.A.M.</given-names></name><name name-style="western"><surname>Salameh</surname><given-names>R.J.M.</given-names></name><name name-style="western"><surname>Idhair</surname><given-names>A.K.F.</given-names></name></person-group><article-title>The prevalence of alcohol and psychotropic drugs in fatalities of road-traffic accidents in Jordan during 2008-2014</article-title><source>J Forensic Leg Med</source><volume>39</volume><year>2016</year><fpage>130</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/j.jflm.2016.01.018</pub-id><pub-id pub-id-type="pmid">26878606</pub-id></element-citation></ref><ref id="bb0780"><label>156</label><element-citation publication-type="journal" id="rf0780"><person-group person-group-type="author"><name name-style="western"><surname>Ahlm</surname><given-names>K.</given-names></name><name name-style="western"><surname>Bjornstig</surname><given-names>U.</given-names></name><name name-style="western"><surname>Ostrom</surname><given-names>M.</given-names></name></person-group><article-title>Alcohol and drugs in fatally and non-fatally injured motor vehicle drivers in northern Sweden</article-title><source>Accid Anal Prev</source><volume>41</volume><year>2009</year><fpage>129</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.aap.2008.10.002</pub-id><pub-id pub-id-type="pmid">19114147</pub-id></element-citation></ref><ref id="bb0785"><label>157.</label><element-citation publication-type="journal" id="rf0785"><person-group person-group-type="author"><name name-style="western"><surname>Andreuccetti</surname><given-names>G.</given-names></name><name name-style="western"><surname>Cherpitel</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>H.B.</given-names></name><etal/></person-group><article-title>Alcohol in combination with illicit drugs among fatal injuries in Sao Paulo, Brazil: An epidemiological study on the association between acute substance use and injury</article-title><source>Injury</source><volume>49</volume><year>2018</year><fpage>2186</fpage><lpage>2192</lpage><pub-id pub-id-type="doi">10.1016/j.injury.2018.09.035</pub-id><pub-id pub-id-type="pmid">30270012</pub-id><pub-id pub-id-type="pmcid">PMC6289625</pub-id></element-citation></ref><ref id="bb0790"><label>158</label><element-citation publication-type="journal" id="rf0790"><person-group person-group-type="author"><name name-style="western"><surname>Anzillotti</surname><given-names>L.</given-names></name><name name-style="western"><surname>Dagoli</surname><given-names>S.</given-names></name><name name-style="western"><surname>Calo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Maglietta</surname><given-names>G.</given-names></name><name name-style="western"><surname>Cecchi</surname><given-names>R.</given-names></name></person-group><article-title>Road traffic deaths: A retrospective analysis (2009-2019) in the north of the Italian region Emilia Romagna</article-title><source>Traffic Inj Prev</source><volume>23</volume><year>2022</year><fpage>29</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1080/15389588.2021.2002853</pub-id><pub-id pub-id-type="pmid">34882488</pub-id></element-citation></ref><ref id="bb0795"><label>159</label><element-citation publication-type="journal" id="rf0795"><person-group person-group-type="author"><name name-style="western"><surname>Asbridge</surname><given-names>M.</given-names></name><name name-style="western"><surname>Macnabb</surname><given-names>K.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Erdelyi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Brubacher</surname><given-names>J.R.</given-names></name></person-group><article-title>Prescription medication use as a risk factor for motor vehicle collisions: a responsibility study</article-title><source>Inj Prev J Int Soc Child Adolesc Inj Prev</source><volume>27</volume><year>2021</year><fpage>324</fpage><lpage>330</lpage><pub-id pub-id-type="doi">10.1136/injuryprev-2020-043840</pub-id><pub-id pub-id-type="pmid">32732340</pub-id></element-citation></ref><ref id="bb0800"><label>160.</label><element-citation publication-type="journal" id="rf0800"><person-group person-group-type="author"><name name-style="western"><surname>Barbone</surname><given-names>F.</given-names></name><name name-style="western"><surname>McMahon</surname><given-names>A.D.</given-names></name><name name-style="western"><surname>Davey</surname><given-names>P.G.</given-names></name><etal/></person-group><article-title>Association of road-traffic accidents with benzodiazepine use</article-title><source>Lancet</source><volume>352</volume><year>1998</year><fpage>1331</fpage><lpage>1336</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(98)04087-2</pub-id><pub-id pub-id-type="pmid">9802269</pub-id></element-citation></ref><ref id="bb0805"><label>161</label><element-citation publication-type="journal" id="rf0805"><person-group person-group-type="author"><name name-style="western"><surname>Bernhoft</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>Steentoft</surname><given-names>A.</given-names></name><name name-style="western"><surname>Johansen</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Klitgaard</surname><given-names>N.A.</given-names></name><name name-style="western"><surname>Larsen</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>L.B.</given-names></name></person-group><article-title>Drugs in injured drivers in Denmark</article-title><source>Forensic Sci Int</source><volume>150</volume><year>2005</year><fpage>181</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">15944058</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.forsciint.2004.12.039</pub-id></element-citation></ref><ref id="bb0810"><label>162</label><element-citation publication-type="journal" id="rf0810"><person-group person-group-type="author"><name name-style="western"><surname>Bjorneboe</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bjorneboe</surname><given-names>G.E.</given-names></name><name name-style="western"><surname>Gjerde</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bugge</surname><given-names>A.</given-names></name><name name-style="western"><surname>Drevon</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Morland</surname><given-names>J.</given-names></name></person-group><article-title>A retrospective study of drugged driving in Norway</article-title><source>Forensic Sci Int</source><volume>33</volume><year>1987</year><fpage>243</fpage><lpage>251</lpage><pub-id pub-id-type="pmid">3034750</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0379-0738(87)90105-8</pub-id></element-citation></ref><ref id="bb0815"><label>163</label><element-citation publication-type="journal" id="rf0815"><person-group person-group-type="author"><name name-style="western"><surname>Blencowe</surname><given-names>T.</given-names></name><name name-style="western"><surname>Vimpari</surname><given-names>K.</given-names></name><name name-style="western"><surname>Lillsunde</surname><given-names>P.</given-names></name></person-group><article-title>Benzodiazepine whole blood concentrations in cases with positive oral fluid on-site screening test results using the DrugWipe(R) single for benzodiazepines</article-title><source>J Anal Toxicol</source><volume>35</volume><year>2011</year><fpage>349</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">21740691</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/anatox/35.6.349</pub-id></element-citation></ref><ref id="bb0820"><label>164</label><element-citation publication-type="journal" id="rf0820"><person-group person-group-type="author"><name name-style="western"><surname>Bogstrand</surname><given-names>S.T.</given-names></name><name name-style="western"><surname>Gjerde</surname><given-names>H.</given-names></name></person-group><article-title>Which drugs are associated with highest risk for being arrested for driving under the influence? A case-control study</article-title><source>Forensic Sci Int</source><volume>240</volume><year>2014</year><fpage>21</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.forsciint.2014.03.027</pub-id><pub-id pub-id-type="pmid">24814328</pub-id></element-citation></ref><ref id="bb0825"><label>165</label><element-citation publication-type="journal" id="rf0825"><person-group person-group-type="author"><name name-style="western"><surname>3rd Booth</surname><given-names>J.N.</given-names></name><name name-style="western"><surname>Behring</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cantor</surname><given-names>R.S.</given-names></name><etal/></person-group><article-title>Zolpidem use and motor vehicle collisions in older drivers</article-title><source>Sleep Med</source><volume>20</volume><year>2016</year><fpage>98</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.sleep.2015.12.004</pub-id><pub-id pub-id-type="pmid">27318232</pub-id><pub-id pub-id-type="pmcid">PMC4913027</pub-id></element-citation></ref><ref id="bb0830"><label>166</label><element-citation publication-type="journal" id="rf0830"><person-group person-group-type="author"><name name-style="western"><surname>Bramness</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Skurtveit</surname><given-names>S.</given-names></name><name name-style="western"><surname>Morland</surname><given-names>J.</given-names></name></person-group><article-title>Clinical impairment of benzodiazepines--relation between benzodiazepine concentrations and impairment in apprehended drivers</article-title><source>Drug Alcohol Depend</source><volume>68</volume><year>2002</year><fpage>131</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">12234642</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0376-8716(02)00188-6</pub-id></element-citation></ref><ref id="bb0835"><label>167</label><element-citation publication-type="journal" id="rf0835"><person-group person-group-type="author"><name name-style="western"><surname>Bramness</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Skurtveit</surname><given-names>S.</given-names></name><name name-style="western"><surname>Morland</surname><given-names>J.</given-names></name></person-group><article-title>Testing for benzodiazepine inebriation--relationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers</article-title><source>Eur J Clin Pharmacol</source><volume>59</volume><year>2003</year><fpage>593</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">14504853</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00228-003-0677-0</pub-id></element-citation></ref><ref id="bb0840"><label>168</label><element-citation publication-type="journal" id="rf0840"><person-group person-group-type="author"><name name-style="western"><surname>Bramness</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Skurtveit</surname><given-names>S.</given-names></name><name name-style="western"><surname>Morland</surname><given-names>J.</given-names></name></person-group><article-title>Flunitrazepam: psychomotor impairment, agitation and paradoxical reactions</article-title><source>Forensic Sci Int</source><volume>159</volume><year>2006</year><fpage>83</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">16087304</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.forsciint.2005.06.009</pub-id></element-citation></ref><ref id="bb0845"><label>169.</label><element-citation publication-type="journal" id="rf0845"><person-group person-group-type="author"><name name-style="western"><surname>Brubacher</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Erdelyi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zed</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Staples</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Etminan</surname><given-names>M.</given-names></name></person-group><article-title>Medications and risk of motor vehicle collision responsibility in British Columbia, Canada: a population-based case-control study., Lancet</article-title><source>Public Health</source><volume>6</volume><year>2021</year><fpage>e374</fpage><lpage>e385</lpage><pub-id pub-id-type="doi">10.1016/S2468-2667(21)00027-X</pub-id><pub-id pub-id-type="pmid">33887232</pub-id></element-citation></ref><ref id="bb0850"><label>170</label><element-citation publication-type="journal" id="rf0850"><person-group person-group-type="author"><name name-style="western"><surname>Bunn</surname><given-names>T.</given-names></name><name name-style="western"><surname>Singleton</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>I.-C.</given-names></name></person-group><article-title>Use of multiple data sources to identify specific drugs and other factors associated with drug and alcohol screening of fatally injured motor vehicle drivers</article-title><source>Accid Anal Prev</source><volume>122</volume><year>2019</year><fpage>287</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1016/j.aap.2018.10.012</pub-id><pub-id pub-id-type="pmid">30396030</pub-id></element-citation></ref><ref id="bb0855"><label>171</label><element-citation publication-type="journal" id="rf0855"><person-group person-group-type="author"><name name-style="western"><surname>Burch</surname><given-names>H.J.</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>E.J.</given-names></name><name name-style="western"><surname>Hubbard</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Scott-Ham</surname><given-names>M.</given-names></name></person-group><article-title>Concentrations of drugs determined in blood samples collected from suspected drugged drivers in England and Wales</article-title><source>J Forensic Leg Med</source><volume>20</volume><year>2013</year><fpage>278</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1016/j.jflm.2012.10.005</pub-id><pub-id pub-id-type="pmid">23622475</pub-id></element-citation></ref><ref id="bb0860"><label>172</label><element-citation publication-type="journal" id="rf0860"><person-group person-group-type="author"><name name-style="western"><surname>Carfora</surname><given-names>A.</given-names></name><name name-style="western"><surname>Campobasso</surname><given-names>C.P.</given-names></name><name name-style="western"><surname>Cassandro</surname><given-names>P.</given-names></name><name name-style="western"><surname>Petrella</surname><given-names>R.</given-names></name><name name-style="western"><surname>Borriello</surname><given-names>R.</given-names></name></person-group><article-title>Alcohol and drugs use among drivers injured in road accidents in Campania (Italy): A 8-years retrospective analysis</article-title><source>Forensic Sci Int</source><volume>288</volume><year>2018</year><fpage>291</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1016/j.forsciint.2018.05.003</pub-id><pub-id pub-id-type="pmid">29793195</pub-id></element-citation></ref><ref id="bb0865"><label>173</label><element-citation publication-type="journal" id="rf0865"><person-group person-group-type="author"><name name-style="western"><surname>Carmen del Rio</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gomez</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sancho</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alvarez</surname><given-names>F.J.</given-names></name></person-group><article-title>Alcohol, illicit drugs and medicinal drugs in fatally injured drivers in Spain between 1991 and 2000</article-title><source>Forensic Sci Int</source><volume>127</volume><year>2002</year><fpage>63</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">12098527</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0379-0738(02)00116-0</pub-id></element-citation></ref><ref id="bb0870"><label>174</label><element-citation publication-type="journal" id="rf0870"><person-group person-group-type="author"><name name-style="western"><surname>Ch&#8217;ng</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Fitzgerald</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gerostamoulos</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Drug use in motor vehicle drivers presenting to an Australian, adult major trauma centre</article-title><source>Emerg Med Australas EMA</source><volume>19</volume><year>2007</year><fpage>359</fpage><lpage>365</lpage><pub-id pub-id-type="pmid">17655640</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1742-6723.2007.00958.x</pub-id></element-citation></ref><ref id="bb0875"><label>175</label><element-citation publication-type="journal" id="rf0875"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>C.-M.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>E.C.-H.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C.-Y.</given-names></name><etal/></person-group><article-title>Psychotropic drugs and risk of motor vehicle accidents: a population-based case-control study</article-title><source>Br J Clin Pharmacol</source><volume>75</volume><year>2013</year><fpage>1125</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2125.2012.04410.x</pub-id><pub-id pub-id-type="pmid">22971090</pub-id><pub-id pub-id-type="pmcid">PMC3612731</pub-id></element-citation></ref><ref id="bb0880"><label>176</label><element-citation publication-type="journal" id="rf0880"><person-group person-group-type="author"><name name-style="western"><surname>Christophersen</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Ceder</surname><given-names>G.</given-names></name><name name-style="western"><surname>Kristinsson</surname><given-names>J.</given-names></name><name name-style="western"><surname>Lillsunde</surname><given-names>P.</given-names></name><name name-style="western"><surname>Steentoft</surname><given-names>A.</given-names></name></person-group><article-title>Drugged driving in the Nordic countries--a comparative study between five countries</article-title><source>Forensic Sci Int</source><volume>106</volume><year>1999</year><fpage>173</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">10680066</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0379-0738(99)00194-2</pub-id></element-citation></ref><ref id="bb0885"><label>177.</label><element-citation publication-type="journal" id="rf0885"><person-group person-group-type="author"><name name-style="western"><surname>Christophersen</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Morland</surname><given-names>J.</given-names></name></person-group><article-title>Frequent detection of benzodiazepines in drugged drivers in Norway</article-title><source>Traffic Inj Prev</source><volume>9</volume><year>2008</year><fpage>98</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1080/15389580701869190</pub-id><pub-id pub-id-type="pmid">18398771</pub-id></element-citation></ref><ref id="bb0890"><label>178.</label><element-citation publication-type="journal" id="rf0890"><person-group person-group-type="author"><name name-style="western"><surname>Christophersen</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Karinen</surname><given-names>R.</given-names></name><name name-style="western"><surname>Morland</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gjerde</surname><given-names>H.</given-names></name></person-group><article-title>The implementation of per-se limits for driving under the influence of benzodiazepines and related drugs: No increased risk for arrest during therapeutic use in Norway</article-title><source>Traffic Inj Prev</source><volume>21</volume><year>2020</year><fpage>122</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1080/15389588.2020.1724977</pub-id><pub-id pub-id-type="pmid">32119573</pub-id></element-citation></ref><ref id="bb0895"><label>179</label><element-citation publication-type="journal" id="rf0895"><person-group person-group-type="author"><name name-style="western"><surname>Cimbura</surname><given-names>G.</given-names></name><name name-style="western"><surname>Lucas</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Warren</surname><given-names>R.A.</given-names></name><name name-style="western"><surname>Simpson</surname><given-names>H.M.</given-names></name></person-group><article-title>Incidence and toxicological aspects of drugs detected in 484 fatally injured drivers and pedestrians in Ontario</article-title><source>J Forensic Sci</source><volume>27</volume><year>1982</year><fpage>855</fpage><lpage>867</lpage><pub-id pub-id-type="pmid">6294215</pub-id></element-citation></ref><ref id="bb0900"><label>180</label><element-citation publication-type="journal" id="rf0900"><person-group person-group-type="author"><name name-style="western"><surname>Drummer</surname><given-names>O.H.</given-names></name><name name-style="western"><surname>Gerostamoulos</surname><given-names>J.</given-names></name><name name-style="western"><surname>Batziris</surname><given-names>H.</given-names></name><etal/></person-group><article-title>The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes</article-title><source>Accid Anal Prev</source><volume>36</volume><year>2004</year><fpage>239</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">14642878</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0001-4575(02)00153-7</pub-id></element-citation></ref><ref id="bb0905"><label>181</label><element-citation publication-type="journal" id="rf0905"><person-group person-group-type="author"><name name-style="western"><surname>Drummer</surname><given-names>O.H.</given-names></name><name name-style="western"><surname>Yap</surname><given-names>S.</given-names></name></person-group><article-title>The involvement of prescribed drugs in road trauma</article-title><source>Forensic Sci Int</source><volume>265</volume><year>2016</year><fpage>17</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.forsciint.2015.12.050</pub-id><pub-id pub-id-type="pmid">26826848</pub-id></element-citation></ref><ref id="bb0910"><label>182.</label><element-citation publication-type="journal" id="rf0910"><person-group person-group-type="author"><name name-style="western"><surname>Drummer</surname><given-names>O.H.</given-names></name><name name-style="western"><surname>Gerostamoulos</surname><given-names>D.</given-names></name><name name-style="western"><surname>Di Rago</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Odds of culpability associated with use of impairing drugs in injured drivers in Victoria, Australia</article-title><source>Accid Anal Prev</source><volume>135</volume><year>2020</year><object-id pub-id-type="publisher-id">105389</object-id><pub-id pub-id-type="doi">10.1016/j.aap.2019.105389</pub-id><pub-id pub-id-type="pmid">31812899</pub-id></element-citation></ref><ref id="bb0915"><label>183</label><element-citation publication-type="journal" id="rf0915"><person-group person-group-type="author"><name name-style="western"><surname>Dubois</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bedard</surname><given-names>M.</given-names></name><name name-style="western"><surname>Weaver</surname><given-names>B.</given-names></name></person-group><article-title>The impact of benzodiazepines on safe driving</article-title><source>Traffic Inj Prev</source><volume>9</volume><year>2008</year><fpage>404</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1080/15389580802161943</pub-id><pub-id pub-id-type="pmid">18836950</pub-id></element-citation></ref><ref id="bb0920"><label>184</label><element-citation publication-type="journal" id="rf0920"><person-group person-group-type="author"><name name-style="western"><surname>Favretto</surname><given-names>D.</given-names></name><name name-style="western"><surname>Visentin</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>A.W.</given-names></name></person-group><article-title>Prevalence and concentrations of sedative-hypnotic drugs in blood of drivers involved in road traffic crashes in the Padova region of Italy - not so easy to interpret</article-title><source>Forensic Sci Int</source><volume>330</volume><year>2022</year><object-id pub-id-type="publisher-id">111097</object-id><pub-id pub-id-type="doi">10.1016/j.forsciint.2021.111097</pub-id><pub-id pub-id-type="pmid">34814082</pub-id></element-citation></ref><ref id="bb0925"><label>185</label><element-citation publication-type="journal" id="rf0925"><person-group person-group-type="author"><name name-style="western"><surname>Fournier</surname><given-names>J.-P.</given-names></name><name name-style="western"><surname>Wilchesky</surname><given-names>M.</given-names></name><name name-style="western"><surname>Patenaude</surname><given-names>V.</given-names></name><name name-style="western"><surname>Suissa</surname><given-names>S.</given-names></name></person-group><article-title>Concurrent use of benzodiazepines and antidepressants and the risk of motor vehicle accident in older drivers: a nested case-control Study</article-title><source>Neurol Ther</source><volume>4</volume><year>2015</year><fpage>39</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1007/s40120-015-0026-0</pub-id><pub-id pub-id-type="pmid">26847674</pub-id><pub-id pub-id-type="pmcid">PMC4470976</pub-id></element-citation></ref><ref id="bb0930"><label>186</label><element-citation publication-type="journal" id="rf0930"><person-group person-group-type="author"><name name-style="western"><surname>Garriott</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Latman</surname><given-names>N.</given-names></name></person-group><article-title>Drug detection in cases of &#8220;driving under the influence,&#8221;</article-title><source>J Forensic Sci</source><volume>21</volume><year>1976</year><fpage>398</fpage><lpage>415</lpage><pub-id pub-id-type="pmid">1262839</pub-id></element-citation></ref><ref id="bb0935"><label>187</label><element-citation publication-type="journal" id="rf0935"><person-group person-group-type="author"><name name-style="western"><surname>Garriott</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>DiMaio</surname><given-names>V.J.</given-names></name><name name-style="western"><surname>Zumwalt</surname><given-names>R.E.</given-names></name><name name-style="western"><surname>Petty</surname><given-names>C.S.</given-names></name></person-group><article-title>Incidence of drugs and alcohol in fatally injured motor vehicle drivers</article-title><source>J Forensic Sci</source><volume>22</volume><year>1977</year><fpage>383</fpage><lpage>389</lpage><pub-id pub-id-type="pmid">618155</pub-id></element-citation></ref><ref id="bb0940"><label>188.</label><element-citation publication-type="journal" id="rf0940"><person-group person-group-type="author"><name name-style="western"><surname>Gerostamoulos</surname><given-names>J.</given-names></name><name name-style="western"><surname>Batziris</surname><given-names>H.</given-names></name><name name-style="western"><surname>Drummer</surname><given-names>O.H.</given-names></name></person-group><article-title>Involvement of drugs in accident causation</article-title><source>Z Zagadnien Nauk Sadowych</source><volume>43</volume><year>2000</year><fpage>79</fpage><lpage>85</lpage></element-citation></ref><ref id="bb0945"><label>189</label><element-citation publication-type="journal" id="rf0945"><person-group person-group-type="author"><name name-style="western"><surname>Gjerde</surname><given-names>H.</given-names></name><name name-style="western"><surname>Beylich</surname><given-names>K.M.</given-names></name><name name-style="western"><surname>Morland</surname><given-names>J.</given-names></name></person-group><article-title>Incidence of alcohol and drugs in fatally injured car drivers in Norway</article-title><source>Accid Anal Prev</source><volume>25</volume><year>1993</year><fpage>479</fpage><lpage>483</lpage><pub-id pub-id-type="pmid">8357462</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0001-4575(93)90078-b</pub-id></element-citation></ref><ref id="bb0950"><label>190</label><element-citation publication-type="journal" id="rf0950"><person-group person-group-type="author"><name name-style="western"><surname>Gjerde</surname><given-names>H.</given-names></name><name name-style="western"><surname>Christophersen</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Normann</surname><given-names>P.T.</given-names></name><name name-style="western"><surname>M&#248;rland</surname><given-names>J.</given-names></name></person-group><article-title>Associations between substance use among car and van drivers in Norway and fatal injury in road traffic accidents: A case-control study</article-title><source>Transp Res Part F Traffic Psychol Behav</source><volume>17</volume><year>2013</year><fpage>134</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.trf.2012.11.004</pub-id></element-citation></ref><ref id="bb0955"><label>191</label><element-citation publication-type="journal" id="rf0955"><person-group person-group-type="author"><name name-style="western"><surname>Gustavsen</surname><given-names>I.</given-names></name><name name-style="western"><surname>Al-Sammurraie</surname><given-names>M.</given-names></name><name name-style="western"><surname>Morland</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bramness</surname><given-names>J.G.</given-names></name></person-group><article-title>Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers</article-title><source>Accid Anal Prev</source><volume>41</volume><year>2009</year><fpage>462</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1016/j.aap.2009.01.011</pub-id><pub-id pub-id-type="pmid">19393793</pub-id></element-citation></ref><ref id="bb0960"><label>192.</label><element-citation publication-type="journal" id="rf0960"><person-group person-group-type="author"><name name-style="western"><surname>Haffner</surname><given-names>J.F.W.</given-names></name><name name-style="western"><surname>Bo</surname><given-names>O.</given-names></name><name name-style="western"><surname>Lunde</surname><given-names>P.K.M.</given-names></name></person-group><article-title>Alcohol and drug consumption as casual factors in road traffic accidents in Norway</article-title><source>Jtraffic Med</source><volume>2</volume><year>1974</year><fpage>52</fpage><lpage>56</lpage></element-citation></ref><ref id="bb0965"><label>193.</label><element-citation publication-type="journal" id="rf0965"><person-group person-group-type="author"><name name-style="western"><surname>Hemmelgarn</surname><given-names>B.</given-names></name><name name-style="western"><surname>Suissa</surname><given-names>S.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>A.</given-names></name><name name-style="western"><surname>Boivin</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Pinard</surname><given-names>G.</given-names></name></person-group><article-title>Benzodiazepine use and the risk of motor vehicle crash in the elderly</article-title><source>JAMA</source><volume>278</volume><year>1997</year><fpage>27</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">9207334</pub-id></element-citation></ref><ref id="bb0970"><label>194</label><element-citation publication-type="journal" id="rf0970"><person-group person-group-type="author"><name name-style="western"><surname>Herrera-G&#243;mez</surname><given-names>F.</given-names></name><name name-style="western"><surname>Garc&#237;a-Mingo</surname><given-names>M.</given-names></name><name name-style="western"><surname>&#193;lvarez</surname><given-names>F.J.</given-names></name></person-group><article-title>Prevalence of alcohol and other psychoactive substances in motor vehicle drivers in Spain, 2018: Cross-sectional dataset analysis with studies from 2008 and 2013</article-title><source>Forensic Sci Int</source><volume>313</volume><year>2020</year><pub-id pub-id-type="doi">10.1016/j.forsciint.2020.110266</pub-id><pub-id pub-id-type="pmid">32480287</pub-id></element-citation></ref><ref id="bb0975"><label>195</label><element-citation publication-type="journal" id="rf0975"><person-group person-group-type="author"><name name-style="western"><surname>Hoiseth</surname><given-names>G.</given-names></name><name name-style="western"><surname>Andas</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bachs</surname><given-names>L.</given-names></name><name name-style="western"><surname>Morland</surname><given-names>J.</given-names></name></person-group><article-title>Impairment due to amphetamines and benzodiazepines, alone and in combination</article-title><source>Drug Alcohol Depend</source><volume>145</volume><year>2014</year><fpage>174</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2014.10.013</pub-id><pub-id pub-id-type="pmid">25456327</pub-id></element-citation></ref><ref id="bb0980"><label>196.</label><element-citation publication-type="journal" id="rf0980"><person-group person-group-type="author"><name name-style="western"><surname>Hoiseth</surname><given-names>G.</given-names></name><name name-style="western"><surname>Austdal</surname><given-names>L.E.</given-names></name><name name-style="western"><surname>Wiik</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bogstrand</surname><given-names>S.T.</given-names></name><name name-style="western"><surname>Morland</surname><given-names>J.</given-names></name></person-group><article-title>Prevalence and concentrations of drugs in older suspected drugged drivers</article-title><source>Traffic Inj Prev</source><volume>18</volume><year>2017</year><fpage>231</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1080/15389588.2016.1247209</pub-id><pub-id pub-id-type="pmid">27740861</pub-id></element-citation></ref><ref id="bb0985"><label>197</label><element-citation publication-type="journal" id="rf0985"><person-group person-group-type="author"><name name-style="western"><surname>Honkanen</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ertama</surname><given-names>L.</given-names></name><name name-style="western"><surname>Linnoila</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Role of drugs in traffic accidents</article-title><source>Br Med J</source><volume>281</volume><year>1980</year><fpage>1309</fpage><lpage>1312</lpage><pub-id pub-id-type="pmid">7437776</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.281.6251.1309</pub-id><pub-id pub-id-type="pmcid">PMC1714792</pub-id></element-citation></ref><ref id="bb0990"><label>198.</label><element-citation publication-type="journal" id="rf0990"><person-group person-group-type="author"><name name-style="western"><surname>Jamt</surname><given-names>R.E.G.</given-names></name><name name-style="western"><surname>Gjerde</surname><given-names>H.</given-names></name><name name-style="western"><surname>Romeo</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bogstrand</surname><given-names>S.T.</given-names></name></person-group><article-title>Association between alcohol and drug use and arrest for driving under the influence after crash involvement in a rural area of Norway: A case-control study</article-title><source>BMJ Open</source><volume>9</volume><year>2019</year><pub-id pub-id-type="doi">10.1136/bmjopen-2018-023563</pub-id><pub-id pub-id-type="pmcid">PMC6326312</pub-id><pub-id pub-id-type="pmid">30610022</pub-id></element-citation></ref><ref id="bb0995"><label>199</label><element-citation publication-type="journal" id="rf0995"><person-group person-group-type="author"><name name-style="western"><surname>Johnell</surname><given-names>K.</given-names></name><name name-style="western"><surname>Laflamme</surname><given-names>L.</given-names></name><name name-style="western"><surname>Moller</surname><given-names>J.</given-names></name><name name-style="western"><surname>Monarrez-Espino</surname><given-names>J.</given-names></name></person-group><article-title>The role of marital status in the association between benzodiazepines, psychotropics and injurious road traffic crashes: a register-based nationwide study of senior drivers in Sweden</article-title><source>PLoS One</source><volume>9</volume><year>2014</year><object-id pub-id-type="publisher-id">e86742</object-id><pub-id pub-id-type="doi">10.1371/journal.pone.0086742</pub-id><pub-id pub-id-type="pmcid">PMC3906075</pub-id><pub-id pub-id-type="pmid">24489781</pub-id></element-citation></ref><ref id="bb1000"><label>200</label><element-citation publication-type="journal" id="rf1000"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>A.W.</given-names></name><name name-style="western"><surname>Holmgren</surname><given-names>A.</given-names></name><name name-style="western"><surname>Holmgren</surname><given-names>P.</given-names></name></person-group><article-title>High concentrations of diazepam and nordiazepam in blood of impaired drivers: association with age, gender and spectrum of other drugs present</article-title><source>Forensic Sci Int</source><volume>146</volume><year>2004</year><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15485715</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.forsciint.2004.05.020</pub-id></element-citation></ref><ref id="bb1005"><label>201</label><element-citation publication-type="journal" id="rf1005"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>A.W.</given-names></name><name name-style="western"><surname>Holmgren</surname><given-names>A.</given-names></name></person-group><article-title>Concentrations of zolpidem and zopiclone in venous blood samples from impaired drivers compared with femoral blood from forensic autopsies</article-title><source>Forensic Sci Int</source><volume>222</volume><year>2012</year><fpage>118</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.forsciint.2012.05.008</pub-id><pub-id pub-id-type="pmid">22673707</pub-id></element-citation></ref><ref id="bb1010"><label>202</label><element-citation publication-type="journal" id="rf1010"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>A.W.</given-names></name><name name-style="western"><surname>Holmgren</surname><given-names>A.</given-names></name></person-group><article-title>Concentrations of alprazolam in blood from impaired drivers and forensic autopsies were not much different but showed a high prevalence of co-ingested illicit drugs</article-title><source>J Psychopharmacol Oxf Engl</source><volume>27</volume><year>2013</year><fpage>276</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1177/0269881112471155</pub-id><pub-id pub-id-type="pmid">23257168</pub-id></element-citation></ref><ref id="bb1015"><label>203</label><element-citation publication-type="journal" id="rf1015"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>A.W.</given-names></name><name name-style="western"><surname>Holmgren</surname><given-names>A.</given-names></name></person-group><article-title>Concentrations of diazepam and nordiazepam in 1,000 blood samples from apprehended drivers--therapeutic use or abuse of anxiolytics?</article-title><source>J Pharm Pract</source><volume>26</volume><year>2013</year><fpage>198</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1177/0897190012451910</pub-id><pub-id pub-id-type="pmid">22797834</pub-id></element-citation></ref><ref id="bb1020"><label>204</label><element-citation publication-type="journal" id="rf1020"><person-group person-group-type="author"><name name-style="western"><surname>Kriikku</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wilhelm</surname><given-names>L.</given-names></name><name name-style="western"><surname>Rintatalo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hurme</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kramer</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ojanpera</surname><given-names>I.</given-names></name></person-group><article-title>Phenazepam abuse in Finland: findings from apprehended drivers, post-mortem cases and police confiscations</article-title><source>Forensic Sci Int</source><volume>220</volume><year>2012</year><fpage>111</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.forsciint.2012.02.006</pub-id><pub-id pub-id-type="pmid">22391477</pub-id></element-citation></ref><ref id="bb1025"><label>205</label><element-citation publication-type="journal" id="rf1025"><person-group person-group-type="author"><name name-style="western"><surname>Kulikowska</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nowicka</surname><given-names>J.</given-names></name><name name-style="western"><surname>Chowaniec</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Psychoactive drugs in the road traffic in the legal and consultative aspects-Experience gained by the Forensic Medicine Department, Silesian University of Medicine, Katowice</article-title><source>Forensic Sci Int Suppl Ser</source><volume>1</volume><year>2009</year><fpage>80</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.fsisup.2009.07.009</pub-id></element-citation></ref><ref id="bb1030"><label>206</label><element-citation publication-type="journal" id="rf1030"><person-group person-group-type="author"><name name-style="western"><surname>Ledingham</surname><given-names>D.</given-names></name></person-group><article-title>Drugs and driving: a retrospective study of the analyses of blood and urine specimens submitted to the Lothian and Borders Police Forensic Laboratory</article-title><source>J Clin Forensic Med</source><volume>6</volume><year>1999</year><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">15335481</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1353-1131(99)90059-7</pub-id></element-citation></ref><ref id="bb1035"><label>207</label><element-citation publication-type="journal" id="rf1035"><person-group person-group-type="author"><name name-style="western"><surname>Legrand</surname><given-names>S.-A.</given-names></name><name name-style="western"><surname>Houwing</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hagenzieker</surname><given-names>M.</given-names></name><name name-style="western"><surname>Verstraete</surname><given-names>A.G.</given-names></name></person-group><article-title>Prevalence of alcohol and other psychoactive substances in injured drivers: comparison between Belgium and The Netherlands</article-title><source>Forensic Sci Int</source><volume>220</volume><year>2012</year><fpage>224</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1016/j.forsciint.2012.03.006</pub-id><pub-id pub-id-type="pmid">22483531</pub-id></element-citation></ref><ref id="bb1040"><label>208</label><element-citation publication-type="journal" id="rf1040"><person-group person-group-type="author"><name name-style="western"><surname>Legrand</surname><given-names>S.-A.</given-names></name><name name-style="western"><surname>Isalberti</surname><given-names>C.</given-names></name><name name-style="western"><surname>der Linden</surname><given-names>T.V.</given-names></name><etal/></person-group><article-title>Alcohol and drugs in seriously injured drivers in six European countries</article-title><source>Drug Test Anal</source><volume>5</volume><year>2013</year><fpage>156</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1002/dta.1393</pub-id><pub-id pub-id-type="pmid">22887894</pub-id></element-citation></ref><ref id="bb1045"><label>209</label><element-citation publication-type="journal" id="rf1045"><person-group person-group-type="author"><name name-style="western"><surname>Legrand</surname><given-names>S.-A.</given-names></name><name name-style="western"><surname>Gjerde</surname><given-names>H.</given-names></name><name name-style="western"><surname>Isalberti</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Prevalence of alcohol, illicit drugs and psychoactive medicines in killed drivers in four European countries</article-title><source>Int J Inj Control Saf Promot</source><volume>21</volume><year>2014</year><fpage>17</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1080/17457300.2012.748809</pub-id><pub-id pub-id-type="pmid">23297822</pub-id></element-citation></ref><ref id="bb1050"><label>210</label><element-citation publication-type="journal" id="rf1050"><person-group person-group-type="author"><name name-style="western"><surname>Logan</surname><given-names>B.K.</given-names></name><name name-style="western"><surname>Couper</surname><given-names>F.J.</given-names></name></person-group><article-title>Zolpidem and driving impairment</article-title><source>J Forensic Sci</source><volume>46</volume><year>2001</year><fpage>105</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">11210892</pub-id></element-citation></ref><ref id="bb1055"><label>211</label><element-citation publication-type="journal" id="rf1055"><person-group person-group-type="author"><name name-style="western"><surname>Longo</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Hunter</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Lokan</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>White</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>White</surname><given-names>M.A.</given-names></name></person-group><article-title>The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part i: the prevalence of drug use in drive the drug-positive group</article-title><source>Accid Anal Prev</source><volume>32</volume><year>2000</year><fpage>613</fpage><lpage>622</lpage><pub-id pub-id-type="pmid">10908133</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0001-4575(99)00111-6</pub-id></element-citation></ref><ref id="bb1060"><label>212</label><element-citation publication-type="journal" id="rf1060"><person-group person-group-type="author"><name name-style="western"><surname>Longo</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Hunter</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Lokan</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>White</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>White</surname><given-names>M.A.</given-names></name></person-group><article-title>The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part ii: the relationship between drug prevalence and drug concentration, and driver culpability</article-title><source>Accid Anal Prev</source><volume>32</volume><year>2000</year><fpage>623</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">10908134</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0001-4575(99)00110-4</pub-id></element-citation></ref><ref id="bb1065"><label>213</label><element-citation publication-type="journal" id="rf1065"><person-group person-group-type="author"><name name-style="western"><surname>Maxwell</surname><given-names>H.G.</given-names></name><name name-style="western"><surname>Dubois</surname><given-names>S.</given-names></name><name name-style="western"><surname>Weaver</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bedard</surname><given-names>M.</given-names></name></person-group><article-title>The additive effects of alcohol and benzodiazepines on driving</article-title><source>Can J Public Health Rev Can Sante Publique</source><volume>101</volume><year>2010</year><fpage>353</fpage><lpage>357</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF03404852</pub-id><pub-id pub-id-type="pmcid">PMC6973881</pub-id><pub-id pub-id-type="pmid">21214047</pub-id></element-citation></ref><ref id="bb1070"><label>214</label><element-citation publication-type="journal" id="rf1070"><person-group person-group-type="author"><name name-style="western"><surname>Mercer</surname><given-names>G.W.</given-names></name><name name-style="western"><surname>Jeffery</surname><given-names>W.K.</given-names></name></person-group><article-title>Alcohol, drugs, and impairment in fatal traffic accidents in British Columbia</article-title><source>Accid Anal Prev</source><volume>27</volume><year>1995</year><fpage>335</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">7639917</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0001-4575(94)00069-x</pub-id></element-citation></ref><ref id="bb1075"><label>215</label><element-citation publication-type="journal" id="rf1075"><person-group person-group-type="author"><name name-style="western"><surname>Movig</surname><given-names>K.L.L.</given-names></name><name name-style="western"><surname>Mathijssen</surname><given-names>M.P.M.</given-names></name><name name-style="western"><surname>Nagel</surname><given-names>P.H.A.</given-names></name><etal/></person-group><article-title>Psychoactive substance use and the risk of motor vehicle accidents</article-title><source>Accid Anal Prev</source><volume>36</volume><year>2004</year><fpage>631</fpage><lpage>636</lpage><pub-id pub-id-type="pmid">15094417</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0001-4575(03)00084-8</pub-id></element-citation></ref><ref id="bb1080"><label>216</label><element-citation publication-type="journal" id="rf1080"><person-group person-group-type="author"><name name-style="western"><surname>Mura</surname><given-names>P.</given-names></name><name name-style="western"><surname>Kintz</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ludes</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study</article-title><source>Forensic Sci Int</source><volume>133</volume><year>2003</year><fpage>79</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">12742692</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0379-0738(03)00052-5</pub-id></element-citation></ref><ref id="bb1085"><label>217</label><element-citation publication-type="journal" id="rf1085"><person-group person-group-type="author"><name name-style="western"><surname>Neutel</surname><given-names>C.I.</given-names></name></person-group><article-title>Risk of traffic accident injury after a prescription for a benzodiazepine</article-title><source>Ann Epidemiol</source><volume>5</volume><year>1995</year><fpage>239</fpage><lpage>244</lpage><pub-id pub-id-type="pmid">7606314</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/1047-2797(94)00112-7</pub-id></element-citation></ref><ref id="bb1090"><label>218</label><element-citation publication-type="journal" id="rf1090"><person-group person-group-type="author"><name name-style="western"><surname>Neutel</surname><given-names>C.I.</given-names></name><name name-style="western"><surname>Downey</surname><given-names>W.</given-names></name><name name-style="western"><surname>Senft</surname><given-names>D.</given-names></name></person-group><article-title>Medical events after a prescription for a benzodiazepine</article-title><source>Pharmacoepidemiol Drug Saf</source><volume>4</volume><year>1995</year><fpage>63</fpage><lpage>73</lpage></element-citation></ref><ref id="bb1095"><label>219.</label><element-citation publication-type="journal" id="rf1095"><person-group person-group-type="author"><name name-style="western"><surname>Neutel</surname><given-names>I.</given-names></name></person-group><article-title>Benzodiazepine-related traffic accidents in young and elderly drivers</article-title><source>Hum Psychopharmacol</source><volume>13</volume><year>1998</year><fpage>S115</fpage><lpage>S123</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1099-1077(1998110)13:2+3.0.CO;2-O</pub-id></element-citation></ref><ref id="bb1100"><label>220.</label><element-citation publication-type="journal" id="rf1100"><person-group person-group-type="author"><name name-style="western"><surname>Nevriana</surname><given-names>A.</given-names></name><name name-style="western"><surname>Moller</surname><given-names>J.</given-names></name><name name-style="western"><surname>Laflamme</surname><given-names>L.</given-names></name><name name-style="western"><surname>Monarrez-Espino</surname><given-names>J.</given-names></name></person-group><article-title>New, occasional, and frequent use of zolpidem or zopiclone (Alone and in Combination) and the risk of injurious road traffic crashes in older adult drivers: A population-based case-control and case-crossover study</article-title><source>CNS Drugs</source><volume>31</volume><year>2017</year><fpage>711</fpage><lpage>722</lpage><pub-id pub-id-type="doi">10.1007/s40263-017-0445-9</pub-id><pub-id pub-id-type="pmid">28669021</pub-id><pub-id pub-id-type="pmcid">PMC5533809</pub-id></element-citation></ref><ref id="bb1105"><label>221</label><element-citation publication-type="journal" id="rf1105"><person-group person-group-type="author"><name name-style="western"><surname>Olesen</surname><given-names>A.V.</given-names></name><name name-style="western"><surname>Madsen</surname><given-names>T.K.O.</given-names></name><name name-style="western"><surname>Lahrmann</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>J.</given-names></name></person-group><article-title>Use of psychotropic medication and risk of road traffic crashes: a registry-based case-control study in Denmark, 1996-2018</article-title><source>Psychopharmacology</source><year>2022</year><pub-id pub-id-type="doi">10.1007/s00213-022-06146-0</pub-id><pub-id pub-id-type="pmcid">PMC9293868</pub-id><pub-id pub-id-type="pmid">35460342</pub-id></element-citation></ref><ref id="bb1110"><label>222.</label><element-citation publication-type="book" id="rf1110"><person-group person-group-type="author"><name name-style="western"><surname>Olszowy</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Albert</surname><given-names>M.</given-names></name><name name-style="western"><surname>Celi&#324;ski</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kulikowska</surname><given-names>J.</given-names></name><name name-style="western"><surname>Nowicka</surname><given-names>J.</given-names></name></person-group><part-title>Psychoactive agents in traffic users in the practice of the Forensic Medicine Department, Medical Academy of Silesia, Katowice, Z Zagadnien Nauk Sadowych</part-title><volume>62</volume><year>2005</year><fpage>210</fpage><lpage>215</lpage></element-citation></ref><ref id="bb1115"><label>223.</label><element-citation publication-type="journal" id="rf1115"><person-group person-group-type="author"><name name-style="western"><surname>Osler</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jorgensen</surname><given-names>M.B.</given-names></name></person-group><article-title>Association of benzodiazepines, Z-drugs, pregabalin, and melatonin with traffic accidents: A nationwide cohort and case-crossover study in Danish adults</article-title><source>J Psychopharmacol Oxf Engl</source><volume>36</volume><year>2022</year><fpage>470</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1177/02698811221080465</pub-id><pub-id pub-id-type="pmid">35485852</pub-id></element-citation></ref><ref id="bb1120"><label>224</label><element-citation publication-type="journal" id="rf1120"><person-group person-group-type="author"><name name-style="western"><surname>Pelletti</surname><given-names>G.</given-names></name><name name-style="western"><surname>Verstraete</surname><given-names>A.G.</given-names></name><name name-style="western"><surname>Reyns</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Prevalence of therapeutic drugs in blood of drivers involved in traffic crashes in the area of Bologna, Italy</article-title><source>Forensic Sci Int</source><volume>302</volume><year>2019</year><object-id pub-id-type="publisher-id">109914</object-id><pub-id pub-id-type="doi">10.1016/j.forsciint.2019.109914</pub-id><pub-id pub-id-type="pmid">31419592</pub-id></element-citation></ref><ref id="bb1125"><label>225</label><element-citation publication-type="journal" id="rf1125"><person-group person-group-type="author"><name name-style="western"><surname>Poklis</surname><given-names>A.</given-names></name><name name-style="western"><surname>Maginn</surname><given-names>D.</given-names></name><name name-style="western"><surname>Barr</surname><given-names>J.L.</given-names></name></person-group><article-title>Drug findings in &#8220;Driving Under the Influence of Drugs&#8221; cases: a problem of illicit drug use</article-title><source>Drug Alcohol Depend</source><volume>20</volume><year>1987</year><fpage>57</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">3678043</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0376-8716(87)90076-7</pub-id></element-citation></ref><ref id="bb1130"><label>226</label><element-citation publication-type="journal" id="rf1130"><person-group person-group-type="author"><name name-style="western"><surname>Poulsen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Moar</surname><given-names>R.</given-names></name><name name-style="western"><surname>Troncoso</surname><given-names>C.</given-names></name></person-group><article-title>The incidence of alcohol and other drugs in drivers killed in New Zealand road crashes 2004-2009</article-title><source>Forensic Sci Int</source><volume>223</volume><year>2012</year><fpage>364</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1016/j.forsciint.2012.10.026</pub-id><pub-id pub-id-type="pmid">23131305</pub-id></element-citation></ref><ref id="bb1135"><label>227</label><element-citation publication-type="journal" id="rf1135"><person-group person-group-type="author"><name name-style="western"><surname>Ray</surname><given-names>W.A.</given-names></name><name name-style="western"><surname>Fought</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Decker</surname><given-names>M.D.</given-names></name></person-group><article-title>Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers</article-title><source>Am J Epidemiol</source><volume>136</volume><year>1992</year><fpage>873</fpage><lpage>883</lpage><pub-id pub-id-type="pmid">1442753</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/aje/136.7.873</pub-id></element-citation></ref><ref id="bb1140"><label>228.</label><element-citation publication-type="journal" id="rf1140"><person-group person-group-type="author"><name name-style="western"><surname>Schumann</surname><given-names>J.</given-names></name><name name-style="western"><surname>Perkins</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dietze</surname><given-names>P.</given-names></name><etal/></person-group><article-title>The prevalence of alcohol and other drugs in fatal road crashes in Victoria, Australia</article-title><source>Accid Anal Prev</source><volume>153</volume><year>2021</year><object-id pub-id-type="publisher-id">105905</object-id><pub-id pub-id-type="doi">10.1016/j.aap.2020.105905</pub-id><pub-id pub-id-type="pmid">33631704</pub-id></element-citation></ref><ref id="bb1145"><label>229</label><element-citation publication-type="journal" id="rf1145"><person-group person-group-type="author"><name name-style="western"><surname>Senna</surname><given-names>M.-C.</given-names></name><name name-style="western"><surname>Augsburger</surname><given-names>M.</given-names></name><name name-style="western"><surname>Aebi</surname><given-names>B.</given-names></name><etal/></person-group><article-title>First nationwide study on driving under the influence of drugs in Switzerland</article-title><source>Forensic Sci Int</source><volume>198</volume><year>2010</year><fpage>11</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.forsciint.2010.02.014</pub-id><pub-id pub-id-type="pmid">20211534</pub-id></element-citation></ref><ref id="bb1150"><label>230.</label><element-citation publication-type="journal" id="rf1150"><person-group person-group-type="author"><name name-style="western"><surname>Seymour</surname><given-names>A.</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>J.S.</given-names></name></person-group><article-title>A study of alcohol and drugs in impaired and fatally injured drivers in the west of Scotland</article-title><source>J Traffic Med</source><volume>28</volume><year>2000</year><fpage>32</fpage><lpage>37</lpage></element-citation></ref><ref id="bb1155"><label>231</label><element-citation publication-type="journal" id="rf1155"><person-group person-group-type="author"><name name-style="western"><surname>Sidlo</surname><given-names>J.</given-names></name></person-group><article-title>Psychoactive substance-related deaths in road traffic accidents in Slovakia between 2000 and 2007</article-title><source>Bratisl Lek Listy</source><volume>110</volume><year>2009</year><fpage>468</fpage><lpage>471</lpage><pub-id pub-id-type="pmid">19750983</pub-id></element-citation></ref><ref id="bb1160"><label>232</label><element-citation publication-type="journal" id="rf1160"><person-group person-group-type="author"><name name-style="western"><surname>Skurtveit</surname><given-names>S.</given-names></name><name name-style="western"><surname>Christophersen</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Morland</surname><given-names>J.</given-names></name></person-group><article-title>Female drivers suspected for drunken or drugged driving</article-title><source>Forensic Sci Int</source><volume>75</volume><year>1995</year><fpage>139</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">8586337</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0379-0738(95)01785-2</pub-id></element-citation></ref><ref id="bb1165"><label>233</label><element-citation publication-type="journal" id="rf1165"><person-group person-group-type="author"><name name-style="western"><surname>Skurtveit</surname><given-names>S.</given-names></name><name name-style="western"><surname>Abotnes</surname><given-names>B.</given-names></name><name name-style="western"><surname>Christophersen</surname><given-names>A.S.</given-names></name></person-group><article-title>Drugged drivers in Norway with benzodiazepine detections</article-title><source>Forensic Sci Int</source><volume>125</volume><year>2002</year><fpage>75</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">11852205</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0379-0738(01)00623-5</pub-id></element-citation></ref><ref id="bb1170"><label>234</label><element-citation publication-type="journal" id="rf1170"><person-group person-group-type="author"><name name-style="western"><surname>Smink</surname><given-names>B.E.</given-names></name><name name-style="western"><surname>Ruiter</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lusthof</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>de Gier</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Uges</surname><given-names>D.R.A.</given-names></name><name name-style="western"><surname>Egberts</surname><given-names>A.C.G.</given-names></name></person-group><article-title>Drug use and the severity of a traffic accident</article-title><source>Accid Anal Prev</source><volume>37</volume><year>2005</year><fpage>427</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">15784196</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.aap.2004.12.003</pub-id></element-citation></ref><ref id="bb1175"><label>235</label><element-citation publication-type="journal" id="rf1175"><person-group person-group-type="author"><name name-style="western"><surname>Smink</surname><given-names>B.E.</given-names></name><name name-style="western"><surname>Lusthof</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>de Gier</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Uges</surname><given-names>D.R.A.</given-names></name><name name-style="western"><surname>Egberts</surname><given-names>A.C.G.</given-names></name></person-group><article-title>The relation between the blood benzodiazepine concentration and performance in suspected impaired drivers</article-title><source>J Forensic Leg Med</source><volume>15</volume><year>2008</year><fpage>483</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1016/j.jflm.2008.04.002</pub-id><pub-id pub-id-type="pmid">18926498</pub-id></element-citation></ref><ref id="bb1180"><label>236</label><element-citation publication-type="journal" id="rf1180"><person-group person-group-type="author"><name name-style="western"><surname>Stephenson</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Golz</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Brasher</surname><given-names>M.J.</given-names></name></person-group><article-title>Phenazepam and its effects on driving</article-title><source>J Anal Toxicol</source><volume>37</volume><year>2013</year><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1093/jat/bks080</pub-id><pub-id pub-id-type="pmid">23074215</pub-id></element-citation></ref><ref id="bb1185"><label>237.</label><element-citation publication-type="journal" id="rf1185"><person-group person-group-type="author"><name name-style="western"><surname>Sybirska</surname><given-names>H.</given-names></name><name name-style="western"><surname>Szczepanski</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kulikowska</surname><given-names>J.</given-names></name></person-group><article-title>Drugs of abuse in the blood of road users the experiences of the Department of Forensic Medicine at the Silesian Medical Academy in Katowice</article-title><source>Z Zagadnien Nauk Sadowych</source><volume>39</volume><year>1999</year><fpage>65</fpage><lpage>76</lpage></element-citation></ref><ref id="bb1190"><label>238</label><element-citation publication-type="journal" id="rf1190"><person-group person-group-type="author"><name name-style="western"><surname>Szeremeta</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ptaszynska-Sarosiek</surname><given-names>I.</given-names></name><name name-style="western"><surname>Wardaszka</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Niemcunowicz-Janica</surname><given-names>A.</given-names></name></person-group><article-title>Analysis of the prevalence of medicines and psychoactive substances among drivers in the material of the Department of Forensic Medicine at the Medical University of Bialystok</article-title><source>Adv Clin Exp Med Off Organ Wroclaw Med Univ</source><volume>23</volume><year>2014</year><fpage>245</fpage><lpage>251</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.17219/acem/37069</pub-id><pub-id pub-id-type="pmid">24913115</pub-id></element-citation></ref><ref id="bb1195"><label>239.</label><element-citation publication-type="journal" id="rf1195"><person-group person-group-type="author"><name name-style="western"><surname>Tsocha</surname><given-names>A.</given-names></name><name name-style="western"><surname>Krokos</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gika</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Drug driving in northern Greece among drivers involved in road traffic accidents</article-title><source>Romanian J Leg Med</source><volume>28</volume><year>2020</year><fpage>50</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.4323/rjlm.2020.50</pub-id></element-citation></ref><ref id="bb1200"><label>240</label><element-citation publication-type="journal" id="rf1200"><person-group person-group-type="author"><name name-style="western"><surname>Valen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bogstrand</surname><given-names>S.T.</given-names></name><name name-style="western"><surname>Vindenes</surname><given-names>V.</given-names></name><name name-style="western"><surname>Gjerde</surname><given-names>H.</given-names></name></person-group><article-title>Toxicological findings in suspected drug-impaired drivers in Norway - Trends during 1990-2015</article-title><source>Forensic Sci Int</source><volume>280</volume><year>2017</year><fpage>15</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.forsciint.2017.09.010</pub-id><pub-id pub-id-type="pmid">28942374</pub-id></element-citation></ref><ref id="bb1205"><label>241</label><element-citation publication-type="journal" id="rf1205"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y.-H.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>J.-N.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>C.-H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.-D.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>P.-C.</given-names></name></person-group><article-title>Increased risk of hospitalization related to motor vehicle accidents among people taking zolpidem: a case-crossover study</article-title><source>J Epidemiol</source><volume>21</volume><year>2011</year><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">21030794</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2188/jea.JE20090195</pub-id><pub-id pub-id-type="pmcid">PMC3899515</pub-id></element-citation></ref><ref id="bb1210"><label>242</label><element-citation publication-type="journal" id="rf1210"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>C.F.</given-names></name><name name-style="western"><surname>Frei</surname><given-names>C.</given-names></name><name name-style="western"><surname>Downes</surname><given-names>N.</given-names></name><name name-style="western"><surname>McTaggart</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Akram</surname><given-names>G.</given-names></name></person-group><article-title>Benzodiazepine and z-hypnotic prescribing for older people in primary care: a cross-sectional population-based study</article-title><source>Br J Gen Pract</source><volume>66</volume><year>2016</year><fpage>e410</fpage><lpage>e415</lpage><pub-id pub-id-type="doi">10.3399/bjgp16X685213</pub-id><pub-id pub-id-type="pmid">27114208</pub-id><pub-id pub-id-type="pmcid">PMC4871306</pub-id></element-citation></ref><ref id="bb1215"><label>243</label><element-citation publication-type="journal" id="rf1215"><person-group person-group-type="author"><name name-style="western"><surname>Milani</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Raji</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>Y.-F.</given-names></name></person-group><article-title>Trends in the Use of Benzodiazepines, Z-Hypnotics, and Serotonergic Drugs Among US Women and Men Before and During the COVID-19 Pandemic</article-title><source>JAMA Netw Open</source><volume>4</volume><year>2021</year><object-id pub-id-type="publisher-id">e2131012</object-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.31012</pub-id><pub-id pub-id-type="pmcid">PMC8546497</pub-id><pub-id pub-id-type="pmid">34694388</pub-id></element-citation></ref><ref id="bb1220"><label>244.</label><element-citation publication-type="book" id="rf1220"><person-group person-group-type="author"><name name-style="western"><surname>Statistics Canada</surname></name></person-group><part-title>Annual Demographic Estimates: Canada, Provinces and Territories, 2020. Analysis: Total Population, Annu. Demogr. Estim. Can. Prov. Territ. 2020 Anal. Total Popul</part-title><year>2020</year><comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www150.statcan.gc.ca/n1/pub/91-215-x/2020001/sec1-eng.htm" id="ir0040">https://www150.statcan.gc.ca/n1/pub/91-215-x/2020001/sec1-eng.htm</ext-link> (accessed May 26, 2023)</comment></element-citation></ref><ref id="bb1225"><label>245.</label><element-citation publication-type="book" id="rf1225"><person-group person-group-type="author"><name name-style="western"><surname>Ontario Drug Policy Research Network</surname></name><name name-style="western"><surname>Campbell</surname><given-names>T.</given-names></name><name name-style="western"><surname>Men</surname><given-names>S.</given-names></name><etal/></person-group><part-title>Characterizing Prescription Benzodiazepine Use among Community-Dwelling Residents of Ontario, Canada, ODPRN</part-title><year>2021</year><pub-id pub-id-type="doi">10.31027/ODPRN.2021.01</pub-id></element-citation></ref><ref id="bb1230"><label>246</label><element-citation publication-type="journal" id="rf1230"><person-group person-group-type="author"><name name-style="western"><surname>Begum</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gonzalez-Chica</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bernardo</surname><given-names>C.</given-names></name><name name-style="western"><surname>Woods</surname><given-names>A.</given-names></name><name name-style="western"><surname>Stocks</surname><given-names>N.</given-names></name></person-group><article-title>Trends in the prescription of drugs used for insomnia: an open-cohort study in Australian general practice, 2011&#8211;2018</article-title><source>Br J Gen Pract</source><volume>71</volume><year>2021</year><fpage>e877</fpage><lpage>e886</lpage><pub-id pub-id-type="doi">10.3399/BJGP.2021.0054</pub-id><pub-id pub-id-type="pmid">33950853</pub-id><pub-id pub-id-type="pmcid">PMC8366783</pub-id></element-citation></ref><ref id="bb1235"><label>247.</label><element-citation publication-type="other" id="rf1235"><person-group person-group-type="author"><name name-style="western"><surname>Jonah</surname><given-names>B.</given-names></name></person-group><article-title>Drugs and Driving Framework</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ccmta.ca/web/default/files/PDF/drugs_driving_framework_final.pdf" id="ir0045">https://www.ccmta.ca/web/default/files/PDF/drugs_driving_framework_final.pdf</ext-link><year>2012</year></element-citation></ref><ref id="bb1240"><label>248.</label><element-citation publication-type="other" id="rf1240"><person-group person-group-type="author"><name name-style="western"><surname>International Pharmaceutical Federation</surname></name></person-group><article-title>The supply of medicines affecting driving performance</article-title><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.fip.org/file/1512" id="ir0050">https://www.fip.org/file/1512</ext-link><year>2014</year></element-citation></ref><ref id="bb1245"><label>249.</label><mixed-citation publication-type="other" id="or0038">Australian Institute of Health and Welfare Alcohol, tobacco &amp; other drugs in Australia: Older people, Canberra. 2024 <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.aihw.gov.au/reports/alcohol/alcohol-tobacco-other-drugs-australia/contents/priority-populations/older-people" id="ir0055">https://www.aihw.gov.au/reports/alcohol/alcohol-tobacco-other-drugs-australia/contents/priority-populations/older-people</ext-link> [accessed February 19, 2003].</mixed-citation></ref><ref id="bb1250"><label>250</label><mixed-citation publication-type="other" id="or0037">Statistics Canada Government Of Canada, Percentage of people who reported having used alcohol, cannabis, cigarettes or an illegal drug in the past year, household population aged 15 and older, Canada, 2019. 2021. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www150.statcan.gc.ca/n1/daily-quotidien/211220/t001c-eng.htm" id="ir0060">https://www150.statcan.gc.ca/n1/daily-quotidien/211220/t001c-eng.htm</ext-link> [accessed February 19, 2023].</mixed-citation></ref><ref id="bb1255"><label>251.</label><element-citation publication-type="book" id="rf1255"><person-group person-group-type="author"><name name-style="western"><surname>Alvarez</surname><given-names>J.</given-names></name><name name-style="western"><surname>de Gier</surname><given-names>H.</given-names></name><name name-style="western"><surname>Mercier-Guyon</surname><given-names>D.C.</given-names></name></person-group><part-title>International Council on alcohol, drugs and traffic safety List Version June 26th, 2007: Categorization of system for medicinal drugs affecing driving performance</part-title><year>2007</year></element-citation></ref><ref id="bb1260"><label>252</label><element-citation publication-type="book" id="rf1260"><person-group person-group-type="author"><name name-style="western"><surname>Louwerens</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Gloerich</surname><given-names>A.B.M.</given-names></name><name name-style="western"><surname>de Vries</surname><given-names>G.</given-names></name><name name-style="western"><surname>Brookhuis</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>O&#8217;Hanlon</surname><given-names>J.F.</given-names></name></person-group><part-title>The relationship between drivers&#8217; blood alcohol concentration (BAC) and actual driving performance during high speed travel</part-title><person-group person-group-type="editor"><name name-style="western"><surname>Noordzij</surname><given-names>P.C.</given-names></name><name name-style="western"><surname>Roszbach</surname><given-names>R.</given-names></name><name name-style="western"><surname>de Gier</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Neuteboom</surname><given-names>W.</given-names></name><name name-style="western"><surname>Zweipfenning</surname><given-names>P.G.M.</given-names></name></person-group><source>Alcohol Drugs Traffic Saf. T86 Proc. 10th Int. Conf. Alcohol Drugs Traffic Saf. Amst. 9&#8211;12 Sept. 1986, Amsterdam&#160;; New York&#160;: Excerpta Medica&#160;; New York, NY, USA&#160;: Sole distributors for the USA and Canada, Elsevier Science Pub. Co., The Netherlands</source><year>1987</year><fpage>183</fpage><lpage>192</lpage><comment>http://archive.org/details/alcoholdrugstraff00inte (accessed June 12, 2023)</comment></element-citation></ref></ref-list><sec id="s0215"><label>Appendix 1</label><title>Inclusion and exclusion criteria</title><p id="p0310">
<table-wrap position="anchor" id="t0025" orientation="portrait"><alt-text id="al0040">Unlabelled Table</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Inclusion criteria</th><th colspan="1" rowspan="1">Exclusion criteria</th></tr></thead><tbody><tr><td colspan="2" rowspan="1">BZRAs</td></tr><tr><td colspan="1" rowspan="1">Study participants taking a BZRA</td><td colspan="1" rowspan="1">No BZRAs Studied (Study did not include any BZRAs), No Single-Entity BZRA use (i.e., exclude those exclusively co-administration cases with no single entity BZRA use, or unclear if mono-use of BZRAs)<break/>Wrong route of administration (i.e., intravenous, intramuscular).<break/>BZRA must be regulated in one or more countries (i.e. exclude &#8220;designer&#8221; BZRAs for illicit use).</td></tr><tr><td colspan="2" rowspan="1">&#8232;&#8232;</td></tr><tr><td colspan="2" rowspan="1">Participants</td></tr><tr><td colspan="1" rowspan="1">Of legal age to drive (e.g., 15 &amp; up)</td><td colspan="1" rowspan="1">Wrong Patient Population<break/>a. Not of legal age to be driving<break/>b. Study subjects in hospital/hospitalized for reasons other than motor vehicle accident or residing in long-term care or assisted living facilities</td></tr><tr><td colspan="1" rowspan="1">Study design: (i) experimental design (randomized or non-randomized prospective study) with one or more study groups; (ii) observational/epidemiological design (cross-sectional study, ecological study, time-series analysis, case control study, cohort study, case series, surveillance, vital statistics) conducted prospectively or retrospectively; (iii)*Systematic Reviews, Scoping Review, Rapid Review, Meta-Analysis<break/>(*citation chasing)</td><td colspan="1" rowspan="1">Wrong Study Design<break/>a. Studies that measure skills indirectly related to driving (i.e. flicker fusion test, EEG, reaction time tests, hand and foot proprioception).<break/>b. Drug-detection sensitivity studies in which impaired performance was not the focus of the study<break/>c. Use of non-standard subjective measures and non-objective self-reported measures of driving impairment<break/>d. Random sampling of drivers (no suspected impairment)<break/>Wrong Publication Type (exclude anecdotes, testimonials, editorials, commentary, conference abstracts, unpublished reports, letters, narrative reviews)</td></tr><tr><td colspan="2" rowspan="1">&#8232;&#8232;</td></tr><tr><td colspan="2" rowspan="1">Context for driving assessment</td></tr><tr><td colspan="1" rowspan="1">Operating/driving a vehicle in real or simulated conditions and assessment of driving performance, driving score (includes crashes, ER visits, sobriety test, police ride checks, etc).</td><td colspan="1" rowspan="1">Wrong Setting/Context<break/>a. Overdose/Toxicity<break/>b. Recreational vehicles (ATV, Bicycles, Boats, etc)<break/>c. Not in the context of driving</td></tr><tr><td colspan="2" rowspan="1">&#8232;&#8232;</td></tr><tr><td colspan="2" rowspan="1">Language</td></tr><tr><td colspan="1" rowspan="1">English language publications</td><td colspan="1" rowspan="1">Non-English Language</td></tr></tbody></table></table-wrap>
</p></sec><sec id="s0220"><label>Appendix 2</label><title>Search strategy</title><sec id="s0225"><label>1</label><title>MEDLINE (Ovid)</title><p id="p0315">(May 3, 2022)</p><p id="p0320">(((Automobile Driving/ or motor vehicles/ or automobiles/ or motorcycles/ or (Automobile* or car or cars or truck* or motorcycle* or motor cycle* or motor vehicle* or vehicle* or traffic or driver* or driving or crash or crashes or crashing or collision*).ti,ab,kw,kf.) and ((Impair* or drug* or intoxicat* or under the influence or somnolen* or fatigue* or sleep* or drows* or hungover or hangover* or drunk*).ti,ab,kw,kf. or Fatigue/) and (&#8220;hypnotics and sedatives&#8221;/ or sleep aids, pharmaceutical/ or Tranquilizing Agents/ or Anti-Anxiety Agents/ or benzodiazepines/ or alprazolam/ or bromazepam/ or clonazepam/ or exp. diazepam/ or flunitrazepam/ or flurazepam/ or lorazepam/ or nitrazepam/ or oxazepam/ or prazepam/ or temazepam/ or chlordiazepoxide/ or clobazam/ or clorazepate dipotassium/ or estazolam/ or medazepam/ or midazolam/ or triazolam/ or Eszopiclone/ or Nordazepam/ or Zolazepam/ or Zolpidem/ or exp. GABA Agonists/ or (Sleep medication* or sleep aid* or hypnotic drug* or hypnotic agent* or sleep promoting agent* or sedative-hypnotic* or benzodiazepine* or benzodiazepinone* or anxiolytic*).ti,ab,kw,kf. or ((anxiolytic* or anti anxiety or anti-anxiety or antianxiety or ataractic*) adj2 (agent* or drug*)).ti,ab,kw,kf. or (minor adj2 tranquiliz*).ti,ab,kw,kf. or ((Benzodiazepine or gaba) adj3 (agonist* or receptor* or stimulant* or stimulator* or stimulating or agent*)).ti,ab,kw,kf. or (benzodiazepine adj2 derivative*).ti,ab,kw,kf. or (alprazolam or bromazepam or brotizolam or clonazepam or cloxazolam or chlordiazepoxide or clobazam or chlorazepate or cinolazepam or clotiazepam or delorazepam or diazepam or estazolam or eszopiclone or etizolam or flunitrazepam or fludiazepam or flutazolam or flutoprazepam or flurazepam or halazepam or haloxazolam or Ketazolam or loprazolam or lorazepam or lormetazepam or midazolam or medazepam or mexazolam or nitrazepam or nimetazepam or nordazepam or oxazepam or Oxazolam or prazepam or phenazepam or pinazepam or quazepam or temazepam or tetrazepam or triazolam or tofisopam or zolazepam or zapizolam or zopiclone or zaleplon or zolpidem or bzra).ti,ab,kw,kf.)) or (((Driver* or driving) adj3 (health or behavio?r* or abilit* or perform* or accident* or crash or crashes or crashing or injur* or collision* or fatalit* or safety or risk* or fatigue* or attention or inattention or sleep* or drows* or alert or alertness or fitness or assess* or evaluat*)).ti,ab,kw,kf. or ((Road* or highway or motorway or traffic) adj3 (accident* or crash or crashes or crashing or injur* or collision* or fatalit* or safety or risk* or fatigue* or attention or inattention or sleep* or drows* or alert or alertness or fitness or assess* or evaluat*)).ti,ab,kw,kf or (fitness to drive or fitness-to-drive).ti,ab,kw,kf. or driving under the influence/ or Accidents, Traffic/) and (&#8220;hypnotics and sedatives&#8221;/ or sleep aids, pharmaceutical/ or Tranquilizing Agents/ or Anti-Anxiety Agents/ or benzodiazepines/ or alprazolam/ or bromazepam/ or clonazepam/ or exp. diazepam/ or flunitrazepam/ or flurazepam/ or lorazepam/ or nitrazepam/ or oxazepam/ or prazepam/ or temazepam/ or chlordiazepoxide/ or clobazam/ or clorazepate dipotassium/ or estazolam/ or medazepam/ or midazolam/ or triazolam/ or Eszopiclone/ or Nordazepam/ or Zolazepam/ or Zolpidem/ or exp. GABA Agonists/ or (Sleep medication* or sleep aid* or hypnotic drug* or hypnotic agent* or sleep promoting agent* or sedative-hypnotic* or benzodiazepine* or benzodiazepinone* or anxiolytic*).ti,ab,kw,kf. or ((anxiolytic* or anti anxiety or anti-anxiety or antianxiety or ataractic*) adj2 (agent* or drug*)).ti,ab,kw,kf. or (minor adj2 tranquiliz*).ti,ab,kw,kf. or ((Benzodiazepine or gaba) adj3 (agonist* or receptor* or stimulant* or stimulator* or stimulating or agent*)).ti,ab,kw,kf. or (benzodiazepine adj2 derivative*).ti,ab,kw,kf. or (alprazolam or bromazepam or brotizolam or clonazepam or cloxazolam or chlordiazepoxide or clobazam or chlorazepate or cinolazepam or clotiazepam or delorazepam or diazepam or estazolam or eszopiclone or etizolam or flunitrazepam or fludiazepam or flutazolam or flutoprazepam or flurazepam or halazepam or haloxazolam or Ketazolam or loprazolam or lorazepam or lormetazepam or midazolam or medazepam or mexazolam or nitrazepam or nimetazepam or nordazepam or oxazepam or Oxazolam or prazepam or phenazepam or pinazepam or quazepam or temazepam or tetrazepam or triazolam or tofisopam or zolazepam or zapizolam or zopiclone or zaleplon or zolpidem or bzra).ti,ab,kw,kf.)) not (exp Animals/ not Humans/)</p></sec></sec><sec id="s0230"><label>Appendix 3</label><title>Experimental studies</title><p id="p0325">
<table-wrap position="anchor" id="t0030" orientation="portrait"><alt-text id="al0045">Unlabelled Table</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Year of publication</th><th colspan="1" rowspan="1">First author</th><th colspan="1" rowspan="1">Experimental study design<sup>a</sup></th><th colspan="1" rowspan="1">number of subjects</th><th colspan="1" rowspan="1">number of females</th><th colspan="1" rowspan="1">Mean age (years)</th><th colspan="1" rowspan="1">Age range (years)</th><th colspan="1" rowspan="1">Consecu-tive days of BZRA use (Yes/No)</th><th colspan="1" rowspan="1">Outcome measures</th><th colspan="1" rowspan="1">Authors' conclusions regarding BZRA and driving impairment</th></tr></thead><tbody><tr><td colspan="10" rowspan="1"><bold>Single driving impairment assessment setting</bold></td></tr><tr><td colspan="10" rowspan="1"><bold>Road Driving (traffic)</bold></td></tr><tr><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Vermeeren, A</td><td colspan="1" rowspan="1">R, DB, PC, AC, CO</td><td colspan="1" rowspan="1">48</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">58.5</td><td colspan="1" rowspan="1">21&#8211;65</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2018</td><td colspan="1" rowspan="1">Jongen, S</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">36.8</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2018</td><td colspan="1" rowspan="1">Verster, J</td><td colspan="1" rowspan="1">R, DB, PC, AC, CO</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">21&#8211;65</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1"># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)<break/>Lapses</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2016</td><td colspan="1" rowspan="1">Vermeeren, A</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">68.8</td><td colspan="1" rowspan="1">65&#8211;76</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2015</td><td colspan="1" rowspan="1">Vermeeren, A</td><td colspan="1" rowspan="1">R, DB, PC, AC, CO</td><td colspan="1" rowspan="1">28</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">45.6</td><td colspan="1" rowspan="1">21&#8211;64</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2014</td><td colspan="1" rowspan="1">Leufkens, T</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">48</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">62.6</td><td colspan="1" rowspan="1">52&#8211;71</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Braking reaction time (BRT)<break/>Standard deviation of speed (SDS)<break/>Gain</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">2014</td><td colspan="1" rowspan="1">Motak, L</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">29.69</td><td colspan="1" rowspan="1">25&#8211;35</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2014</td><td colspan="1" rowspan="1">Leufkens, T</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">101</td><td colspan="1" rowspan="1">51</td><td colspan="1" rowspan="1">39.6</td><td colspan="1" rowspan="1">21&#8211;73</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2014</td><td colspan="1" rowspan="1">Verster, J</td><td colspan="1" rowspan="1">R, DB, PC, AC, CO</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">21&#8211;65</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Lapses</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2011</td><td colspan="1" rowspan="1">Vermeeren, A</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">37.3</td><td colspan="1" rowspan="1">21&#8211;64</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">2011</td><td colspan="1" rowspan="1">Mets, M</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">21&#8211;55</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Average lateral position (ALP)<break/>Standard deviation of speed (SDS)<break/>Mean speed (MS)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">2011</td><td colspan="1" rowspan="1">Ramaekers, JG</td><td colspan="1" rowspan="1">R, DB, PC, AC, CO</td><td colspan="1" rowspan="1">32</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">33</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2009</td><td colspan="1" rowspan="1">Leufkens, T</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">64.3</td><td colspan="1" rowspan="1">55&#8211;75</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">2009</td><td colspan="1" rowspan="1">Leufkens, T</td><td colspan="1" rowspan="1">R, DB, PC, AC, CO</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">31.4</td><td colspan="1" rowspan="1">22&#8211;44</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2007</td><td colspan="1" rowspan="1">Leufkens, T</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">32.3</td><td colspan="1" rowspan="1">20&#8211;45</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">2002</td><td colspan="1" rowspan="1">Verster, J</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">22&#8211;26</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">2002</td><td colspan="1" rowspan="1">Verster J</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)<break/>Mean speed (MS)<break/># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2002</td><td colspan="1" rowspan="1">Vermeeren, A</td><td colspan="1" rowspan="1">R, DB, PC, AC, CO</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">31.6</td><td colspan="1" rowspan="1">21&#8211;45</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">2001</td><td colspan="1" rowspan="1">van Laar, M</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">28</td><td colspan="1" rowspan="1">25&#8211;36</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)<break/># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1998</td><td colspan="1" rowspan="1">Vermeeren, A</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">22&#8211;45</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Average reaction time (ART)<break/>Standard deviation of speed (SDS)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1998</td><td colspan="1" rowspan="1">Vermeeren, A</td><td colspan="1" rowspan="1">R, DB, PC, AC, CO</td><td colspan="1" rowspan="1">28</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">31</td><td colspan="1" rowspan="1">23&#8211;40</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">1995</td><td colspan="1" rowspan="1">O'Hanlon, JF</td><td colspan="1" rowspan="1">R, DB, PC, Parallel</td><td colspan="1" rowspan="1">56</td><td colspan="1" rowspan="1">36</td><td colspan="1" rowspan="1">43</td><td colspan="1" rowspan="1">24&#8211;64</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1993</td><td colspan="1" rowspan="1">O'Hanlon, JF</td><td colspan="1" rowspan="1">R, DB, PC, Parallel</td><td colspan="1" rowspan="1">56</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">21&#8211;65</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1986</td><td colspan="1" rowspan="1">O'Hanlon, JF</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">26&#8211;38</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">1986</td><td colspan="1" rowspan="1">Schmidt, U</td><td colspan="1" rowspan="1">R, DB, AC, Parallel</td><td colspan="1" rowspan="1">32</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Steering angle velocity<break/>Optimization Quotient</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">1982</td><td colspan="1" rowspan="1">O'Hanlon, JF</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">24&#8211;34</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)<break/>Mean speed (MS)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">1979</td><td colspan="1" rowspan="1">Biehl, B</td><td colspan="1" rowspan="1">R, DB, PC, Parallel</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">18&#8211;24</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Observer rated behavioural measures of driver impairment</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">2021</td><td colspan="1" rowspan="1">Vinckenbosch, FRJ</td><td colspan="1" rowspan="1">NR, Open study, PC, parallel</td><td colspan="1" rowspan="1">126</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">55</td><td colspan="1" rowspan="1">21&#8211;75</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">van der Sluiszen, N</td><td colspan="1" rowspan="1">NR, Open study, Parallel</td><td colspan="1" rowspan="1">109</td><td colspan="1" rowspan="1">54</td><td colspan="1" rowspan="1">56.2</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">2014</td><td colspan="1" rowspan="1">Leufkens, T</td><td colspan="1" rowspan="1">NR, Open study, Parallel</td><td colspan="1" rowspan="1">63</td><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">61.6</td><td colspan="1" rowspan="1">50&#8211;75</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Average reaction time (ART)<break/>Standard deviation of speed (SDS)<break/>Mean speed (MS)<break/>Gain</td><td colspan="1" rowspan="1">No driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1995</td><td colspan="1" rowspan="1">O'Hanlon, JF</td><td colspan="1" rowspan="1">NR, DB, PC, CO</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">34</td><td colspan="1" rowspan="1">25&#8211;43</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1995</td><td colspan="1" rowspan="1">O'Hanlon, JF</td><td colspan="1" rowspan="1">NR, DB, PC, CO</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">22&#8211;34</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP<break/>Average reaction time (ART)<break/>Standard deviation of following distance (SDFD)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1995</td><td colspan="1" rowspan="1">Vermeeren, A</td><td colspan="1" rowspan="1">NR, DB, PC, AC, CO</td><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">40.8</td><td colspan="1" rowspan="1">25&#8211;51</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)</td><td colspan="1" rowspan="1">No driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1992</td><td colspan="1" rowspan="1">vanLaar, M</td><td colspan="1" rowspan="1">NR, DB, PC, Parallel</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">18&#8211;50</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP),Standard deviation of speed (SDS)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1990</td><td colspan="1" rowspan="1">Brookhuis, KA</td><td colspan="1" rowspan="1">NR, DB, PC, CO</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">26&#8211;41</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">1981</td><td colspan="1" rowspan="1">deGier, JJ</td><td colspan="1" rowspan="1">NR, Open study, Parallel</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">43.1</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">110 item driving behaviour checklist</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="10" rowspan="1">&#8232;&#8232;</td></tr><tr><td colspan="10" rowspan="1"><bold>Driving Course (non-traffic)</bold></td></tr><tr><td colspan="1" rowspan="1">2008</td><td colspan="1" rowspan="1">Boyle, J</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">64</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">27</td><td colspan="1" rowspan="1">19&#8211;47</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Braking reaction time (BRT)</td><td colspan="1" rowspan="1">No driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2005</td><td colspan="1" rowspan="1">Hindmarch, I</td><td colspan="1" rowspan="1">R, DB, PC, AC, CO</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Braking reaction time (BRT)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">1999</td><td colspan="1" rowspan="1">Mercier-Guyon, C</td><td colspan="1" rowspan="1">R, DB, AC, CO</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">29&#8211;44</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Gap estimation/acceptance task<break/>Weaving task</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">1980</td><td colspan="1" rowspan="1">Hindmarch, I</td><td colspan="1" rowspan="1">R, TB, PC, CO</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">34</td><td colspan="1" rowspan="1">26&#8211;40</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Braking reaction time (BRT)<break/>Gap estimation/acceptance task<break/>Weaving task<break/>Parking task</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">1979</td><td colspan="1" rowspan="1">Wetherell, A</td><td colspan="1" rowspan="1">R, DB, PC, Parallel</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">25.5</td><td colspan="1" rowspan="1">19&#8211;41</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Gap estimation/acceptance task</td><td colspan="1" rowspan="1">No driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1972</td><td colspan="1" rowspan="1">Betts, TA</td><td colspan="1" rowspan="1">R, DB, PC</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">18&#8211;30</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Gap estimation/acceptance task,<break/>Weaving task<break/>Parking task</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1982</td><td colspan="1" rowspan="1">Betts, TA</td><td colspan="1" rowspan="1">NR, DB, PC, CO</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Gap estimation/acceptance task<break/>Weaving task</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1977</td><td colspan="1" rowspan="1">Hindmarch, I</td><td colspan="1" rowspan="1">NR, DB, PC, CO</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">27</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Gap estimation/acceptance task<break/>Weaving task<break/>Parking task</td><td colspan="1" rowspan="1">No driving impairment identified</td></tr><tr><td colspan="10" rowspan="1">&#8232;&#8232;</td></tr><tr><td colspan="10" rowspan="1"><bold>Simulated driving (car)</bold></td></tr><tr><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">Su, S</td><td colspan="1" rowspan="1">R, DB, PC, AC, CO</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">41</td><td colspan="1" rowspan="1">38.1</td><td colspan="1" rowspan="1">22&#8211;59</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)<break/># of collisions</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">Torres, R</td><td colspan="1" rowspan="1">R, DB, PC, AC, CO</td><td colspan="1" rowspan="1">48</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">21&#8211;55</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">Muehlan, C</td><td colspan="1" rowspan="1">R, DB, PC, AC, CO</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">64.6</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)<break/>Mean speed (MS)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">Iwamoto, K</td><td colspan="1" rowspan="1">R, DB, PC,CO</td><td colspan="1" rowspan="1">28</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">33.1</td><td colspan="1" rowspan="1">22&#8211;59</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Braking reaction time (BRT)<break/>Standard deviation of speed (SDS)<break/>Following distance coefficient of variation (CV)<break/># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)<break/># of collisions</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">2021</td><td colspan="1" rowspan="1">Moller, HJ</td><td colspan="1" rowspan="1">R, DB, PC, AC, CO</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">33.1</td><td colspan="1" rowspan="1">25&#8211;55</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Average reaction time (ART)<break/># of collisions</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Huizinga, RH</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">26</td><td colspan="1" rowspan="1">20&#8211;43</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2018</td><td colspan="1" rowspan="1">Brown, TL</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2017</td><td colspan="1" rowspan="1">Kay, GG</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">72</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">32.4</td><td colspan="1" rowspan="1">18&#8211;50</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2016</td><td colspan="1" rowspan="1">Kay, GG</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">59</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">41.1</td><td colspan="1" rowspan="1">25&#8211;55</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)<break/># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2014</td><td colspan="1" rowspan="1">Miyata, A</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">17</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">34.1</td><td colspan="1" rowspan="1">23&#8211;44</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Braking reaction time (BRT)<break/>Following distance coefficient of variation (CV)<break/># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">2013</td><td colspan="1" rowspan="1">Brown, T</td><td colspan="1" rowspan="1">R, DB, PC, Parallel</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">19&#8211;50</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">2013</td><td colspan="1" rowspan="1">Sarris, J</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">33</td><td colspan="1" rowspan="1">18&#8211;65</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Braking reaction time (BRT)<break/>Standard deviation of speed (SDS)<break/>Lapses<break/># of collisions</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">2010</td><td colspan="1" rowspan="1">Takahashi, M</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">37.1</td><td colspan="1" rowspan="1">32&#8211;44</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Braking reaction time (BRT)<break/>Following distance coefficient of variation (CV)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">2008</td><td colspan="1" rowspan="1">Otmani, S</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">59.4</td><td colspan="1" rowspan="1">55&#8211;65</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Standard deviation of speed (SDS)<break/>Mean speed (MS)<break/># of collisions</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">2003</td><td colspan="1" rowspan="1">Partinen, M</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">49.5</td><td colspan="1" rowspan="1">35&#8211;60</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Average lateral position (ALP)<break/>Average reaction time (ART)<break/>Mean time to collision (MTTC)</td><td colspan="1" rowspan="1">No driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">Vanakoski, J</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">22&#8211;24</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Cumulative reaction time (CRT)<break/>Tracking error severity index</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">Vanakoski, J</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">55&#8211;77</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Cumulative reaction time (CRT)<break/>Tracking error severity index</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">1994</td><td colspan="1" rowspan="1">Mattila, MJ</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">19&#8211;32</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Cumulative reaction time (CRT)<break/>Tracking error severity index</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1993</td><td colspan="1" rowspan="1">Mattila, MJ</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">22&#8211;26</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1"># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)<break/>Tracking error severity index</td><td colspan="1" rowspan="1">No driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1990</td><td colspan="1" rowspan="1">Tornros, J</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">20&#8211;35</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Braking reaction time (BRT)</td><td colspan="1" rowspan="1">No driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1986</td><td colspan="1" rowspan="1">Smiley, A</td><td colspan="1" rowspan="1">R, DB, PC, Parallel</td><td colspan="1" rowspan="1">48</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">21&#8211;40</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Lane position variability</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1984</td><td colspan="1" rowspan="1">Willumeit, H</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">26.4</td><td colspan="1" rowspan="1">20&#8211;33</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Average reaction time (ART)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1984</td><td colspan="1" rowspan="1">Willumeit, H</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">28</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Average reaction time (ART)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">1978</td><td colspan="1" rowspan="1">Dureman, I</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">19&#8211;30</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Braking reaction time (BRT)<break/>Number of errors in car simulator</td><td colspan="1" rowspan="1">No driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1975</td><td colspan="1" rowspan="1">Dureman, I</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">42</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">19&#8211;29</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Braking reaction time (BRT)<break/>Mean speed (MS)<break/>Steering precision</td><td colspan="1" rowspan="1">No driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1974</td><td colspan="1" rowspan="1">Berry, P A</td><td colspan="1" rowspan="1">R, DB, PC and AC, Parallel</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">25&#8211;44</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Braking reaction time (BRT)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2015</td><td colspan="1" rowspan="1">Stone, BT</td><td colspan="1" rowspan="1">NR, DB, PC, CO</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">25.3</td><td colspan="1" rowspan="1">18&#8211;38</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2011</td><td colspan="1" rowspan="1">Bocca, ML</td><td colspan="1" rowspan="1">NR, DB, PC, AC, CO</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">60.3</td><td colspan="1" rowspan="1">55&#8211;65</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)<break/># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">2009</td><td colspan="1" rowspan="1">Meskali, M</td><td colspan="1" rowspan="1">NR, DB, PC, AC, CO</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">60.3</td><td colspan="1" rowspan="1">55&#8211;65</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Average lateral position (ALP)<break/>Mean speed (MS)<break/># of collisions</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">2001</td><td colspan="1" rowspan="1">T&#246;rnros, J</td><td colspan="1" rowspan="1">NR, Open study, PC, AC, Parallel</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">42</td><td colspan="1" rowspan="1">28&#8211;55</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Braking reaction time (BRT)<break/>Standard deviation of speed (SDS)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">1999</td><td colspan="1" rowspan="1">Bocca, ML</td><td colspan="1" rowspan="1">NR, DB, PC, AC, CO</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">24.5</td><td colspan="1" rowspan="1">20&#8211;30</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Variance of lateral position (VLP)<break/>Variance of velocity (VV)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">1991</td><td colspan="1" rowspan="1">Friedel, B</td><td colspan="1" rowspan="1">NR, Open study, Parallel</td><td colspan="1" rowspan="1">60</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">22&#8211;26</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Braking reaction time (BRT)<break/>Mean speed (MS)<break/>Following distance coefficient of variation (CV)<break/># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)<break/># of collisions</td><td colspan="1" rowspan="1">No driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1982</td><td colspan="1" rowspan="1">Moskowitz, H</td><td colspan="1" rowspan="1">NR, DB, PC, Parallel</td><td colspan="1" rowspan="1">48</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">21&#8211;40</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Standard deviation of speed (SDS)<break/># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1978</td><td colspan="1" rowspan="1">Palva, ES</td><td colspan="1" rowspan="1">NR, DB, PC, CO</td><td colspan="1" rowspan="1">38</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">22.9</td><td colspan="1" rowspan="1">20&#8211;29</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Cumulative reaction time (CRT)<break/>Co-ordination test</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">1974</td><td colspan="1" rowspan="1">Linnoila, M</td><td colspan="1" rowspan="1">NR, DB, PC, Parallel</td><td colspan="1" rowspan="1">70</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">19&#8211;22</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Braking reaction time (BRT)<break/>Mean speed (MS)<break/># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)<break/># of collisions</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">1973</td><td colspan="1" rowspan="1">Linnoila, M</td><td colspan="1" rowspan="1">NR, DB, PC, Parallel</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">19&#8211;21</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1"># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs),<break/># of collisions<break/>Instructions ignored by driver</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="10" rowspan="1">&#8232;&#8232;</td></tr><tr><td colspan="10" rowspan="1"><bold>Simulated driving (computer)</bold></td></tr><tr><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Carter, SG</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">28</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">45</td><td colspan="1" rowspan="1">18&#8211;65</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Braking reaction time (BRT)<break/>Standard deviation of speed (SDS)<break/>% of individuals that crashed</td><td colspan="1" rowspan="1">No driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2017</td><td colspan="1" rowspan="1">Carter</td><td colspan="1" rowspan="1">R, DB, PC, Parallel</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">48</td><td colspan="1" rowspan="1">18&#8211;65</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Braking reaction time (BRT)<break/>Standard deviation of speed (SDS)</td><td colspan="1" rowspan="1">No driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2002</td><td colspan="1" rowspan="1">Ludice, A</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">31</td><td colspan="1" rowspan="1">27&#8211;38</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Speed exceedances<break/>Length of run, infractions, time to collision</td><td colspan="1" rowspan="1">No driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1998</td><td colspan="1" rowspan="1">Mattila, MJ</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">21&#8211;28</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Cumulative reaction time (CRT)<break/>Tracking error severity index</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1994</td><td colspan="1" rowspan="1">Kuitunen, T</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">20&#8211;28</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Cumulative reaction time (CRT)<break/>Tracking error severity index</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1986</td><td colspan="1" rowspan="1">Subhan, Z</td><td colspan="1" rowspan="1">R, DB, CO</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">28&#8211;45</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Average reaction time (ART)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">1976</td><td colspan="1" rowspan="1">Seppala, T</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">37</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Choice reaction test: Mistake Percentage</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">2003</td><td colspan="1" rowspan="1">Berthelon, C</td><td colspan="1" rowspan="1">NR, DB, PC, AC, CO</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">28</td><td colspan="1" rowspan="1">23&#8211;42</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Error rates (ERs)<break/>response times (RTs)<break/>points of subjective equalization (PESs)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">1983</td><td colspan="1" rowspan="1">Willumeit, HP</td><td colspan="1" rowspan="1">NR, DB, PC, AC, CO</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">21&#8211;30</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Cumulative reaction time (CRT)<break/>Choice reaction test</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="10" rowspan="1">&#8232;&#8232;</td></tr><tr><td colspan="10" rowspan="1"><bold>Multiple driving impairment assessment settings</bold></td></tr><tr><td colspan="1" rowspan="1">2013</td><td colspan="1" rowspan="1">Daurat, A</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">29.79</td><td colspan="1" rowspan="1">25&#8211;35</td><td colspan="1" rowspan="1">No</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/># Road exits (REs) or # Inappropriate lane crossings (ILCs) or # lane departures (LDs)</td><td colspan="1" rowspan="1">Driving impairment identified</td></tr><tr><td colspan="1" rowspan="1">1992</td><td colspan="1" rowspan="1">Volkerts E.R</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">26.3</td><td colspan="1" rowspan="1">25&#8211;31</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Standard deviation of lateral position (SDLP)<break/>Average reaction time (ART)<break/>Standard deviation of speed (SDS)</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr><tr><td colspan="1" rowspan="1">1986</td><td colspan="1" rowspan="1">Laurell, H</td><td colspan="1" rowspan="1">R, DB, PC, CO</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">20&#8211;34</td><td colspan="1" rowspan="1">Yes</td><td colspan="1" rowspan="1">Braking reaction time (BRT), Weaving task</td><td colspan="1" rowspan="1">Mixed results - driving impairment identified with some measures</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup>AC: active control; DB: double blind; CO: cross-over; NR: non-randomized; PC: placebo controlled; R: randomized.</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="s0235"><label>Appendix 4</label><title>Experimental studies' impairment measures and medications</title><p id="p0330">
<table-wrap position="anchor" id="t0035" orientation="portrait"><alt-text id="al0050">Unlabelled Table</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1"><hr/></th><th colspan="1" rowspan="1"><hr/></th><th colspan="5" rowspan="1">Impairment measures<hr/></th><th colspan="21" rowspan="1">Medications<hr/></th></tr><tr><th colspan="1" rowspan="1">Author, Year</th><th colspan="1" rowspan="1">Country</th><th colspan="1" rowspan="1">SDLP</th><th colspan="1" rowspan="1">SDS</th><th colspan="1" rowspan="1">RE</th><th colspan="1" rowspan="1">BRT</th><th colspan="1" rowspan="1">Other</th><th colspan="1" rowspan="1">ZC</th><th colspan="1" rowspan="1">DZ</th><th colspan="1" rowspan="1">ZD</th><th colspan="1" rowspan="1">LO</th><th colspan="1" rowspan="1">AL</th><th colspan="1" rowspan="1">LT</th><th colspan="1" rowspan="1">OX</th><th colspan="1" rowspan="1">TM</th><th colspan="1" rowspan="1">FT</th><th colspan="1" rowspan="1">FL</th><th colspan="1" rowspan="1">NT</th><th colspan="1" rowspan="1">TR</th><th colspan="1" rowspan="1">ZA</th><th colspan="1" rowspan="1">BT</th><th colspan="1" rowspan="1">CX</th><th colspan="1" rowspan="1">CB</th><th colspan="1" rowspan="1">CR</th><th colspan="1" rowspan="1">BR</th><th colspan="1" rowspan="1">CL</th><th colspan="1" rowspan="1">EZ</th><th colspan="1" rowspan="1">MX</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Road Driving (traffic)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Randomized controlled trials</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Vermeeren, A 2019</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Jongen, S 2018</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Verster, J 2018</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Vermeeren, A 2016</td><td colspan="1" rowspan="1">Belgium</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Vermeeren, A 2015</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Leufkens, T 2014</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Motak, L 2014</td><td colspan="1" rowspan="1">France</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Leufkens, T 2014</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Verster, J 2014</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Vermeeren, A 2011</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Mets, M 2011</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Ramaekers, JG 2011</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Leufkens, T 2009</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Leufkens, T 2009</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Leufkens, T 2007</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Verster, J 2002</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Verster J 2002</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Vermeeren, A 2002</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">van Laar, M 2001</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Vermeeren, A 1998</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Vermeeren, A 1998</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">O'Hanlon, JF 1995</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">O'Hanlon, JF 1993</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">O'Hanlon, JF 1986</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Schmidt, U 1986</td><td colspan="1" rowspan="1">Germany</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">O'Hanlon, JF 1982</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Biehl, B 1979</td><td colspan="1" rowspan="1">Germany</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Non-randomized controlled trials</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Vinckenbosch, F.R.J. 2021</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">1</td></tr><tr><td colspan="1" rowspan="1">vanderSluiszen, N 2019</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">Leufkens, T 2014</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">3</td></tr><tr><td colspan="1" rowspan="1">O'Hanlon, JF 1995</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">O'Hanlon, JF 1995</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Vermeeren, A 1995</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">vanLaar, M 1992</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Brookhuis, KA 1990</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">deGier, JJ 1981</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Driving course (non-traffic)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Randomized controlled trials</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Boyle, J 2008</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Hindmarch, I 2005</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Mercier-Guyon, C 1999</td><td colspan="1" rowspan="1">France</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Hindmarch, I 1980</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Wetherell, A 1979</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Betts, TA 1972</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Non-randomized controlled trials</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Betts, TA 1982</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Hindmarch, I 1977</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Simulated driving (car)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Randomized controlled trials</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Su, S 2022</td><td colspan="1" rowspan="1">United States &amp; Canada</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Torres, R 2022</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Muehlan, C 2022</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Iwamoto, K 2022</td><td colspan="1" rowspan="1">Japan</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Moller, HJ 2021</td><td colspan="1" rowspan="1">Germany</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Huizinga, RH 2019</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Brown, TL 2018</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Kay, GG 2017</td><td colspan="1" rowspan="1">Canada</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Kay, GG 2016</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Miyata, A 2014</td><td colspan="1" rowspan="1">Japan</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Brown, T 2013</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Sarris, J 2013</td><td colspan="1" rowspan="1">Australia</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Takahashi, M 2010</td><td colspan="1" rowspan="1">Japan</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Otmani, S 2008</td><td colspan="1" rowspan="1">France</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Partinen, M 2003</td><td colspan="1" rowspan="1">Finland</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Vanakoski, J 2000</td><td colspan="1" rowspan="1">Finland</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Vanakoski, J 2000</td><td colspan="1" rowspan="1">Finland</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Mattila, MJ 1994</td><td colspan="1" rowspan="1">Finland</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Mattila, MJ 1993</td><td colspan="1" rowspan="1">Finland</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Tornros, J 1990</td><td colspan="1" rowspan="1">Sweden</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Smiley, A 1986</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Willumeit, H 1984</td><td colspan="1" rowspan="1">Germany</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Willumeit, H 1984</td><td colspan="1" rowspan="1">Germany</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Dureman, I 1978</td><td colspan="1" rowspan="1">Sweden</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Dureman, I 1975</td><td colspan="1" rowspan="1">Sweden</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Berry, PA 1974</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="2" rowspan="1">Non-randomized controlled trials</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Stone, BT 2015</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Bocca, ML 2011</td><td colspan="1" rowspan="1">France</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Meskali, M 2009</td><td colspan="1" rowspan="1">France</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">T&#246;rnros, J 2001</td><td colspan="1" rowspan="1">Sweden</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Bocca, ML 1999</td><td colspan="1" rowspan="1">France</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Friedel, B 1991</td><td colspan="1" rowspan="1">Germany</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Moskowitz, H 1982</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Palva, ES 1978</td><td colspan="1" rowspan="1">Finland</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Linnoila, M 1974</td><td colspan="1" rowspan="1">Finland</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Linnoila, M 1973</td><td colspan="1" rowspan="1">Finland</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="2" rowspan="1">Simulated driving (computer)</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Randomized controlled trials</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Carter, SG 2020</td><td colspan="1" rowspan="1">Australia</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Carter, SG 2017</td><td colspan="1" rowspan="1">Australia</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Ludice, A 2002</td><td colspan="1" rowspan="1">Italy</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Mattila, MJ 1998</td><td colspan="1" rowspan="1">Finland</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Kuitunen, T 1994</td><td colspan="1" rowspan="1">Finland</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Subhan, Z 1986</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Seppala, T 1976</td><td colspan="1" rowspan="1">Finland</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="2" rowspan="1">Non-randomized controlled trials</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Berthelon, C 2003</td><td colspan="1" rowspan="1">France</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Willumeit, H P 1983</td><td colspan="1" rowspan="1">Germany</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="2" rowspan="1">Multiple driving impairment assessment settings</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="2" rowspan="1">Randomized controlled trials</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Daurat, A 2013<xref rid="tf0020" ref-type="table-fn">a</xref></td><td colspan="1" rowspan="1">France</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Volkerts E.R 1992<xref rid="tf0025" ref-type="table-fn">b</xref></td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Laurell, H 1986<xref rid="tf0030" ref-type="table-fn">c</xref></td><td colspan="1" rowspan="1">Sweden</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1">&#10003;</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">Total count</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">54</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">49</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">24</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td></tr></tbody></table><table-wrap-foot><fn><p>Table abbreviations: Impairment measures: SDLP: standard deviation of lateral position; SDS: standard deviation of speed; RE: Number of road exits; BRT: brake reaction time; ZC: zopiclone; DZ: diazepam; ZD: zolpidem; LO: lorazepam; AL: alprazolam; LT: lormetazepam; FT: flunitrazepam; FL: flurazepam; OX: oxazepam; TM: temazepam; TR: triazolam; ZA: zaleplon; NT: nitrazepam; CX: chlordiazepoxide; CB: clobazam; CR: clorazepate; BR: bromazepam; BT: brotizolam; CL: clonazepam; EZ: eszopiclone; MX: Mixed BZRAs; MX1: groups based on BZRA concentration; MX2: groups based on BZRA concentration; MX3: groups based frequency of use.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0020"><label>a</label><p id="np0020">Daurat&#160;=&#160;road traffic and simulated car.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0025"><label>b</label><p id="np0025">Volkerts&#160;=&#160;road traffic and simulated car.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0030"><label>c</label><p id="np0030">Laurell&#160;=&#160;driving course and simulated car</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="s0240"><label>Appendix 5</label><title>Benzodiazepine receptor agonist dose, dose timing, and consecutive days of dosing when assessed in driving studies with placebo comparators</title><p id="p0335">
<table-wrap position="anchor" id="t0040" orientation="portrait"><alt-text id="al0055">Unlabelled Table</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Year of study publication</th><th colspan="1" rowspan="1">First author (surname, initials)</th><th colspan="1" rowspan="1">BZRA</th><th colspan="1" rowspan="1">BZRA dose (mg/24&#160;h)</th><th colspan="1" rowspan="1">BZRA consecutive days of use</th><th colspan="1" rowspan="1">Interval between BZRA administration and assessment of impairment (hrs)</th><th colspan="1" rowspan="1">Diazepam Equivalent dose</th></tr></thead><tbody><tr><td colspan="7" rowspan="1"><bold>Single driving impairment assessment setting</bold></td></tr><tr><td colspan="7" rowspan="1"><bold>Road Driving (traffic)</bold></td></tr><tr><td colspan="1" rowspan="1">1981</td><td colspan="1" rowspan="1">deGier, JJ</td><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td></tr><tr><td colspan="1" rowspan="1">2014</td><td colspan="1" rowspan="1">Leufkens, T</td><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2014</td><td colspan="1" rowspan="1">Leufkens, T</td><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2011</td><td colspan="1" rowspan="1">Mets, M</td><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">8.5</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2014</td><td colspan="1" rowspan="1">Motak, L</td><td colspan="1" rowspan="1">Lorazepam</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1993</td><td colspan="1" rowspan="1">O'Hanlon, JF</td><td colspan="1" rowspan="1">Lorazepam</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1995</td><td colspan="1" rowspan="1">O'Hanlon, JF</td><td colspan="1" rowspan="1">Lorazepam</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">1995</td><td colspan="1" rowspan="1">O'Hanlon, JF</td><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1">1995</td><td colspan="1" rowspan="1">O'Hanlon, JF</td><td colspan="1" rowspan="1">Lorazepam</td><td colspan="1" rowspan="1">1.5</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">7.5</td></tr><tr><td colspan="1" rowspan="1">2011</td><td colspan="1" rowspan="1">Ramaekers, JG</td><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">1992</td><td colspan="1" rowspan="1">vanLaar, M</td><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">28</td><td colspan="1" rowspan="1">1.5</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1">2001</td><td colspan="1" rowspan="1">vanLaar, M</td><td colspan="1" rowspan="1">Lorazepam</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1">1998</td><td colspan="1" rowspan="1">Vermeeren, A</td><td colspan="1" rowspan="1">Flurazepam</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1">2015</td><td colspan="1" rowspan="1">Vermeeren, A</td><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2016</td><td colspan="1" rowspan="1">Vermeeren, A</td><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Vermeeren, A</td><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2002</td><td colspan="1" rowspan="1">Verster, J</td><td colspan="1" rowspan="1">Alprazolam</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="7" rowspan="1">&#8232;&#8232;</td></tr><tr><td colspan="7" rowspan="1"><bold>Driving Course (non-traffic)</bold></td></tr><tr><td colspan="1" rowspan="1">1974</td><td colspan="1" rowspan="1">Berry, PA</td><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1, 2, 3, 4</td><td colspan="1" rowspan="1">2</td></tr><tr><td colspan="1" rowspan="1">1972</td><td colspan="1" rowspan="1">Betts, TA</td><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">36</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">2008</td><td colspan="1" rowspan="1">Boyle, J</td><td colspan="1" rowspan="1">Eszopiclone</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">9.5&#8211;10.25</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2018</td><td colspan="1" rowspan="1">Brown, TL</td><td colspan="1" rowspan="1">Alprazolam</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1977</td><td colspan="1" rowspan="1">Hindmarch, I</td><td colspan="1" rowspan="1">Clobazam</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2005</td><td colspan="1" rowspan="1">Hindmarch, I</td><td colspan="1" rowspan="1">Alprazolam</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">14&#8211;16</td><td colspan="1" rowspan="1">30</td></tr><tr><td colspan="1" rowspan="1">2019</td><td colspan="1" rowspan="1">Huizinga, RH</td><td colspan="1" rowspan="1">Alprazolam</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">Iwamoto, K</td><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2016</td><td colspan="1" rowspan="1">Kay, GG</td><td colspan="1" rowspan="1">Triazolam</td><td colspan="1" rowspan="1">0.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">7.25</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">2017</td><td colspan="1" rowspan="1">Kay, GG</td><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">1974</td><td colspan="1" rowspan="1">Linnoila, M</td><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0.5</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1993</td><td colspan="1" rowspan="1">Mattila, MJ</td><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1.5, 3, 4.5, 6</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1">1994</td><td colspan="1" rowspan="1">Mattila, MJ</td><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1.5, 3.5, 6</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2014</td><td colspan="1" rowspan="1">Miyata, A</td><td colspan="1" rowspan="1">Triazolam</td><td colspan="1" rowspan="1">0.125</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1, 4</td><td colspan="1" rowspan="1">2.5</td></tr><tr><td colspan="1" rowspan="1">2021</td><td colspan="1" rowspan="1">Moller, HJ</td><td colspan="1" rowspan="1">Lorazepam</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1.5</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">1982</td><td colspan="1" rowspan="1">Moskowitz, H</td><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">Muehlan, C</td><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2008</td><td colspan="1" rowspan="1">Otmani, S</td><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">2, 13</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2013</td><td colspan="1" rowspan="1">Sarris, J</td><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1.5</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1986</td><td colspan="1" rowspan="1">Smiley, A</td><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1">2015</td><td colspan="1" rowspan="1">Stone, BT</td><td colspan="1" rowspan="1">Alprazolam</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">Su, S</td><td colspan="1" rowspan="1">Alprazolam</td><td colspan="1" rowspan="1">0.75</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1.5</td><td colspan="1" rowspan="1">7.5</td></tr><tr><td colspan="1" rowspan="1">2010</td><td colspan="1" rowspan="1">Takahashi, M</td><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1, 4</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2001</td><td colspan="1" rowspan="1">T&#246;rnros, J</td><td colspan="1" rowspan="1">BZRA general</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">&#8211;</td></tr><tr><td colspan="1" rowspan="1">2022</td><td colspan="1" rowspan="1">Torres, R</td><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">9.5</td><td colspan="1" rowspan="1">&#8211;</td></tr><tr><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">Vanakoski, J</td><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1.5, 4</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">Vanakoski, J</td><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1.5, 4</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="7" rowspan="1">&#8232;&#8232;</td></tr><tr><td colspan="7" rowspan="1"><bold>Simulated driving (computer)</bold></td></tr><tr><td colspan="1" rowspan="1">2017</td><td colspan="1" rowspan="1">Carter, SG</td><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2020</td><td colspan="1" rowspan="1">Carter, SG</td><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">8.5</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">2002</td><td colspan="1" rowspan="1">Ludice, A</td><td colspan="1" rowspan="1">Lormetazepam</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">1976</td><td colspan="1" rowspan="1">Seppala, T</td><td colspan="1" rowspan="1">Bromazepam</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">0.5, 1, 1.5</td><td colspan="1" rowspan="1">30</td></tr><tr><td colspan="7" rowspan="1">&#8232;&#8232;</td></tr><tr><td colspan="7" rowspan="1"><bold>Multiple driving impairment assessment settings</bold></td></tr><tr><td colspan="1" rowspan="1">2013</td><td colspan="1" rowspan="1">Daurat, A</td><td colspan="1" rowspan="1">Lorazepam</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">10</td></tr></tbody></table></table-wrap>
</p></sec><sec id="s0245"><label>Appendix 6</label><title>Benzodiazepine receptor agonist dose, dose timing, and consecutive days of dosing when assessed in driving studies with multiple active comparators and placebo</title><p id="p0340">
<table-wrap position="anchor" id="t0045" orientation="portrait"><alt-text id="al0060">Unlabelled Table</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Year of study publication</th><th colspan="1" rowspan="1">First author (surname, initials)<xref rid="tf0035" ref-type="table-fn">a</xref></th><th colspan="1" rowspan="1">Active comparators</th><th colspan="1" rowspan="1">BZRA dose (mg/24&#160;h)</th><th colspan="1" rowspan="1">BZRA consecutive days of use</th><th colspan="1" rowspan="1">Interval between BZRA administration and assessment of impairment (hrs)</th><th colspan="1" rowspan="1">Diazepam Equivalent dose</th></tr></thead><tbody><tr><td colspan="7" rowspan="1"><bold>Single driving impairment assessment setting</bold></td></tr><tr><td colspan="7" rowspan="1"><bold>Road Driving (traffic)</bold></td></tr><tr><td colspan="1" rowspan="1">1979</td><td colspan="1" rowspan="1">Biehl, B</td><td colspan="1" rowspan="1">Clobazam</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1990</td><td colspan="1" rowspan="1">Brookhuis, KA</td><td colspan="1" rowspan="1">Flurazepam</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">10&#8211;11, 16&#8211;17</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Lormetazepam</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">10&#8211;11, 16&#8211;17</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Lormetazepam</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">10&#8211;11, 16&#8211;17</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">2018</td><td colspan="1" rowspan="1">Jongen, S</td><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">3.33</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">2007</td><td colspan="1" rowspan="1">Leufkens, T</td><td colspan="1" rowspan="1">Alprazolam XR</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Alprazolam XR</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">2009</td><td colspan="1" rowspan="1">Leufkens, T</td><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2009</td><td colspan="1" rowspan="1">Leufkens, T</td><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2014</td><td colspan="1" rowspan="1">Leufkens, T</td><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">10<break/>20</td><td colspan="1" rowspan="1">1<break/>1</td><td colspan="1" rowspan="1">10<break/>10</td><td colspan="1" rowspan="1">5<break/>10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">3.75<break/>7.5</td><td colspan="1" rowspan="1">1<break/>1</td><td colspan="1" rowspan="1">10<break/>10</td><td colspan="1" rowspan="1">2.5<break/>5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Nitrazepam</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">10<break/>20<break/>50</td><td colspan="1" rowspan="1">1<break/>1<break/>1</td><td colspan="1" rowspan="1">10<break/>10<break/>10</td><td colspan="1" rowspan="1">3.33<break/>6.67<break/>16.67</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Flurazepam</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Clonazepam</td><td colspan="1" rowspan="1">0.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Lormetazepam</td><td colspan="1" rowspan="1">0.5<break/>2</td><td colspan="1" rowspan="1">1<break/>1</td><td colspan="1" rowspan="1">10<break/>10</td><td colspan="1" rowspan="1">2.5<break/>10</td></tr><tr><td colspan="1" rowspan="1">1982</td><td colspan="1" rowspan="1">O'Hanlon, JF</td><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1986</td><td colspan="1" rowspan="1">O'Hanlon, JF</td><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">8&#8211;11, 14&#8211;17</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Nitrazepam</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">8&#8211;11, 14&#8211;17</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">1986</td><td colspan="1" rowspan="1">Schmidt, U</td><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Flunitrazepam</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1995</td><td colspan="1" rowspan="1">Vermeeren, A</td><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10&#8211;11</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Flunitrazepam</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10&#8211;11</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1998</td><td colspan="1" rowspan="1">Vermeeren, A</td><td colspan="1" rowspan="1">Zaleplon</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">5&#8211;6, 10&#8211;11</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zaleplon</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">5&#8211;6, 10&#8211;11</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">5&#8211;6, 10&#8211;11</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2002</td><td colspan="1" rowspan="1">Vermeeren, A</td><td colspan="1" rowspan="1">Zaleplon</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2011</td><td colspan="1" rowspan="1">Vermeeren, A</td><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">3.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">1.75</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">3.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">1.75</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2002</td><td colspan="1" rowspan="1">Verster, J</td><td colspan="1" rowspan="1">Zaleplon</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zaleplon</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">2014</td><td colspan="1" rowspan="1">Verster, J</td><td colspan="1" rowspan="1">Zaleplon</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zaleplon</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">8.5</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2018</td><td colspan="1" rowspan="1">Verster, J</td><td colspan="1" rowspan="1">Zaleplon</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zaleplon</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">8.5</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="7" rowspan="1">&#8232;&#8232;</td></tr><tr><td colspan="7" rowspan="1"><bold>Driving Course (non-traffic)</bold></td></tr><tr><td colspan="1" rowspan="1">1982</td><td colspan="1" rowspan="1">Betts, TA</td><td colspan="1" rowspan="1">Flurazepam</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1998</td><td colspan="1" rowspan="1">Hindmarch, I</td><td colspan="1" rowspan="1">Clobazam</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">0.5</td><td colspan="1" rowspan="1">7.5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Lorazepam</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">0.5</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1">1999</td><td colspan="1" rowspan="1">Mercier-Guyon, C<xref rid="tf0040" ref-type="table-fn">b</xref></td><td colspan="1" rowspan="1">Lorazepam</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="7" rowspan="1">&#8232;&#8232;</td></tr><tr><td colspan="7" rowspan="1"><bold>Simulated driving (car)</bold></td></tr><tr><td colspan="1" rowspan="1">1999</td><td colspan="1" rowspan="1">Bocca, ML</td><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10&#8211;12</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10&#8211;12</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Flunitrazepam</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10&#8211;12</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2011</td><td colspan="1" rowspan="1">Bocca, ML</td><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Flunitrazepam</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">2013</td><td colspan="1" rowspan="1">Brown, T</td><td colspan="1" rowspan="1">Triazolam</td><td colspan="1" rowspan="1">0.125</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">2.5</td><td colspan="1" rowspan="1">2.5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Triazolam</td><td colspan="1" rowspan="1">0.25</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">2.5</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">1975</td><td colspan="1" rowspan="1">Dureman, I</td><td colspan="1" rowspan="1">Clorazepate</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Clorazepate</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Clorazepate</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">1978</td><td colspan="1" rowspan="1">Dureman, I</td><td colspan="1" rowspan="1">Clorazepate</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Clorazepate</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1991</td><td colspan="1" rowspan="1">Friedel, B</td><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">7</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">14</td></tr><tr><td colspan="1" rowspan="1">1973</td><td colspan="1" rowspan="1">Linnoila, M<xref rid="tf0040" ref-type="table-fn">b</xref></td><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0.5</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">2009</td><td colspan="1" rowspan="1">Meskali, M</td><td colspan="1" rowspan="1">Flunitrazepam</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">1978</td><td colspan="1" rowspan="1">Palva, ES</td><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">45</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">0.5, 1, 2.5</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">0.5, 1, 2.5</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">0.5, 1, 2.5</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">2003</td><td colspan="1" rowspan="1">Partinen, M</td><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">5.5</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">5.5</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1990</td><td colspan="1" rowspan="1">T&#246;rnros, J</td><td colspan="1" rowspan="1">Nitrazepam</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">9.5</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Brotizolam</td><td colspan="1" rowspan="1">0.25</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">9.5</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">1984</td><td colspan="1" rowspan="1">Willumeit, H</td><td colspan="1" rowspan="1">Lormetazepam</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1, 2, 3</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1, 2, 3</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1984</td><td colspan="1" rowspan="1">Willumeit, H</td><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">1, 2, 3</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Flurazepam</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">1, 2, 3</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Lormetazepam</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">1, 2, 3</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="7" rowspan="1"><bold>Simulated driving (computer)</bold></td></tr><tr><td colspan="1" rowspan="1">2003</td><td colspan="1" rowspan="1">Berthelon, C</td><td colspan="1" rowspan="1">Flunitrazepam</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">1994</td><td colspan="1" rowspan="1">Kuitunen, T</td><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1.5&#8211;4.5</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1.5&#8211;4.5</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Triazolam</td><td colspan="1" rowspan="1">0.25</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1.5&#8211;4.5</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1">1998</td><td colspan="1" rowspan="1">Mattila, MJ</td><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1, 3.5, 5</td><td colspan="1" rowspan="1">7.5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Zopiclone</td><td colspan="1" rowspan="1">7.5</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1, 3.5, 5</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1, 3.5, 5</td><td colspan="1" rowspan="1">15</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">1, 3.5, 5</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1976</td><td colspan="1" rowspan="1">Seppala, T</td><td colspan="1" rowspan="1">Bromazepam</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">14</td><td colspan="1" rowspan="1">0.5, 1, 1.5</td><td colspan="1" rowspan="1">30</td></tr><tr><td colspan="1" rowspan="1">1986</td><td colspan="1" rowspan="1">Subhan, Z</td><td colspan="1" rowspan="1">Alprazolam</td><td colspan="1" rowspan="1">0.5</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Lorazepam</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1983</td><td colspan="1" rowspan="1">Willumeit, HP</td><td colspan="1" rowspan="1">Lormetazepam</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Flurazepam</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">7</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="7" rowspan="1">&#8232;&#8232;</td></tr><tr><td colspan="7" rowspan="1"><bold>Multiple driving impairment assessment settings</bold></td></tr><tr><td colspan="1" rowspan="1">1986</td><td colspan="1" rowspan="1">Laurell, H</td><td colspan="1" rowspan="1">Triazolam</td><td colspan="1" rowspan="1">0.25</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Nitrazepam</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">10</td></tr><tr><td colspan="1" rowspan="1">1992</td><td colspan="1" rowspan="1">Volkerts, ER</td><td colspan="1" rowspan="1">Lormetazepam</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">10&#8211;11.5</td><td colspan="1" rowspan="1">5</td></tr><tr><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">10&#8211;11.5</td><td colspan="1" rowspan="1">16.67</td></tr></tbody></table><table-wrap-foot><fn id="tf0035"><label>a</label><p id="np0035">Three studies (T&#246;rnros, 2001; van der Sluiszen, 2019; and Vinckenbosch, 2021) grouped BZRAs together and individual data cannot be presented).</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0040"><label>b</label><p id="np0040">Non-BZRAs (e.g., barbiturates, antipsychotics, alcohol, codeine) were used for comparators.</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="s0250"><label>Appendix 7</label><title>Observational studies</title><p id="p0345">
<table-wrap position="anchor" id="t0050" orientation="portrait"><alt-text id="al0065">Unlabelled Table</alt-text><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1">Date, author</th><th colspan="1" rowspan="1">Country</th><th colspan="1" rowspan="1">Observation Period</th><th colspan="1" rowspan="1">Sample<break/>n / mean age (y) / age range (y)</th><th colspan="1" rowspan="1">Description</th><th colspan="1" rowspan="1">Groups</th><th colspan="1" rowspan="1">Drug Identification</th><th colspan="1" rowspan="1">Indicator of impairment</th></tr></thead><tbody><tr><td colspan="8" rowspan="1"><bold>Comparative studies</bold></td></tr><tr><td colspan="8" rowspan="1"><bold>Cohort studies</bold></td></tr><tr><td colspan="1" rowspan="1">2022<break/>Osler, M</td><td colspan="1" rowspan="1">Denmark</td><td colspan="1" rowspan="1">01/2002 to 12/2018</td><td colspan="1" rowspan="1">3,832,588<break/>n/a<break/>&#8805;18</td><td colspan="1" rowspan="1">Cohort study using the Danish Civil Registration System of new users of BZRAs, pregabalin, or melatonin with no previous registered traffic accident followed for incident MVAs.</td><td colspan="1" rowspan="1">New BZRA user: 738,019<break/>No BZRA use: 3,094,569</td><td colspan="1" rowspan="1">Prescription record</td><td colspan="1" rowspan="1">MVA</td></tr><tr><td colspan="1" rowspan="1">2016<break/>Booth, JN</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">10/2008 to 08/2011</td><td colspan="1" rowspan="1">2000<break/>77<break/>&#8805;70</td><td colspan="1" rowspan="1">In-person clinical assessment, interviewer questionnaire, and pill-bottle review of older adult drivers from north-central Alabama who responded to a general mailed invitation for study participants. Focus was on driving risk with z-drug zolpidem.</td><td colspan="1" rowspan="1">Zolpidem users: 75<break/>Controls: 1925</td><td colspan="1" rowspan="1">Pill bottle review</td><td colspan="1" rowspan="1">MVA</td></tr><tr><td colspan="1" rowspan="1">2014<break/>Hoiseth, G</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">03/2012 to 09/2013</td><td colspan="1" rowspan="1">13,225<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Compared probability of being assessed as impaired by CTI based on drug use status: BZRA alone, amphetamine alone, combination of BZRA and amphetamine. Blood samples were collected among apprehended drivers suspected of DWI (drug and alcohol).</td><td colspan="1" rowspan="1">BZRA alone: 196<break/>Amphetamine alone: 322<break/>Combination (BZRA and amphetamine only): 899</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2009<break/>Gustavsen, I</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">01/2000 to 12/2007</td><td colspan="1" rowspan="1">3602<break/>39<break/>19&#8211;88</td><td colspan="1" rowspan="1">Association study of z-drug blood concentration (zopiclone, zolpidem) and level of impairment of Norwegian drivers with only one single drug detected who were apprehended due to suspicion of DUID. Alcohol group of drivers was used as a comparison.</td><td colspan="1" rowspan="1">Z-drug group: 122 (zolpidem 43, zopiclone 79)<break/>Blood test categories: i) possible therapeutic (9/122); ii) moderately elevated (57); iii) highly elevated (56)<break/><break/>Alcohol group: 3480 alcohol-only<break/>Blood alcohol content: i) 0.004&#8211;0.05&#160;%; ii) 0.051&#8211;0.1&#160;%; iii) 0.101&#8211;0.15&#160;%; iv) &gt;0.15&#160;%</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2008<break/>Gustavsen, I</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">01/2004 to 12/2006</td><td colspan="1" rowspan="1">3,100,000<break/>n/a<break/>18&#8211;69</td><td colspan="1" rowspan="1">Comparison of MVA risk involving a personal injury within the 7&#160;days of dispensing z-drugs (zopiclone, zolpidem), nitrazepam, and flunitrazepam of all Norwegian drivers aged 18&#8211;69&#160;years.</td><td colspan="1" rowspan="1">Zopiclone: 28,435 person-years<break/>Zolpidem: 4537 person-years<break/>Nitrazepam: 4549 person-years<break/>Flunitrazepam: 1958 person-years</td><td colspan="1" rowspan="1">Prescription record</td><td colspan="1" rowspan="1">MVA with injury</td></tr><tr><td colspan="1" rowspan="1">2003<break/>Bramness, JG</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">01/1987 to 12/1998</td><td colspan="1" rowspan="1">818<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Assessed relationship between BZRA drug concentration and clinical test for impairment sub-scores using data from Norwegian drivers suspected of being under the influence of non-alcoholic drugs with blood samples containing only one BZRA.</td><td colspan="1" rowspan="1">Therapeutic BZRA concentration: 351 (reference)<break/>Mildly elevated BZRA concentration: 198<break/>Moderately elevated BZRA concentration: 116<break/>Highly elevated BZRA concentration: 153</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2002<break/>Bramness, JG</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">01/1987 to 12/1998</td><td colspan="1" rowspan="1">11,577<break/>32.6<break/>n/a</td><td colspan="1" rowspan="1">Drivers apprehended in Norway for suspected driving under the influence of drugs or alcohol.</td><td colspan="1" rowspan="1">Single benzodiazepine: 818<break/>Alcohol only: 10,759</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2000<break/>Longo, MC</td><td colspan="1" rowspan="1">Australia</td><td colspan="1" rowspan="1">04/1995 to 08/1996</td><td colspan="1" rowspan="1">2500<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Blood samples collected following MVAs in South Australia.</td><td colspan="1" rowspan="1">BZRA detected: 392<break/>Prescription or illicit drug not detected: 1887</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">1998<break/>Neutel, I</td><td colspan="1" rowspan="1">Canada</td><td colspan="1" rowspan="1">01/1979 to 12/1986</td><td colspan="1" rowspan="1">323,658<break/>n/a<break/>&#8805;20</td><td colspan="1" rowspan="1">Association of MVAs in the province of Saskatchewan with dispensing records for five BZRAs (triazolam, flurazepam, oxazepam, lorazepam or diazepam), new starts and repeats, sex, and age.</td><td colspan="1" rowspan="1">BZRA dispensed: 225,796<break/>No BZRA dispensed: 97,862</td><td colspan="1" rowspan="1">Prescription record</td><td colspan="1" rowspan="1">MVA with hospitalization</td></tr><tr><td colspan="1" rowspan="1">1995<break/>Neutel, CI</td><td colspan="1" rowspan="1">Canada</td><td colspan="1" rowspan="1">01/1979 to 12/1986</td><td colspan="1" rowspan="1">323,658<break/>n/a<break/>&#8805;20</td><td colspan="1" rowspan="1">Rate of MVA-related hospitalizations in the province of Saskatchewan with new starts of BZRAs (triazolam, flurazepam, oxazepam, lorazepam or diazepam) within 2&#160;weeks and 4&#160;weeks of new start</td><td colspan="1" rowspan="1">BZRA dispensed: 225,796<break/>No BZRA dispensed: 97,862</td><td colspan="1" rowspan="1">Prescription record</td><td colspan="1" rowspan="1">MVA with hospitalization</td></tr><tr><td colspan="1" rowspan="1">1995<break/>Neutel, CI</td><td colspan="1" rowspan="1">Canada</td><td colspan="1" rowspan="1">01/1979 to 12/1986</td><td colspan="1" rowspan="1">323,658<break/>n/a<break/>&#8805;20</td><td colspan="1" rowspan="1">Compared the risk of hospitalizations due to MVAs in the province of Saskatchewan in association with new starts of BZRA hypnotics, BZRA anxiolytics, and no BZRAs within 1&#160;week, 2&#160;weeks, and 4&#160;weeks of receiving a new prescription in the province of Saskatchewan.</td><td colspan="1" rowspan="1">BZRA hypnotic dispensed: 78,000<break/>BZRA anxiolytic dispensed: 148,000<break/>Controls: 98,000</td><td colspan="1" rowspan="1">Prescription record</td><td colspan="1" rowspan="1">MVA</td></tr><tr><td colspan="1" rowspan="1">1977<break/>Garriott, JC</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">06/1974 to 12/1975</td><td colspan="1" rowspan="1">127<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive analysis of blood, urine, and other biological sample findings of drivers fatally injured in traffic accidents in the Dallas area.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA</td></tr><tr><td colspan="8" rowspan="1">&#8232;&#8232;</td></tr><tr><td colspan="8" rowspan="1"><bold>Case-crossover studies</bold></td></tr><tr><td colspan="1" rowspan="1">2022<break/>Osler, M</td><td colspan="1" rowspan="1">Denmark</td><td colspan="1" rowspan="1">01/2002&#8211;12/2018</td><td colspan="1" rowspan="1">738,019<break/>n/a<break/>&#8805;18</td><td colspan="1" rowspan="1">Case cross-over study using the Danish Civil Registration System of new users of BZRAs, pregabalin, or melatonin with no previous registered traffic accident followed for incident MVAs</td><td colspan="1" rowspan="1">Cases: 738,019 incident MVAs<break/>Controls: 738,019 with 3 selected time periods before MVA period<break/>Exposure period: any BZRA use 100&#160;days prior to incident MVA or during control periods</td><td colspan="1" rowspan="1">Prescription record</td><td colspan="1" rowspan="1">MVA</td></tr><tr><td colspan="1" rowspan="1">2017<break/>Nevriana, A</td><td colspan="1" rowspan="1">Sweden</td><td colspan="1" rowspan="1">02/2006&#8211;12/2009</td><td colspan="1" rowspan="1">26,586<break/>n/a<break/>50&#8211;80</td><td colspan="1" rowspan="1">Case-crossover analysis of Swedish drivers in a first MVA causing injury and suspected of DWI. Individuals were assessed for use of z-drugs (zolpidem, zopiclone). Case period was 4&#160;weeks prior to MVA and an equal period at least 12&#160;weeks earlier.</td><td colspan="1" rowspan="1">Cases: 26,586 MVAs causing injury<break/>Controls: 26,586 no MVA record<break/>Exposure period: 28&#160;days prior to incident MVA or control period</td><td colspan="1" rowspan="1">Prescription record</td><td colspan="1" rowspan="1">MVA with injury<break/>DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2011<break/>Yang, Y</td><td colspan="1" rowspan="1">Taiwan</td><td colspan="1" rowspan="1">01/1998&#8211;12/2004</td><td colspan="1" rowspan="1">12,929<break/>n/a<break/>&#8805;18</td><td colspan="1" rowspan="1">Association study among Taiwanese drivers experiencing hospitalization following a first-time MVA and dispensing of z-drugs (zolpidem, zopiclone), short half-life BZRAs, and long half-life BZRAs.</td><td colspan="1" rowspan="1">Cases: 12,929 MVAs causing hospitalization<break/>Controls: 12,929 3 earlier control periods per subject with no MVA record<break/>Case period: day before MVA and for controls the 91st, 182nd, and 273rd days before the case period<break/>Washout period: 13&#160;weeks between the case period and each of the 3 control periods to reduce the likelihood of overlapping prescriptions between these periods</td><td colspan="1" rowspan="1">Prescription record</td><td colspan="1" rowspan="1">MVA with hospitalization</td></tr><tr><td colspan="1" rowspan="1">1998<break/>Barbone, F</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1">08/1992&#8211;06/1995</td><td colspan="1" rowspan="1">1731<break/>n/a<break/>&#8805;18</td><td colspan="1" rowspan="1">MVA involving police of all Tayside, United Kingdom residents (410,306) attached to a general practitioner. Exposures included 235 BZRAs among 1731 subjects taking psychotropics.</td><td colspan="1" rowspan="1">Cases: 235 MVAs involving police<break/>Controls: 235 no MVA record<break/>Exposure period: day of MVA and up to 18 previous matching weekdays</td><td colspan="1" rowspan="1">Prescription record</td><td colspan="1" rowspan="1">MVA<break/>DWI suspect</td></tr><tr><td colspan="8" rowspan="1">&#8232;&#8232;</td></tr><tr><td colspan="8" rowspan="1"><bold>Case-control studies</bold></td></tr><tr><td colspan="1" rowspan="1">2022<break/>Olesen, AV</td><td colspan="1" rowspan="1">Denmark</td><td colspan="1" rowspan="1">01/1996&#8211;12/2018</td><td colspan="1" rowspan="1">779,844<break/>n/a<break/>&#8805;17</td><td colspan="1" rowspan="1">Analysis of dispensing records of Danish drivers experiencing an MVA resulting in a police-recorded personal injury</td><td colspan="1" rowspan="1">Cases: 129,974 drivers with personal injury from MVA<break/>Controls: 649,870 (5:1 sex-, age-matched)</td><td colspan="1" rowspan="1">Prescription record</td><td colspan="1" rowspan="1">MVA</td></tr><tr><td colspan="1" rowspan="1">2021<break/>Brubacher, JR</td><td colspan="1" rowspan="1">Canada</td><td colspan="1" rowspan="1">01/1997 to 12/2016</td><td colspan="1" rowspan="1">714,944<break/>n/a<break/>&#8805;17</td><td colspan="1" rowspan="1">Drivers in the province of British Columbia with a first MVA that resulted in a police report. Driver accident culpability was categorized as indeterminate, responsible, or not responsible for the MVA. Numerous drugs categories examined, including: long-acting BZRAs, short-acting BZRAs, and z-drugs.</td><td colspan="1" rowspan="1">Cases: 382,685 drivers responsible for MVA<break/>Controls: 332,259 drivers not responsible for MVA</td><td colspan="1" rowspan="1">Prescription record</td><td colspan="1" rowspan="1">MVA<break/>DWI suspect<break/>Culpability assessment</td></tr><tr><td colspan="1" rowspan="1">2021<break/>Asbridge, M</td><td colspan="1" rowspan="1">Canada</td><td colspan="1" rowspan="1">01/2010 to 07/2016</td><td colspan="1" rowspan="1">2318<break/>44<break/>16&#8211;93</td><td colspan="1" rowspan="1">Moderately injured drivers involved in MVAs leading to a police report and emergency visit in the province of British Columbia. Driver culpability was categorized as indeterminate, responsible, or not responsible for the MVA. Blood samples were collected within 6&#160;h of the MVA. BZRA group combined BZRAs and z-drugs.</td><td colspan="1" rowspan="1">Cases: 1178 drivers responsible for MVA<break/>Controls: 647 drivers not responsible for MVA</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA with A&amp;E visit<break/>DWI suspect<break/>Culpability assessment</td></tr><tr><td colspan="1" rowspan="1">2020<break/>Drummer, OH</td><td colspan="1" rowspan="1">Australia</td><td colspan="1" rowspan="1">07/2013 to 06/2018</td><td colspan="1" rowspan="1">4988<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Drivers of MVAs leading to hospital admission or emergency department visit with blood sample collected for toxicology analysis in state of Victoria. Multiple categories of drugs investigated for culpability that were scored as culpable, partial (contributory), or non-culpable.</td><td colspan="1" rowspan="1">Cases: 612 MVA with BZRA detected<break/>Controls: 1837 MVA with no drug substance</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA<break/>DWI suspect<break/>Culpability assessment</td></tr><tr><td colspan="1" rowspan="1">2019<break/>Jamt, R</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">01/2000 to 12/2015</td><td colspan="1" rowspan="1">3639<break/>38<break/>&#8805;18</td><td colspan="1" rowspan="1">Drivers in Finnmark, a northern county of Norway, involved in a MVA and arrested due to suspicion of impaired driving. Blood samples collected at time of arrest. Oral fluid samples collected from controls identified in routine driver survey. <italic toggle="yes">Z</italic>-drug and BZRAs reported: diazepam, clonazepam, alprazolam, zopiclone, oxazepam, flunitrazepam, zolpidem, nitrazepam, phenazepam.</td><td colspan="1" rowspan="1">Cases: 612 MVA arrested suspected DUI (alcohol or drugs)<break/>Controls: 3027 random drivers selected from police roadside survey</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA<break/>DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2017<break/>Nevriana, A</td><td colspan="1" rowspan="1">Sweden</td><td colspan="1" rowspan="1">01/2006 to 12/2009</td><td colspan="1" rowspan="1">135,480<break/>n/a<break/>50&#8211;80</td><td colspan="1" rowspan="1">Older adult drivers of a first MVA with injury suspected of DWI (not due to alcohol). Focus was on zolpidem and zopiclone use. Z-drug exposure groups included: newly initiated use (1&#8211;30&#160;days only); occasional use (1&#8211;2 dispensations 31&#8211;180&#160;days before MVA); frequent use (&gt;2 dispensings within 180&#160;days); and non-Z-drug use (dispensing of other medications); and no medication use.</td><td colspan="1" rowspan="1">Cases: 27,096 with first MVA involving injury<break/>Controls: 108,384 4:1 matched for sex, age, and area of residence</td><td colspan="1" rowspan="1">Prescription record</td><td colspan="1" rowspan="1">MVA<break/>DWI suspect</td></tr><tr><td colspan="1" rowspan="1">1982<break/>Cimbura, G</td><td colspan="1" rowspan="1">Canada</td><td colspan="1" rowspan="1">04/1978 to 03/1979</td><td colspan="1" rowspan="1">401<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive analysis of blood, urine, and other biological sample findings of all drivers fatally injured in traffic accidents in the province of Ontario.</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA</td></tr><tr><td colspan="1" rowspan="1">2015<break/>Fournier, JP</td><td colspan="1" rowspan="1">Canada</td><td colspan="1" rowspan="1">06/1990 to 06/2000</td><td colspan="1" rowspan="1">819,166<break/>n/a<break/>67&#8211;84</td><td colspan="1" rowspan="1">Association between BZRA use and first MVA causing injury or property damage involving older adult drivers of the province of Quebec.</td><td colspan="1" rowspan="1">Cases: 74,503 MVAs with injury or property damage<break/>Controls: 744,663 no MVA</td><td colspan="1" rowspan="1">Prescription record</td><td colspan="1" rowspan="1">MVA</td></tr><tr><td colspan="1" rowspan="1">2014<break/>Bogstrand, ST</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">04/2008 to 03/2009</td><td colspan="1" rowspan="1">12,113<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Assessed drugs associated with being arrested for DWI. Included drivers arrested on suspicion of DWI due to drugs with blood samples collected (with BAC&#160;&lt;&#160;0.2&#160;g/L) and unimpaired drivers randomly selected who provided an oral fluid sample. Reports individual BZRA risks of arrest (e.g., alprazolam, clonazepam, oxazepam, z-drugs (zolpidem, zopiclone)</td><td colspan="1" rowspan="1">Cases: 2738 arrested on suspicion of drugged driving (MVAs, dangerous driving, traffic control stop, citizen reports).<break/>Controls: 9375 randomly selected drivers from normal traffic</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA<break/>DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2014<break/>Johnell, K</td><td colspan="1" rowspan="1">Sweden</td><td colspan="1" rowspan="1">07/2005 to 12/2009</td><td colspan="1" rowspan="1">154,225<break/>n/a<break/>50&#8211;80</td><td colspan="1" rowspan="1">Nationwide Swedish study of older adult drivers with a first MVA and associated injury with police suspicion of DWI (excluding alcohol). Crash and injury data extracted from the Swedish Traffic Accident Data Acquisition (STRADA) register.</td><td colspan="1" rowspan="1">Cases: 30,845 MVAs with injury<break/>Controls: 123,380 matched drivers with no MVA</td><td colspan="1" rowspan="1">Prescription record</td><td colspan="1" rowspan="1">MVA with injury</td></tr><tr><td colspan="1" rowspan="1">1992<break/>Ray, WA</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">01/1984 to 12/1988</td><td colspan="1" rowspan="1">16,262<break/>n/a<break/>65&#8211;84</td><td colspan="1" rowspan="1">Assessed the association between the use of BZRAs and 3 other medication categories and injurious MVAs involving older adult drivers (65&#8211;84&#160;years) in the Tennessee state Medicaid program.</td><td colspan="1" rowspan="1">BZRA only: 2978 person-years<break/>Non-use of psychoactive prescriptions drugs: 21,578 person-years</td><td colspan="1" rowspan="1">Prescription record</td><td colspan="1" rowspan="1">Fatal MVA<break/>MVA with hospitalization<break/>MVA with A&amp;E visit</td></tr><tr><td colspan="1" rowspan="1">2013<break/>Chang, CM</td><td colspan="1" rowspan="1">Taiwan</td><td colspan="1" rowspan="1">01/2000 to 12/2009</td><td colspan="1" rowspan="1">36,276<break/>38.4<break/>&#8805;18</td><td colspan="1" rowspan="1">Association study evaluating the relationship between exposure to BDZs (all, short-, long-acting), z-drugs, antidepressants, and antipsychotics and risk of MVAs. Examined risk when medication dispensed within 1&#160;month, 1&#160;week, and 1&#160;day of the MVA.</td><td colspan="1" rowspan="1">Cases: 5183 MVA drivers<break/>Controls: 31,093 matched outpatients with no MVA history</td><td colspan="1" rowspan="1">Prescription record</td><td colspan="1" rowspan="1">MVA</td></tr><tr><td colspan="1" rowspan="1">1993<break/>Gjerde, H</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">01/1989 to 12/1990</td><td colspan="1" rowspan="1">159<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive report of blood sample analysis for alcohol and psychoactive drugs in fatally injured drivers involved in MVAs.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA</td></tr><tr><td colspan="1" rowspan="1">1995<break/>Mercer, GW</td><td colspan="1" rowspan="1">Canada</td><td colspan="1" rowspan="1">10/1990 to 09/1991</td><td colspan="1" rowspan="1">227<break/>36.8<break/>n/a</td><td colspan="1" rowspan="1">Descriptive report using police traffic accident reports and toxicological analysis of blood samples from drivers involved in fatal MVAs in the province of British Columbia.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA</td></tr><tr><td colspan="1" rowspan="1">2000<break/>Gerostamoulos, J</td><td colspan="1" rowspan="1">Australia</td><td colspan="1" rowspan="1">01/1995 to 12/1996</td><td colspan="1" rowspan="1">921<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Responsibility analysis of drivers involved in fatal accidents, categorized as culpable or non-culpable using a validated scoring system. Toxicological information on drug exposure was based on anti-mortem specimen analysis.</td><td colspan="1" rowspan="1">Cases: culpable drivers who were fatally injured in a MVA<break/>Controls: non-culpable drivers who were fatally injured in a MVA</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA<break/>Culpability assessment</td></tr><tr><td colspan="1" rowspan="1">2004<break/>Movig, K</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">05/2000 to 08/2001</td><td colspan="1" rowspan="1">926<break/>38.6<break/>n/a</td><td colspan="1" rowspan="1">Drivers involved in a MVA requiring hospitalization and drivers recruited at random while driving on public roads. Urine of blood samples were obtained from all participants.</td><td colspan="1" rowspan="1">Cases: 110 injured drivers admitted to A&amp;E<break/>Controls: 816 drivers randomly selected for a roadside survey</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA with A&amp;E visit</td></tr><tr><td colspan="1" rowspan="1">2003<break/>Mura, P</td><td colspan="1" rowspan="1">France</td><td colspan="1" rowspan="1">06/2000 to 09/2001</td><td colspan="1" rowspan="1">1800<break/>n/a<break/>&#8805;18</td><td colspan="1" rowspan="1">Comparison of substances in blood samples of drivers injured in road accidents and a matched group of people attending emergency services for non-trauma reasons. Six emergency service sites from across France participated. BZRAs, among other substances, were included in the toxicological screen.</td><td colspan="1" rowspan="1">Cases: 900 drivers involved in a nonfatal MVA attending an A&amp;E centre Controls: 900 patients attending the same A&amp;E centres for any non-traumatic reasons</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA with A&amp;E visit</td></tr><tr><td colspan="1" rowspan="1">2000<break/>Seymour, A</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1">01/1999 to 12/1999</td><td colspan="1" rowspan="1">214<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive analysis of psychoactive drugs identified from blood and urine samples from drivers in police custody suspected DUID and from fatally injured drivers involved in MVAs.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA<break/>DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2000<break/>Longo, MC</td><td colspan="1" rowspan="1">Australia</td><td colspan="1" rowspan="1">04/1995 to 08/1996</td><td colspan="1" rowspan="1">2500<break/>31<break/>n/a</td><td colspan="1" rowspan="1">Culpability analysis using an objective scoring system and measurement of drug concentration (cannabinoids, BZRAs and stimulants) and alcohol content of blood samples of injured drivers attending A&amp;E centres in South Australia following MVAs. Driver responsibility was rates as culpable, contributory, and not culpable.</td><td colspan="1" rowspan="1">Cases: 55&#160;% of 2029 drivers culpable of the MVA<break/>Controls: 39&#160;% of 2029 drivers not culpable of the MVA</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA with A&amp;E visit<break/>Culpability assessment</td></tr><tr><td colspan="1" rowspan="1">1997<break/>Hemmelgarn, B</td><td colspan="1" rowspan="1">Canada</td><td colspan="1" rowspan="1">01/1990 to 12/1993</td><td colspan="1" rowspan="1">61,369<break/>n/a<break/>67&#8211;84</td><td colspan="1" rowspan="1">Assessed BZRA prescription records of older adult drivers in the province of Quebec involved in a first MVA resulting in injury per police report compared to individuals with no MVA. BZRAs were categorized by half-life as short- (&#8804;24&#160;h) or long-acting (&gt;24&#160;h).</td><td colspan="1" rowspan="1">Cases: 5579 drivers with a MVA<break/>Controls: 55,790 matched controls with no MVA</td><td colspan="1" rowspan="1">Prescription record</td><td colspan="1" rowspan="1">MVA with injury</td></tr><tr><td colspan="1" rowspan="1">1980<break/>Honkanen, R</td><td colspan="1" rowspan="1">Finland</td><td colspan="1" rowspan="1">04/1977 to 10/1977</td><td colspan="1" rowspan="1">526<break/>35<break/>&#8805;15</td><td colspan="1" rowspan="1">Blood sample analysis collected in A&amp;E of injured drivers involved in MVAs in one urban centre were compared to a random selection of people screened for drugs at gas service stations.</td><td colspan="1" rowspan="1">Cases: 201 injured drivers presenting to a Helsinki emergency departments Controls: 325 drivers randomly selected at service stations</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA with A&amp;E visit</td></tr><tr><td colspan="8" rowspan="1">&#8232;&#8232;</td></tr><tr><td colspan="8" rowspan="1"><bold>Non-comparative studies</bold></td></tr><tr><td colspan="1" rowspan="1">2002<break/>Carmen del Rio, M</td><td colspan="1" rowspan="1">Spain</td><td colspan="1" rowspan="1">01/1991 to 12/2000</td><td colspan="1" rowspan="1">5745<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive analysis of alcohol, illicit drugs, and medicines of fatally injured drivers involved in MVAs.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA</td></tr><tr><td colspan="1" rowspan="1">2022<break/>Favretto, D</td><td colspan="1" rowspan="1">Italy</td><td colspan="1" rowspan="1">01/2014 to 01/2018</td><td colspan="1" rowspan="1">4066<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">A retrospective blood sample analysis of sedative-hypnotic prevalence and concentrations in drivers involved in MVAs admitted to hospital in the province of Padova.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA with hospitalization</td></tr><tr><td colspan="1" rowspan="1">2004<break/>Drummer, OH</td><td colspan="1" rowspan="1">Australia</td><td colspan="1" rowspan="1">01/1990 to 12/1999</td><td colspan="1" rowspan="1">3398<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">MVAs with driver fatalities in 3 Australian states (i.e., Victoria, New South Wales, Western Australia). Responsibility assessment based on validated scale categorized drivers as culpable or non-culpable.</td><td colspan="1" rowspan="1">Cases: 1694 drug- and alcohol-positive fatally injured drivers<break/>Controls: 1704 drug- and alcohol-free fatally injured drivers</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA<break/>Culpability assessment</td></tr><tr><td colspan="1" rowspan="1">2008<break/>Dubois, S</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">01/1993 to 12/2006</td><td colspan="1" rowspan="1">72,026<break/>43.9<break/>n/a</td><td colspan="1" rowspan="1">Fatal crashes (occupant or non-motorist) identified using the United States Fatality Analysis Reporting System database. Excluded drivers with non-zero blood alcohol concentration. Unsafe driver actions used as proxy of responsibility. BZRA categories based on half-life: short: &lt;6&#160;h; intermediate: 6 to &lt;24&#160;h as intermediate; long &gt;24&#160;h.</td><td colspan="1" rowspan="1">Cases: 44,066 drivers with &#8805;1 potentially unsafe driving actions in relation to the crash (e.g., speeding)<break/>Controls: 27,960 no unsafe driver actions recorded</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA</td></tr><tr><td colspan="1" rowspan="1">2020<break/>Christophersen, AS</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">01/2013 to 12/2015</td><td colspan="1" rowspan="1">17,201<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Comparison of BZRA blood concentrations in apprehended drug-impaired drivers and the maximal obtainable steady state concentrations if the drug had been used in accordance with Norwegian Health recommendations. BZRAs were present in 10,248 (60&#160;%) of drivers suspected of DRUID. Reports rates of single-entity BZRAs (clonazepam, diazepam, alprazolam, oxazepam, nitrazepam) and z-drugs (zopiclone, zolpidem).</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2020<break/>Herrera-G&#243;mez, F</td><td colspan="1" rowspan="1">Spain</td><td colspan="1" rowspan="1">10/2018 to 11/2018</td><td colspan="1" rowspan="1">2881<break/>39<break/>16&#8211;84</td><td colspan="1" rowspan="1">Prevalence study for alcohol (breath) and psychoactive drugs (oral fluids) of a representative sample of Spanish drivers. Drivers were randomly selected during normal traffic conditions.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Drivers randomly selected</td></tr><tr><td colspan="1" rowspan="1">2019<break/>Pelletti, G</td><td colspan="1" rowspan="1">Italy</td><td colspan="1" rowspan="1">01/2017 to 03/2018</td><td colspan="1" rowspan="1">1026<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive study of toxicological analysis of blood samples of drivers involved in MVAs in the Bologna area including 53 psychoactive substances (illicit and medical).</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2019<break/>Bunn, T</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">01/2010 to 12/2014</td><td colspan="1" rowspan="1">2235<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Prevalence of alcohol and drugs present in fatally injured drivers in the state of Kentucky.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA</td></tr><tr><td colspan="1" rowspan="1">2009<break/>Alhm, K</td><td colspan="1" rowspan="1">Sweden</td><td colspan="1" rowspan="1">12/2004 to 02/2021</td><td colspan="1" rowspan="1">200<break/>39<break/>14&#8211;82</td><td colspan="1" rowspan="1">Prospective study from northern Sweden of drugs and alcohol identified from blood samples of drivers in a MVA who were hospitalized or fatally injured.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA<break/>MVA with hospitalization</td></tr><tr><td colspan="1" rowspan="1">2018<break/>Carfora, A</td><td colspan="1" rowspan="1">Italy</td><td colspan="1" rowspan="1">01/2009 to 12/2016</td><td colspan="1" rowspan="1">1797<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Toxicological (blood, urine) reports of hospitalized drivers involved in a MVA suspected of DUID.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA with hospitalization</td></tr><tr><td colspan="1" rowspan="1">2017<break/>Hoiseth, G</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">02/2012 to 05/2013</td><td colspan="1" rowspan="1">410<break/>n/a<break/>65&#8211;86</td><td colspan="1" rowspan="1">Prevalence and concentration of single entity z-drugs (zopiclone, zolpidem) and BZRAs (clonazepam, oxazepam, diazepam) measured from blood samples taken from older adult drivers apprehended under suspicion of DUID.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2017<break/>Valen, A</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">01/1990 to 12/2015</td><td colspan="1" rowspan="1">112,348<break/>32<break/>n/a</td><td colspan="1" rowspan="1">Toxicological data from apprehended Norwegian drivers investigated for illicit and psychoactive medicinal drugs.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2009<break/>Sidlo, J</td><td colspan="1" rowspan="1">Slovakia</td><td colspan="1" rowspan="1">01/2000 to 12/2007</td><td colspan="1" rowspan="1">75<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive analysis of 75 cases of road traffic fatalities (drivers and others) under the influence of psychoactive substances (not including alcohol). Includes psychoactive substances identified in fatally injured drivers.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA</td></tr><tr><td colspan="1" rowspan="1">2010<break/>Maxwell, HG</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">01/1993 to 12/2006</td><td colspan="1" rowspan="1">116,510<break/>42<break/>&#8805;20</td><td colspan="1" rowspan="1">Used the United States Fatality Analysis Reporting System to identify fatal crashes (occupant or non-motorist) with &#8805;1 unsafe driver action. BZRAs, identified by blood sample, were grouped as short-, intermediate- and long-acting.</td><td colspan="1" rowspan="1">Cases: 1179 drivers &#8805;1 unsafe driver action (e.g., weaving or speeding) recorded in relation to the fatal MVA<break/>Controls: 70,440 drivers who did not have an unsafe driver action (unsafe driver action; e.g., weaving or speeding) recorded in relation to the fatal MVA</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA</td></tr><tr><td colspan="1" rowspan="1">2012<break/>Poulsen, H</td><td colspan="1" rowspan="1">New Zealand</td><td colspan="1" rowspan="1">07/2004 to 06/2009</td><td colspan="1" rowspan="1">1046<break/>39<break/>14&#8211;92</td><td colspan="1" rowspan="1">Prevalence of alcohol and illicit and psychoactive drugs analysis of blood samples collected immediately after crash in fatally injured drivers involved in MVAs.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA</td></tr><tr><td colspan="1" rowspan="1">2013<break/>Legrand, SA</td><td colspan="1" rowspan="1">Belgium, Denmark, Finland, Italy, Lithuania, Netherlands</td><td colspan="1" rowspan="1">10/2007 to 04/2010</td><td colspan="1" rowspan="1">2492<break/>n/a<break/>&#8805;18</td><td colspan="1" rowspan="1">Analysis and characterization of alcohol and drug presence in blood samples of injured drivers admitted to emergency departments in the six countries involved (Belgium, Denmark, Finland, Italy, Lithuania, Netherlands). Reports rates of single-entity and combination psychoactive drugs for BZRAs and subgroups z-drugs and BZRAs.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA with A&amp;E visit</td></tr><tr><td colspan="1" rowspan="1">2013<break/>Jones, AW</td><td colspan="1" rowspan="1">Sweden</td><td colspan="1" rowspan="1">Not reported</td><td colspan="1" rowspan="1">1000<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Toxicological analysis of blood samples containing both diazepam and nordiazepam to infer rates of therapeutic and non-therapeutic use of diazepam among drivers apprehended under the suspicion of DUID in Sweden.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2013<break/>Jones, AW</td><td colspan="1" rowspan="1">Sweden</td><td colspan="1" rowspan="1">01/2001 to 12/2005</td><td colspan="1" rowspan="1">2205<break/>32<break/>n/a</td><td colspan="1" rowspan="1">Comparison of alprazolam concentration in blood samples from impaired drivers and from forensic autopsies classified as intoxication or other causes of death.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2013<break/>Burch, HJ</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1">02/2010 to 03/2011</td><td colspan="1" rowspan="1">376<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Measured concentrations of drugs in blood samples of drivers suspected DUIDs.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2013<break/>Stephenson, JB</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">03/2010 to 08/2011</td><td colspan="1" rowspan="1">11<break/>27<break/>18&#8211;40</td><td colspan="1" rowspan="1">Case series of 11 phenazepam-positive drivers arrested due to suspicion of impaired driving.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2012<break/>Legrand, SA</td><td colspan="1" rowspan="1">Belgium, Netherlands</td><td colspan="1" rowspan="1">01/2008 to 05/2010</td><td colspan="1" rowspan="1">535<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Analysis and characterization of alcohol and drug presence in blood samples of injured drivers admitted to emergency departments in Belgium and the Netherlands.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA with A&amp;E visit</td></tr><tr><td colspan="1" rowspan="1">2012<break/>Kriikku, P</td><td colspan="1" rowspan="1">Finland, Norway, Portugal, Sweden</td><td colspan="1" rowspan="1">07/2010 to 06/2011</td><td colspan="1" rowspan="1">141<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Blood concentrations of phenazepam in drivers suspected of DUID.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2013<break/>Gjerde, H</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">01/2003 to 12/2010</td><td colspan="1" rowspan="1">9769<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Association study of alcohol and substance use from blood samples among car and van drivers with fatal injuries from MVAs in Norway compared with randomly selected drivers selected from normal traffic conditions who provided oral fluid samples. Risk estimates for BZRAs, diazepam-only, and zopiclone-only.</td><td colspan="1" rowspan="1">Cases: 508 driver fatalities with blood sample collection<break/>Controls: 9261 randomly identified drivers</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA</td></tr><tr><td colspan="1" rowspan="1">2012<break/>Jones, AW</td><td colspan="1" rowspan="1">Sweden</td><td colspan="1" rowspan="1">01/2001 to 12/2010</td><td colspan="1" rowspan="1">7302<break/>41.5<break/>n/a</td><td colspan="1" rowspan="1">Comparison of z-drug (zolpidem and zopiclone) concentrations in blood samples from impaired drivers and from forensic autopsies classified as intoxication or other causes of death.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2011<break/>Blencowe, T</td><td colspan="1" rowspan="1">Finland</td><td colspan="1" rowspan="1">05/2004 to 12/2008</td><td colspan="1" rowspan="1">224<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Testing of new oral sample technology to identify BZRAs and other drugs in cases of suspected DUID.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2010<break/>Senna, MC</td><td colspan="1" rowspan="1">Switzerland</td><td colspan="1" rowspan="1">01/2005 to 12/2005</td><td colspan="1" rowspan="1">4794<break/>31<break/>14&#8211;92</td><td colspan="1" rowspan="1">Nationwide study of blood and urine sample analysis for psychoactive drugs from drivers suspected of DUID (excluding drivers considered to be under the influence of alcohol).</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2009<break/>Kulikowska, J</td><td colspan="1" rowspan="1">Poland</td><td colspan="1" rowspan="1">01/1997 to 12/2007</td><td colspan="1" rowspan="1">785<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive analysis of psychoactive drugs identified from blood samples of drivers causing MVAs.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA</td></tr><tr><td colspan="1" rowspan="1">2014<break/>Legrand, S</td><td colspan="1" rowspan="1">Finland, Norway, Portugal, Sweden</td><td colspan="1" rowspan="1">01/2006 to 12/2009</td><td colspan="1" rowspan="1">1118<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Prevalence of alcohol, illicit drugs and psychoactive medicines in fatally injured drivers in four European countries (Finland, Norway, Portugal, Sweden). Reports poly- and single-entity BZRAs and z-drug fatalities per country.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA</td></tr><tr><td colspan="1" rowspan="1">2014<break/>Szeremeta, M</td><td colspan="1" rowspan="1">Poland</td><td colspan="1" rowspan="1">01/2010 to 12/2011</td><td colspan="1" rowspan="1">274<break/>28.6<break/>17&#8211;69</td><td colspan="1" rowspan="1">Report of psychoactive medicines and substances identified in blood samples of drivers who died as the result of an MVA, survived an MVA, or were engaged in a roadside survey.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA<break/>MVA</td></tr><tr><td colspan="1" rowspan="1">2008<break/>Smink, BE</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">01/1999 to 12/2004</td><td colspan="1" rowspan="1">171<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive retrospective descriptive study of driver impairment characteristics based on BZRA blood concentration taken at the time of apprehension for suspected DUID. BZRA concentration categories were: subtherapeutic, therapeutic, and elevated.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2008<break/>Christophersen, AS</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">01/2004 to 12/2004</td><td colspan="1" rowspan="1">796<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Drug concentration analysis of BZRAs in Norwegian drivers suspected of DUID.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2007<break/>Ch'ng, CW</td><td colspan="1" rowspan="1">Australia</td><td colspan="1" rowspan="1">12/2000 to 04/2002</td><td colspan="1" rowspan="1">436<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive analysis of psychoactive drugs identified from blood samples taken from drivers presenting to an emergency trauma centre following a MVA in the state of Victoria.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA with A&amp;E visit</td></tr><tr><td colspan="1" rowspan="1">2006<break/>Bramness, JG</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">01/1987 to 02/2003</td><td colspan="1" rowspan="1">415<break/>30<break/>n/a</td><td colspan="1" rowspan="1">Descriptive report of DUID cases in which flunitrazepam was detected from blood samples as the only psychoactive drug present.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2005<break/>Bernhoft, IM</td><td colspan="1" rowspan="1">Denmark</td><td colspan="1" rowspan="1">11/2002 to 03/2004</td><td colspan="1" rowspan="1">379<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Analysis of drugs identified from saliva and blood samples obtained from injured drivers involved in MVAs presenting to hospital emergency departments.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA with A&amp;E visit</td></tr><tr><td colspan="1" rowspan="1">2005<break/>Smink, BE</td><td colspan="1" rowspan="1">Netherlands</td><td colspan="1" rowspan="1">10/1998 to 09/1999</td><td colspan="1" rowspan="1">993<break/>35<break/>15&#8211;90</td><td colspan="1" rowspan="1">An analysis to assess the relationship between exposure to different classes of psychoactive drugs (alcohol, illicit drugs, medicines) and accident severity (severe: hospitalization or death) of drivers involved in MVAs from whom blood samples were obtained.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA</td></tr><tr><td colspan="1" rowspan="1">2005<break/>Olszowy, Z</td><td colspan="1" rowspan="1">Poland</td><td colspan="1" rowspan="1">01/1997 to 12/2003</td><td colspan="1" rowspan="1">157<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Drug analysis of blood samples taken from drivers suspected of DUID.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2004<break/>Jones, AW</td><td colspan="1" rowspan="1">Sweden</td><td colspan="1" rowspan="1">01/2001 to 12/2002</td><td colspan="1" rowspan="1">94<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Retrospective descriptive analysis of drivers arrested for DUID with diazepam and nordiazepam identified from blood samples.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2002<break/>Skurtveit, S</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">01/1995 to 12/1995</td><td colspan="1" rowspan="1">3343<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive analysis of driver and drug characteristics of people apprehended for suspected DUID in which a BZRA was identified by blood sample.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2016<break/>Al-Abdallat, IM</td><td colspan="1" rowspan="1">Jordan</td><td colspan="1" rowspan="1">01/2008 to 12/2014</td><td colspan="1" rowspan="1">68<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Prevalence data of alcohol and psychotropic drugs in fatally injured drivers involved in a MVA in Jordan.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA</td></tr><tr><td colspan="1" rowspan="1">2001<break/>Logan, BK</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">01/1997 to 12/1999</td><td colspan="1" rowspan="1">29<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive report of drivers in Washington state arrested for DUID in which zolpidem was identified alone or in combination with other psychoactive substances.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2016<break/>Drummer, OH</td><td colspan="1" rowspan="1">Australia</td><td colspan="1" rowspan="1">01/2000 to 12/2013</td><td colspan="1" rowspan="1">2638<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Fatally injured drivers involved in MVAs in state of Victoria. Data collected from coroner's office records. Multiple categories of drugs investigated for culpability that were scored as culpable, contributory, or non-culpable.</td><td colspan="1" rowspan="1">Cases: 1263 MVA driver fatalities who were drug- and alcohol-positive (19 cases of BZRA-monotherapy)<break/>Controls: 1105 MVA driver fatalities who were drug- and alcohol-free</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA<break/>Culpability assessment</td></tr><tr><td colspan="1" rowspan="1">1999<break/>Christophersen, AS</td><td colspan="1" rowspan="1">Denmark, Finland, Iceland, Norway, Sweden</td><td colspan="1" rowspan="1">03/1996</td><td colspan="1" rowspan="1">800<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">A 1-week survey for psychoactive drugs including alcohol identified in blood samples of drivers apprehended by police in 5 Nordic (Denmark, Finland, Iceland, Norway, Sweden) countries due to the suspicion of driving while impaired.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">1999<break/>Sybirska, H</td><td colspan="1" rowspan="1">Poland</td><td colspan="1" rowspan="1">1990s</td><td colspan="1" rowspan="1">112<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive report of blood sample results of drug use profiles for drivers involved in MVAs in police custody under suspicion of DUID with negative alcohol screens.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA<break/>DWI suspect</td></tr><tr><td colspan="1" rowspan="1">1999<break/>Ledingham, D</td><td colspan="1" rowspan="1">United Kingdom</td><td colspan="1" rowspan="1">01/1995 to 05/1997</td><td colspan="1" rowspan="1">72<break/>23.3<break/>16&#8211;36</td><td colspan="1" rowspan="1">Descriptive report of psychoactive drugs identified in blood and urine samples of drivers in police custody in south-east Scotland suspected of DUIDs.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2018<break/>Andreuccetti, G</td><td colspan="1" rowspan="1">Brazil</td><td colspan="1" rowspan="1">06/2014 to 12/2015</td><td colspan="1" rowspan="1">365<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Toxicological analyses of blood samples from sudden, unexpected fatalities (including from MVAs).</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA</td></tr><tr><td colspan="1" rowspan="1">1995<break/>Skurtveit, S</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">01/1992 to 12/1993</td><td colspan="1" rowspan="1">5642<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive analysis of alcohol and drug use from blood samples taken from drivers apprehended for suspected DWI.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">1994<break/>Kuitunen, T</td><td colspan="1" rowspan="1">Finland</td><td colspan="1" rowspan="1">01/1977 to 12/1992</td><td colspan="1" rowspan="1">10,976<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Analysis of the association between diazepam and nordiazepam concentrations from blood samples and indications of impairment measured using the 13-item CTD in acute and chronic users of diazepam who were in police custody under suspicion of DUID. The analysis included people who screened negative for all other substances other than diazepam and nordiazepam.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2020<break/>Tsocha, A</td><td colspan="1" rowspan="1">Greece</td><td colspan="1" rowspan="1">01/2015 to 12/2018</td><td colspan="1" rowspan="1">169<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Report of the prevalence of psychoactive drugs detected in blood and urine samples of drivers involved in MVAs, both injurious and fatal, from northern Greece.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA<break/>DWI suspect</td></tr><tr><td colspan="1" rowspan="1">1987<break/>Bjorneboe, A</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">01/1978 to 12/1983</td><td colspan="1" rowspan="1">393<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive analysis of psychoactive drugs identified from blood samples of drivers in police custody under suspicion of DUID.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">1987<break/>Poklis, A</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">06/1983 to 05/1986</td><td colspan="1" rowspan="1">137<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive analysis of psychoactive drugs detected in blood and urine samples taken from drivers apprehended by police who were suspected of driving while impaired who had a negative alcohol screen.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">2021<break/>Schumann, J</td><td colspan="1" rowspan="1">Australia</td><td colspan="1" rowspan="1">07/2006 to 06/2016</td><td colspan="1" rowspan="1">2287<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Prevalence study of alcohol and other drugs (illicit and medications) from biological samples taken from people fatally injured in MVAs in the state of Victoria.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA</td></tr><tr><td colspan="1" rowspan="1">2022<break/>Anzillotti, L</td><td colspan="1" rowspan="1">Italy</td><td colspan="1" rowspan="1">01/2009 to 12/2019</td><td colspan="1" rowspan="1">327<break/>49<break/>n/a</td><td colspan="1" rowspan="1">Descriptive report of blood sample analysis for alcohol and psychoactive drugs in fatally injured drivers involved in MVAs in one region of Italy.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">Fatal MVA</td></tr><tr><td colspan="1" rowspan="1">1976<break/>Garriott, JC</td><td colspan="1" rowspan="1">United States</td><td colspan="1" rowspan="1">06/1973 to 12/1974</td><td colspan="1" rowspan="1">135<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive analysis of blood sample findings of drivers apprehended under the suspicion of DUID (when alcohol ruled out).</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">DWI suspect</td></tr><tr><td colspan="1" rowspan="1">1974<break/>Haffner, J</td><td colspan="1" rowspan="1">Norway</td><td colspan="1" rowspan="1">01/1973 to 12/1973</td><td colspan="1" rowspan="1">74<break/>n/a<break/>n/a</td><td colspan="1" rowspan="1">Descriptive analysis of blood tests for alcohol and diazepam of drivers involved in MVAs and admitted to an Oslo hospital due to their injuries.</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">Biological detection</td><td colspan="1" rowspan="1">MVA with hospitalization</td></tr></tbody></table><table-wrap-foot><fn><p>BZRA: benzodiazepine receptor agonist; DUID: driving under the influence of drugs; DWI: driving while impaired; MVA: motor vehicle accident.</p></fn></table-wrap-foot></table-wrap>
</p></sec><ack id="ac0005"><title>Acknowledgements</title><p id="p0305">We would like to thank Kristy Hancock, who at the time of writing the protocol was at the W.K. Kellogg Health Sciences Library, Dalhousie University, for her assistance developing and running the searches. During the review process, pharmacy students (Ioana Apreutesei, Emilie Pelletier, Tiffany Samaan, Katherine Simon, and Sowon Suh) at Dalhousie University trained in critical appraisal of the literature assisted in supporting aspects of the review (e.g., title and abstract screening, data organization).</p></ack></back></article></pmc-articleset>